Gene Symbol | Gene ID | Gene Info |
---|---|---|
SP3
|
ENSG00000172845.9 | Sp3 transcription factor |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr2_174830769_174830920 | SP3 | 414 | 0.915412 | 0.78 | 1.3e-02 | Click! |
chr2_174695846_174695997 | SP3 | 133026 | 0.054819 | -0.75 | 1.9e-02 | Click! |
chr2_174788209_174788360 | SP3 | 40663 | 0.216534 | -0.75 | 1.9e-02 | Click! |
chr2_174844394_174844545 | SP3 | 14039 | 0.297279 | -0.71 | 3.2e-02 | Click! |
chr2_174918785_174919084 | SP3 | 88504 | 0.091892 | 0.71 | 3.4e-02 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr15_48937816_48938257 | 1.63 |
FBN1 |
fibrillin 1 |
10 |
0.99 |
chr2_145275512_145275663 | 1.50 |
ZEB2-AS1 |
ZEB2 antisense RNA 1 |
77 |
0.56 |
chr17_72984009_72984428 | 1.47 |
CDR2L |
cerebellar degeneration-related protein 2-like |
491 |
0.63 |
chr1_154988213_154988563 | 1.41 |
ZBTB7B |
zinc finger and BTB domain containing 7B |
1464 |
0.18 |
chr22_41843929_41844303 | 1.39 |
TOB2 |
transducer of ERBB2, 2 |
1089 |
0.43 |
chr1_1564281_1564601 | 1.36 |
MIB2 |
mindbomb E3 ubiquitin protein ligase 2 |
572 |
0.55 |
chr22_38392003_38392339 | 1.34 |
ENSG00000264505 |
. |
7370 |
0.1 |
chr17_1655742_1656238 | 1.32 |
SERPINF1 |
serpin peptidase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium derived factor), member 1 |
9263 |
0.1 |
chr11_119561542_119562348 | 1.30 |
ENSG00000199217 |
. |
34924 |
0.14 |
chr19_10981564_10981715 | 1.30 |
CARM1 |
coactivator-associated arginine methyltransferase 1 |
550 |
0.67 |
chr4_85886857_85887120 | 1.29 |
WDFY3 |
WD repeat and FYVE domain containing 3 |
515 |
0.87 |
chr17_79886052_79886276 | 1.28 |
MAFG-AS1 |
MAFG antisense RNA 1 (head to head) |
113 |
0.8 |
chr16_85588898_85589049 | 1.26 |
GSE1 |
Gse1 coiled-coil protein |
56042 |
0.12 |
chr11_65360702_65360944 | 1.24 |
KCNK7 |
potassium channel, subfamily K, member 7 |
149 |
0.83 |
chr10_13889227_13889752 | 1.23 |
FRMD4A |
FERM domain containing 4A |
11423 |
0.24 |
chr10_33624260_33624479 | 1.22 |
NRP1 |
neuropilin 1 |
363 |
0.91 |
chr9_132427553_132427874 | 1.22 |
PRRX2 |
paired related homeobox 2 |
207 |
0.91 |
chr2_175207067_175207382 | 1.20 |
AC018470.1 |
Uncharacterized protein FLJ46347 |
5073 |
0.18 |
chr19_1455635_1455880 | 1.20 |
APC2 |
adenomatosis polyposis coli 2 |
3560 |
0.08 |
chr3_183416191_183416342 | 1.19 |
YEATS2 |
YEATS domain containing 2 |
660 |
0.73 |
chr19_49946307_49946739 | 1.19 |
SLC17A7 |
solute carrier family 17 (vesicular glutamate transporter), member 7 |
906 |
0.28 |
chr10_118501252_118501433 | 1.18 |
HSPA12A |
heat shock 70kDa protein 12A |
743 |
0.71 |
chr9_21802516_21802667 | 1.17 |
MTAP |
methylthioadenosine phosphorylase |
49 |
0.98 |
chr6_37023589_37023822 | 1.17 |
COX6A1P2 |
cytochrome c oxidase subunit VIa polypeptide 1 pseudogene 2 |
11098 |
0.2 |
chr19_13266437_13266669 | 1.17 |
CTC-250I14.6 |
|
1546 |
0.23 |
chr4_1606518_1606669 | 1.16 |
FAM53A |
family with sequence similarity 53, member A |
50542 |
0.12 |
chr17_42386389_42386620 | 1.15 |
RUNDC3A |
RUN domain containing 3A |
540 |
0.42 |
chr7_19156075_19156556 | 1.15 |
TWIST1 |
twist family bHLH transcription factor 1 |
980 |
0.47 |
chr16_54320231_54320412 | 1.14 |
IRX3 |
iroquois homeobox 3 |
354 |
0.91 |
chr1_6209132_6209392 | 1.13 |
CHD5 |
chromodomain helicase DNA binding protein 5 |
30921 |
0.12 |
chr1_155293017_155293168 | 1.13 |
RUSC1 |
RUN and SH3 domain containing 1 |
636 |
0.39 |
chr4_141072389_141072607 | 1.13 |
MAML3 |
mastermind-like 3 (Drosophila) |
1625 |
0.44 |
chr11_76495133_76495321 | 1.12 |
TSKU |
tsukushi, small leucine rich proteoglycan |
35 |
0.95 |
chr2_167232587_167233011 | 1.11 |
SCN9A |
sodium channel, voltage-gated, type IX, alpha subunit |
296 |
0.93 |
chr19_51228108_51228259 | 1.11 |
CLEC11A |
C-type lectin domain family 11, member A |
1403 |
0.27 |
chr4_77227931_77228082 | 1.11 |
FAM47E-STBD1 |
FAM47E-STBD1 readthrough |
827 |
0.62 |
chr1_156470113_156470264 | 1.08 |
MEF2D |
myocyte enhancer factor 2D |
341 |
0.82 |
chr12_103888824_103889067 | 1.08 |
C12orf42 |
chromosome 12 open reading frame 42 |
786 |
0.73 |
chr16_727350_727692 | 1.08 |
RHBDL1 |
rhomboid, veinlet-like 1 (Drosophila) |
1446 |
0.13 |
chr20_30155053_30155349 | 1.07 |
HM13-IT1 |
HM13 intronic transcript 1 (non-protein coding) |
4232 |
0.13 |
chr10_102989742_102989893 | 1.07 |
LBX1 |
ladybird homeobox 1 |
266 |
0.65 |
chr2_71192233_71192438 | 1.07 |
ENSG00000241159 |
. |
366 |
0.69 |
chr2_71693709_71693860 | 1.07 |
DYSF |
dysferlin |
48 |
0.98 |
chr11_63685001_63685428 | 1.06 |
RCOR2 |
REST corepressor 2 |
898 |
0.46 |
chr11_3185463_3185685 | 1.06 |
OSBPL5 |
oxysterol binding protein-like 5 |
79 |
0.96 |
chr5_177665749_177666095 | 1.06 |
PHYKPL |
5-phosphohydroxy-L-lysine phospho-lyase |
6136 |
0.21 |
chr7_94023956_94024240 | 1.05 |
COL1A2 |
collagen, type I, alpha 2 |
225 |
0.96 |
chr17_80274023_80274286 | 1.05 |
CD7 |
CD7 molecule |
1274 |
0.31 |
chr20_62183766_62184103 | 1.05 |
C20orf195 |
chromosome 20 open reading frame 195 |
439 |
0.69 |
chr16_11706407_11706689 | 1.05 |
LITAF |
lipopolysaccharide-induced TNF factor |
14192 |
0.19 |
chr6_36684328_36684602 | 1.05 |
RAB44 |
RAB44, member RAS oncogene family |
1209 |
0.43 |
chr4_81118406_81118599 | 1.04 |
PRDM8 |
PR domain containing 8 |
156 |
0.96 |
chr8_144655209_144655539 | 1.04 |
MROH6 |
maestro heat-like repeat family member 6 |
233 |
0.51 |
chr6_17281167_17281463 | 1.04 |
RBM24 |
RNA binding motif protein 24 |
262 |
0.95 |
chr17_80259260_80259561 | 1.03 |
CD7 |
CD7 molecule |
16018 |
0.1 |
chr8_37889042_37889299 | 1.03 |
EIF4EBP1 |
eukaryotic translation initiation factor 4E binding protein 1 |
1311 |
0.38 |
chr3_184080123_184080481 | 1.03 |
POLR2H |
polymerase (RNA) II (DNA directed) polypeptide H |
101 |
0.9 |
chr1_6485309_6485740 | 1.03 |
ESPN |
espin |
676 |
0.4 |
chr1_215255825_215256068 | 1.03 |
KCNK2 |
potassium channel, subfamily K, member 2 |
521 |
0.89 |
chr17_30333890_30334183 | 1.03 |
LRRC37B |
leucine rich repeat containing 37B |
855 |
0.61 |
chr22_46339641_46339792 | 1.03 |
WNT7B |
wingless-type MMTV integration site family, member 7B |
28879 |
0.15 |
chr1_27468222_27468378 | 1.03 |
SLC9A1 |
solute carrier family 9, subfamily A (NHE1, cation proton antiporter 1), member 1 |
12673 |
0.2 |
chr15_81071526_81071677 | 1.02 |
KIAA1199 |
KIAA1199 |
83 |
0.98 |
chr3_33137793_33137944 | 1.02 |
GLB1 |
galactosidase, beta 1 |
416 |
0.46 |
chr14_21539449_21539600 | 1.02 |
NDRG2 |
NDRG family member 2 |
493 |
0.53 |
chr22_42695306_42695687 | 1.01 |
TCF20 |
transcription factor 20 (AR1) |
44126 |
0.14 |
chr14_99712424_99712575 | 1.01 |
AL109767.1 |
|
16786 |
0.21 |
chr16_30959644_30959858 | 1.01 |
ORAI3 |
ORAI calcium release-activated calcium modulator 3 |
636 |
0.48 |
chr17_76531085_76531470 | 1.01 |
ENSG00000243426 |
. |
2140 |
0.28 |
chr3_50176368_50176664 | 1.01 |
SEMA3F |
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3F |
15962 |
0.12 |
chr16_87838229_87838380 | 1.01 |
RP4-536B24.2 |
|
31834 |
0.13 |
chr15_82336812_82337149 | 1.01 |
ENSG00000222521 |
. |
345 |
0.84 |
chr6_168227030_168227296 | 1.01 |
MLLT4 |
myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 4 |
439 |
0.86 |
chr3_18465405_18465909 | 1.01 |
SATB1 |
SATB homeobox 1 |
408 |
0.87 |
chr4_1753783_1753977 | 1.00 |
TACC3 |
transforming, acidic coiled-coil containing protein 3 |
23749 |
0.13 |
chr18_46501891_46502080 | 1.00 |
SMAD7 |
SMAD family member 7 |
24904 |
0.19 |
chr16_727114_727282 | 1.00 |
RHBDL1 |
rhomboid, veinlet-like 1 (Drosophila) |
1123 |
0.18 |
chr16_57061998_57062263 | 0.99 |
NLRC5 |
NLR family, CARD domain containing 5 |
1339 |
0.36 |
chr8_143875672_143875823 | 0.99 |
LY6D |
lymphocyte antigen 6 complex, locus D |
7739 |
0.1 |
chr7_69063793_69064178 | 0.99 |
AUTS2 |
autism susceptibility candidate 2 |
80 |
0.98 |
chr15_41164512_41164663 | 0.99 |
RHOV |
ras homolog family member V |
1900 |
0.19 |
chr10_134001199_134001495 | 0.99 |
DPYSL4 |
dihydropyrimidinase-like 4 |
943 |
0.54 |
chr5_176857919_176858519 | 0.99 |
GRK6 |
G protein-coupled receptor kinase 6 |
4364 |
0.11 |
chr9_33129582_33129938 | 0.99 |
B4GALT1 |
UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1 |
1563 |
0.35 |
chr17_1082802_1083000 | 0.99 |
ABR |
active BCR-related |
177 |
0.94 |
chr6_151815465_151815858 | 0.98 |
CCDC170 |
coiled-coil domain containing 170 |
486 |
0.81 |
chr12_6643029_6643180 | 0.98 |
GAPDH |
glyceraldehyde-3-phosphate dehydrogenase |
11 |
0.85 |
chr1_3620512_3620701 | 0.98 |
TP73 |
tumor protein p73 |
5984 |
0.12 |
chr10_73723963_73724261 | 0.98 |
CHST3 |
carbohydrate (chondroitin 6) sulfotransferase 3 |
11 |
0.99 |
chr4_9154040_9154333 | 0.98 |
ENSG00000264372 |
. |
15834 |
0.12 |
chr7_4802332_4802483 | 0.98 |
AP5Z1 |
adaptor-related protein complex 5, zeta 1 subunit |
12846 |
0.15 |
chr4_1757900_1758051 | 0.98 |
TACC3 |
transforming, acidic coiled-coil containing protein 3 |
27844 |
0.12 |
chr17_7348880_7349137 | 0.97 |
CHRNB1 |
cholinergic receptor, nicotinic, beta 1 (muscle) |
158 |
0.84 |
chr10_71390210_71390493 | 0.97 |
C10orf35 |
chromosome 10 open reading frame 35 |
51 |
0.98 |
chr3_52002056_52002408 | 0.97 |
PCBP4 |
poly(rC) binding protein 4 |
32 |
0.93 |
chr7_43152736_43153252 | 0.97 |
HECW1 |
HECT, C2 and WW domain containing E3 ubiquitin protein ligase 1 |
750 |
0.6 |
chr3_128720363_128720529 | 0.97 |
EFCC1 |
EF-hand and coiled-coil domain containing 1 |
26 |
0.97 |
chr17_48277708_48277975 | 0.97 |
COL1A1 |
collagen, type I, alpha 1 |
289 |
0.84 |
chr4_779522_779673 | 0.97 |
RP11-440L14.1 |
|
3960 |
0.15 |
chr17_54857835_54858212 | 0.96 |
C17orf67 |
chromosome 17 open reading frame 67 |
35227 |
0.15 |
chr5_1005247_1005480 | 0.96 |
ENSG00000221244 |
. |
1061 |
0.41 |
chr1_31214307_31214682 | 0.96 |
ENSG00000264773 |
. |
2415 |
0.24 |
chr13_37393640_37393791 | 0.96 |
RFXAP |
regulatory factor X-associated protein |
354 |
0.89 |
chr3_184286763_184286975 | 0.96 |
EPHB3 |
EPH receptor B3 |
7297 |
0.2 |
chr12_53719053_53719204 | 0.95 |
AAAS |
achalasia, adrenocortical insufficiency, alacrimia |
586 |
0.6 |
chr9_139000936_139001087 | 0.95 |
C9orf69 |
chromosome 9 open reading frame 69 |
9109 |
0.19 |
chr9_137271552_137271741 | 0.95 |
ENSG00000263897 |
. |
389 |
0.89 |
chr9_130616785_130616936 | 0.95 |
ENG |
endoglin |
55 |
0.94 |
chrX_39964958_39965304 | 0.95 |
BCOR |
BCL6 corepressor |
8475 |
0.32 |
chr9_138999867_139000258 | 0.95 |
C9orf69 |
chromosome 9 open reading frame 69 |
10058 |
0.19 |
chr22_47056423_47056825 | 0.95 |
GRAMD4 |
GRAM domain containing 4 |
2380 |
0.36 |
chr19_45667322_45667563 | 0.94 |
NKPD1 |
NTPase, KAP family P-loop domain containing 1 |
4034 |
0.12 |
chr3_196755651_196755899 | 0.94 |
MFI2 |
antigen p97 (melanoma associated) identified by monoclonal antibodies 133.2 and 96.5 |
883 |
0.59 |
chr12_49182159_49182371 | 0.94 |
ADCY6 |
adenylate cyclase 6 |
555 |
0.61 |
chr2_95941109_95941447 | 0.94 |
PROM2 |
prominin 2 |
1033 |
0.58 |
chr10_31609488_31609880 | 0.93 |
ENSG00000237036 |
. |
308 |
0.56 |
chr17_42299223_42299469 | 0.93 |
RP5-882C2.2 |
|
63 |
0.8 |
chr3_149375939_149376119 | 0.93 |
WWTR1-AS1 |
WWTR1 antisense RNA 1 |
32 |
0.63 |
chr4_775014_775218 | 0.93 |
RP11-440L14.1 |
|
502 |
0.7 |
chr1_242688135_242688482 | 0.93 |
PLD5 |
phospholipase D family, member 5 |
310 |
0.95 |
chr19_14184872_14185147 | 0.93 |
hsa-mir-1199 |
hsa-mir-1199 |
615 |
0.53 |
chr4_142558013_142558295 | 0.93 |
IL15 |
interleukin 15 |
54 |
0.99 |
chr11_834729_834935 | 0.93 |
CD151 |
CD151 molecule (Raph blood group) |
40 |
0.92 |
chr17_73996453_73996604 | 0.92 |
CDK3 |
cyclin-dependent kinase 3 |
459 |
0.68 |
chr16_85369002_85369321 | 0.92 |
RP11-680G10.1 |
Uncharacterized protein |
21908 |
0.2 |
chr2_111880585_111880736 | 0.92 |
BCL2L11 |
BCL2-like 11 (apoptosis facilitator) |
413 |
0.88 |
chr6_83073756_83074156 | 0.92 |
TPBG |
trophoblast glycoprotein |
5 |
0.99 |
chr12_26985476_26985627 | 0.92 |
ITPR2 |
inositol 1,4,5-trisphosphate receptor, type 2 |
163 |
0.97 |
chr19_7746061_7746212 | 0.92 |
TRAPPC5 |
trafficking protein particle complex 5 |
371 |
0.7 |
chr4_7043959_7044306 | 0.92 |
TADA2B |
transcriptional adaptor 2B |
506 |
0.46 |
chr11_10952893_10953186 | 0.92 |
ZBED5-AS1 |
ZBED5 antisense RNA 1 |
66231 |
0.1 |
chr10_124907717_124907868 | 0.92 |
HMX2 |
H6 family homeobox 2 |
154 |
0.95 |
chr17_54673284_54673519 | 0.91 |
NOG |
noggin |
2341 |
0.43 |
chr11_118889854_118890205 | 0.91 |
ENSG00000266398 |
. |
375 |
0.42 |
chr17_48278292_48278683 | 0.91 |
COL1A1 |
collagen, type I, alpha 1 |
506 |
0.68 |
chr8_81490427_81490652 | 0.91 |
ENSG00000223327 |
. |
7469 |
0.23 |
chr17_73840969_73841154 | 0.91 |
UNC13D |
unc-13 homolog D (C. elegans) |
263 |
0.81 |
chr9_139891354_139891734 | 0.91 |
CLIC3 |
chloride intracellular channel 3 |
289 |
0.72 |
chr7_917217_917368 | 0.91 |
GET4 |
golgi to ER traffic protein 4 homolog (S. cerevisiae) |
250 |
0.9 |
chr1_6532391_6532542 | 0.91 |
TNFRSF25 |
tumor necrosis factor receptor superfamily, member 25 |
6211 |
0.12 |
chr12_90101557_90101708 | 0.91 |
ATP2B1 |
ATPase, Ca++ transporting, plasma membrane 1 |
976 |
0.58 |
chr12_54783002_54783412 | 0.91 |
ZNF385A |
zinc finger protein 385A |
1858 |
0.19 |
chr19_42463079_42463289 | 0.91 |
RABAC1 |
Rab acceptor 1 (prenylated) |
118 |
0.95 |
chr9_95499833_95500389 | 0.91 |
BICD2 |
bicaudal D homolog 2 (Drosophila) |
26983 |
0.17 |
chr1_36771499_36771945 | 0.90 |
SH3D21 |
SH3 domain containing 21 |
266 |
0.89 |
chr21_37508205_37508500 | 0.90 |
CBR3 |
carbonyl reductase 3 |
1142 |
0.37 |
chr9_132113946_132114209 | 0.90 |
ENSG00000242281 |
. |
18663 |
0.21 |
chr6_41395432_41395618 | 0.90 |
ENSG00000238867 |
. |
72338 |
0.08 |
chr18_23670867_23671186 | 0.90 |
SS18 |
synovial sarcoma translocation, chromosome 18 |
130 |
0.97 |
chr1_71513323_71513584 | 0.90 |
PTGER3 |
prostaglandin E receptor 3 (subtype EP3) |
18 |
0.95 |
chr19_1767662_1767813 | 0.90 |
ONECUT3 |
one cut homeobox 3 |
15365 |
0.11 |
chr7_97914536_97914851 | 0.90 |
BRI3 |
brain protein I3 |
3706 |
0.21 |
chr1_2374491_2374772 | 0.90 |
PLCH2 |
phospholipase C, eta 2 |
17212 |
0.1 |
chr2_54557855_54558006 | 0.89 |
C2orf73 |
chromosome 2 open reading frame 73 |
109 |
0.98 |
chr22_20849036_20849458 | 0.89 |
KLHL22 |
kelch-like family member 22 |
835 |
0.33 |
chr4_55523598_55523834 | 0.89 |
KIT |
v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog |
369 |
0.93 |
chr1_167424277_167424611 | 0.89 |
RP11-104L21.2 |
|
3454 |
0.27 |
chr1_155163105_155163422 | 0.89 |
MUC1 |
mucin 1, cell surface associated |
557 |
0.42 |
chr12_67463577_67463927 | 0.89 |
CAND1 |
cullin-associated and neddylation-dissociated 1 |
199309 |
0.03 |
chr20_4152983_4153134 | 0.89 |
SMOX |
spermine oxidase |
701 |
0.72 |
chr8_144099332_144099749 | 0.89 |
LY6E |
lymphocyte antigen 6 complex, locus E |
141 |
0.96 |
chr2_85360155_85360383 | 0.88 |
TCF7L1 |
transcription factor 7-like 1 (T-cell specific, HMG-box) |
264 |
0.93 |
chr16_88878537_88878783 | 0.88 |
APRT |
adenine phosphoribosyltransferase |
308 |
0.79 |
chr4_141073512_141073663 | 0.88 |
MAML3 |
mastermind-like 3 (Drosophila) |
536 |
0.82 |
chr3_150421131_150421314 | 0.88 |
RP11-103G8.2 |
|
129 |
0.84 |
chr7_138720207_138720441 | 0.88 |
ZC3HAV1L |
zinc finger CCCH-type, antiviral 1-like |
451 |
0.85 |
chr2_72370399_72370550 | 0.88 |
CYP26B1 |
cytochrome P450, family 26, subfamily B, polypeptide 1 |
261 |
0.96 |
chr19_51412625_51412842 | 0.87 |
KLK4 |
kallikrein-related peptidase 4 |
149 |
0.9 |
chr19_1455205_1455403 | 0.87 |
APC2 |
adenomatosis polyposis coli 2 |
3107 |
0.09 |
chr10_28032089_28032240 | 0.87 |
MKX |
mohawk homeobox |
310 |
0.87 |
chr16_27879052_27879203 | 0.87 |
ENSG00000212382 |
. |
4555 |
0.25 |
chr7_1706254_1706638 | 0.87 |
ELFN1 |
extracellular leucine-rich repeat and fibronectin type III domain containing 1 |
21309 |
0.17 |
chr10_15130737_15130888 | 0.87 |
ACBD7 |
acyl-CoA binding domain containing 7 |
37 |
0.97 |
chr13_24153750_24153949 | 0.87 |
TNFRSF19 |
tumor necrosis factor receptor superfamily, member 19 |
330 |
0.93 |
chr10_103329534_103329705 | 0.87 |
DPCD |
deleted in primary ciliary dyskinesia homolog (mouse) |
787 |
0.61 |
chr17_8025338_8025489 | 0.87 |
HES7 |
hes family bHLH transcription factor 7 |
1989 |
0.15 |
chr19_41700111_41700281 | 0.87 |
CYP2S1 |
cytochrome P450, family 2, subfamily S, polypeptide 1 |
1044 |
0.4 |
chr1_53386842_53387121 | 0.87 |
ECHDC2 |
enoyl CoA hydratase domain containing 2 |
395 |
0.76 |
chr9_140205856_140206007 | 0.87 |
NRARP |
NOTCH-regulated ankyrin repeat protein |
9228 |
0.1 |
chr17_46675290_46675535 | 0.86 |
HOXB-AS3 |
HOXB cluster antisense RNA 3 |
1611 |
0.15 |
chr17_27918013_27918164 | 0.86 |
RP11-68I3.7 |
|
1171 |
0.2 |
chr11_370113_370264 | 0.86 |
B4GALNT4 |
beta-1,4-N-acetyl-galactosaminyl transferase 4 |
384 |
0.72 |
chr16_2040564_2040867 | 0.86 |
SYNGR3 |
synaptogyrin 3 |
410 |
0.54 |
chr17_35293439_35293727 | 0.86 |
RP11-445F12.1 |
|
338 |
0.59 |
chr6_143267830_143268235 | 0.86 |
HIVEP2 |
human immunodeficiency virus type I enhancer binding protein 2 |
1694 |
0.46 |
chr19_42444720_42444954 | 0.85 |
ARHGEF1 |
Rho guanine nucleotide exchange factor (GEF) 1 |
17591 |
0.12 |
chr16_31153489_31153640 | 0.85 |
PRSS8 |
protease, serine, 8 |
6481 |
0.07 |
chr4_8858997_8859229 | 0.85 |
RP13-582L3.4 |
|
3440 |
0.28 |
chr4_141490140_141490356 | 0.85 |
UCP1 |
uncoupling protein 1 (mitochondrial, proton carrier) |
289 |
0.9 |
chr1_183119063_183119214 | 0.85 |
RP11-181K3.4 |
|
8721 |
0.22 |
chr19_45753774_45754062 | 0.85 |
MARK4 |
MAP/microtubule affinity-regulating kinase 4 |
598 |
0.65 |
chr10_62703240_62703501 | 0.85 |
RHOBTB1 |
Rho-related BTB domain containing 1 |
635 |
0.8 |
chr19_31830295_31831113 | 0.85 |
AC007796.1 |
|
9083 |
0.25 |
chr16_31487672_31488016 | 0.85 |
TGFB1I1 |
transforming growth factor beta 1 induced transcript 1 |
3097 |
0.12 |
chr2_172379149_172379300 | 0.85 |
CYBRD1 |
cytochrome b reductase 1 |
237 |
0.95 |
chr19_30717911_30718429 | 0.85 |
ZNF536 |
zinc finger protein 536 |
1251 |
0.42 |
chr1_203044798_203045050 | 0.85 |
MYOG |
myogenin (myogenic factor 4) |
10240 |
0.13 |
chr16_89188787_89189003 | 0.85 |
CTD-2555A7.3 |
|
7208 |
0.16 |
chr5_134871706_134871930 | 0.85 |
NEUROG1 |
neurogenin 1 |
179 |
0.95 |
chr19_50312509_50312661 | 0.85 |
AC006942.4 |
|
395 |
0.53 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.0 | 3.1 | GO:0021798 | forebrain dorsal/ventral pattern formation(GO:0021798) |
1.0 | 3.1 | GO:0043578 | nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
1.0 | 4.0 | GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
0.9 | 2.8 | GO:0019372 | lipoxygenase pathway(GO:0019372) |
0.9 | 0.9 | GO:0048145 | regulation of fibroblast proliferation(GO:0048145) |
0.9 | 2.7 | GO:0046137 | negative regulation of calcidiol 1-monooxygenase activity(GO:0010956) negative regulation of vitamin D biosynthetic process(GO:0010957) negative regulation of vitamin metabolic process(GO:0046137) |
0.9 | 2.7 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
0.9 | 7.0 | GO:0021527 | spinal cord association neuron differentiation(GO:0021527) |
0.9 | 2.6 | GO:0061030 | epithelial cell differentiation involved in mammary gland alveolus development(GO:0061030) |
0.9 | 5.3 | GO:0032464 | positive regulation of protein homooligomerization(GO:0032464) |
0.9 | 4.4 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
0.9 | 3.4 | GO:0042483 | negative regulation of odontogenesis(GO:0042483) |
0.8 | 3.2 | GO:0014012 | peripheral nervous system axon regeneration(GO:0014012) |
0.8 | 2.3 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
0.8 | 0.8 | GO:0010803 | regulation of tumor necrosis factor-mediated signaling pathway(GO:0010803) |
0.8 | 4.6 | GO:0042487 | regulation of odontogenesis of dentin-containing tooth(GO:0042487) |
0.7 | 0.7 | GO:0015802 | basic amino acid transport(GO:0015802) |
0.7 | 2.9 | GO:0018101 | protein citrullination(GO:0018101) |
0.7 | 2.2 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
0.7 | 2.1 | GO:0001705 | ectoderm formation(GO:0001705) |
0.7 | 0.7 | GO:0043113 | receptor clustering(GO:0043113) |
0.7 | 2.8 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
0.7 | 0.7 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
0.7 | 2.1 | GO:0010159 | specification of organ position(GO:0010159) |
0.7 | 3.4 | GO:0090205 | positive regulation of cholesterol metabolic process(GO:0090205) |
0.7 | 2.7 | GO:0036072 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.7 | 1.3 | GO:0072160 | nephron tubule epithelial cell differentiation(GO:0072160) regulation of nephron tubule epithelial cell differentiation(GO:0072182) regulation of epithelial cell differentiation involved in kidney development(GO:2000696) |
0.7 | 2.0 | GO:0001743 | optic placode formation(GO:0001743) |
0.6 | 1.9 | GO:1900116 | sequestering of extracellular ligand from receptor(GO:0035581) sequestering of TGFbeta in extracellular matrix(GO:0035583) protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) extracellular regulation of signal transduction(GO:1900115) extracellular negative regulation of signal transduction(GO:1900116) |
0.6 | 1.9 | GO:0010761 | fibroblast migration(GO:0010761) |
0.6 | 1.8 | GO:0071421 | manganese ion transmembrane transport(GO:0071421) |
0.6 | 1.8 | GO:0060999 | positive regulation of dendritic spine development(GO:0060999) |
0.6 | 1.2 | GO:0060340 | positive regulation of type I interferon-mediated signaling pathway(GO:0060340) |
0.6 | 2.3 | GO:0009912 | auditory receptor cell fate commitment(GO:0009912) inner ear receptor cell fate commitment(GO:0060120) |
0.6 | 3.4 | GO:0060317 | cardiac epithelial to mesenchymal transition(GO:0060317) |
0.6 | 2.8 | GO:0042415 | norepinephrine metabolic process(GO:0042415) |
0.6 | 1.7 | GO:0060584 | regulation of prostaglandin-endoperoxide synthase activity(GO:0060584) positive regulation of prostaglandin-endoperoxide synthase activity(GO:0060585) |
0.6 | 1.7 | GO:0002693 | positive regulation of cellular extravasation(GO:0002693) |
0.6 | 0.6 | GO:0030851 | granulocyte differentiation(GO:0030851) |
0.6 | 1.7 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
0.6 | 1.7 | GO:2000380 | regulation of mesodermal cell fate specification(GO:0042661) regulation of mesoderm development(GO:2000380) |
0.6 | 4.4 | GO:1902668 | negative regulation of axon guidance(GO:1902668) |
0.6 | 0.6 | GO:0070059 | intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress(GO:0070059) |
0.5 | 3.3 | GO:0035095 | behavioral response to nicotine(GO:0035095) |
0.5 | 0.5 | GO:0034138 | toll-like receptor 3 signaling pathway(GO:0034138) |
0.5 | 0.5 | GO:2000980 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
0.5 | 3.2 | GO:0035020 | regulation of Rac protein signal transduction(GO:0035020) |
0.5 | 0.5 | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) positive regulation of signal transduction by p53 class mediator(GO:1901798) |
0.5 | 1.6 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.5 | 1.0 | GO:0048319 | axial mesoderm morphogenesis(GO:0048319) |
0.5 | 1.5 | GO:0070295 | renal water absorption(GO:0070295) |
0.5 | 1.5 | GO:0019919 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) |
0.5 | 1.5 | GO:0021819 | layer formation in cerebral cortex(GO:0021819) |
0.5 | 1.5 | GO:0006065 | UDP-glucuronate biosynthetic process(GO:0006065) |
0.5 | 1.0 | GO:0046185 | aldehyde catabolic process(GO:0046185) |
0.5 | 1.5 | GO:0032928 | regulation of superoxide anion generation(GO:0032928) |
0.5 | 2.0 | GO:0019367 | fatty acid elongation, saturated fatty acid(GO:0019367) |
0.5 | 1.5 | GO:0007144 | female meiosis I(GO:0007144) |
0.5 | 1.0 | GO:0072201 | negative regulation of mesenchymal cell proliferation(GO:0072201) |
0.5 | 1.0 | GO:0061526 | acetylcholine secretion, neurotransmission(GO:0014055) regulation of acetylcholine secretion, neurotransmission(GO:0014056) acetylcholine secretion(GO:0061526) |
0.5 | 1.4 | GO:0021516 | dorsal spinal cord development(GO:0021516) |
0.5 | 4.3 | GO:0036296 | response to increased oxygen levels(GO:0036296) response to hyperoxia(GO:0055093) |
0.5 | 3.8 | GO:0046885 | regulation of hormone biosynthetic process(GO:0046885) |
0.5 | 0.5 | GO:0048742 | regulation of skeletal muscle fiber development(GO:0048742) |
0.5 | 1.4 | GO:0015816 | glycine transport(GO:0015816) |
0.5 | 1.4 | GO:0001866 | NK T cell proliferation(GO:0001866) |
0.5 | 1.4 | GO:0046607 | positive regulation of centrosome cycle(GO:0046607) |
0.5 | 1.4 | GO:0034969 | histone arginine methylation(GO:0034969) |
0.5 | 1.8 | GO:0043497 | regulation of protein heterodimerization activity(GO:0043497) |
0.5 | 0.5 | GO:0014049 | positive regulation of glutamate secretion(GO:0014049) |
0.5 | 0.5 | GO:0048170 | positive regulation of long-term neuronal synaptic plasticity(GO:0048170) |
0.5 | 1.4 | GO:0045901 | translational frameshifting(GO:0006452) positive regulation of translational elongation(GO:0045901) positive regulation of translational termination(GO:0045905) |
0.5 | 3.6 | GO:0030903 | notochord development(GO:0030903) |
0.5 | 0.5 | GO:0043392 | negative regulation of DNA binding(GO:0043392) |
0.5 | 0.5 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
0.5 | 1.4 | GO:0035283 | central nervous system segmentation(GO:0035283) brain segmentation(GO:0035284) |
0.4 | 0.9 | GO:0001661 | conditioned taste aversion(GO:0001661) |
0.4 | 2.7 | GO:0031269 | pseudopodium assembly(GO:0031269) regulation of pseudopodium assembly(GO:0031272) positive regulation of pseudopodium assembly(GO:0031274) |
0.4 | 1.3 | GO:0021898 | commitment of multipotent stem cells to neuronal lineage in forebrain(GO:0021898) |
0.4 | 1.3 | GO:0030517 | negative regulation of axon extension(GO:0030517) |
0.4 | 1.8 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
0.4 | 1.3 | GO:0006295 | nucleotide-excision repair, DNA incision, 3'-to lesion(GO:0006295) |
0.4 | 2.2 | GO:0006561 | proline biosynthetic process(GO:0006561) |
0.4 | 1.3 | GO:0032909 | transforming growth factor beta2 production(GO:0032906) regulation of transforming growth factor beta2 production(GO:0032909) |
0.4 | 0.9 | GO:0043589 | skin morphogenesis(GO:0043589) |
0.4 | 0.9 | GO:0045669 | positive regulation of osteoblast differentiation(GO:0045669) |
0.4 | 0.4 | GO:2000040 | planar cell polarity pathway involved in axis elongation(GO:0003402) regulation of establishment of planar polarity involved in neural tube closure(GO:0090178) planar cell polarity pathway involved in neural tube closure(GO:0090179) regulation of planar cell polarity pathway involved in axis elongation(GO:2000040) negative regulation of planar cell polarity pathway involved in axis elongation(GO:2000041) |
0.4 | 0.9 | GO:0072216 | positive regulation of metanephros development(GO:0072216) |
0.4 | 2.2 | GO:0060363 | cranial suture morphogenesis(GO:0060363) craniofacial suture morphogenesis(GO:0097094) |
0.4 | 2.2 | GO:0006975 | DNA damage induced protein phosphorylation(GO:0006975) |
0.4 | 1.3 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.4 | 0.9 | GO:1903019 | negative regulation of glycoprotein metabolic process(GO:1903019) |
0.4 | 1.7 | GO:0046322 | negative regulation of fatty acid oxidation(GO:0046322) |
0.4 | 2.1 | GO:0032957 | inositol trisphosphate metabolic process(GO:0032957) |
0.4 | 1.3 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
0.4 | 0.4 | GO:0060586 | multicellular organismal iron ion homeostasis(GO:0060586) |
0.4 | 0.9 | GO:0002689 | negative regulation of leukocyte chemotaxis(GO:0002689) |
0.4 | 3.0 | GO:0042976 | activation of Janus kinase activity(GO:0042976) |
0.4 | 0.8 | GO:0060748 | tertiary branching involved in mammary gland duct morphogenesis(GO:0060748) |
0.4 | 0.4 | GO:0007172 | signal complex assembly(GO:0007172) |
0.4 | 0.4 | GO:0010629 | negative regulation of gene expression(GO:0010629) |
0.4 | 0.4 | GO:0043092 | L-amino acid import(GO:0043092) |
0.4 | 1.7 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.4 | 0.8 | GO:0072033 | renal vesicle formation(GO:0072033) |
0.4 | 0.4 | GO:0021694 | cerebellar Purkinje cell layer morphogenesis(GO:0021692) cerebellar Purkinje cell layer formation(GO:0021694) cerebellar Purkinje cell differentiation(GO:0021702) |
0.4 | 0.8 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
0.4 | 1.6 | GO:0046618 | drug export(GO:0046618) |
0.4 | 0.4 | GO:0002019 | regulation of renal output by angiotensin(GO:0002019) |
0.4 | 1.2 | GO:0015801 | aromatic amino acid transport(GO:0015801) |
0.4 | 1.6 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
0.4 | 1.2 | GO:0001996 | positive regulation of heart rate by epinephrine-norepinephrine(GO:0001996) |
0.4 | 0.4 | GO:1901419 | regulation of response to alcohol(GO:1901419) |
0.4 | 1.2 | GO:0034063 | stress granule assembly(GO:0034063) |
0.4 | 1.6 | GO:0032693 | negative regulation of interleukin-10 production(GO:0032693) |
0.4 | 0.4 | GO:0061154 | endothelial tube morphogenesis(GO:0061154) |
0.4 | 2.4 | GO:0090103 | cochlea morphogenesis(GO:0090103) |
0.4 | 3.2 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) |
0.4 | 2.4 | GO:0010871 | negative regulation of receptor biosynthetic process(GO:0010871) |
0.4 | 0.4 | GO:0032713 | negative regulation of interleukin-4 production(GO:0032713) |
0.4 | 1.6 | GO:0071480 | cellular response to gamma radiation(GO:0071480) |
0.4 | 2.4 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.4 | 0.4 | GO:0042982 | amyloid precursor protein metabolic process(GO:0042982) |
0.4 | 1.6 | GO:0046831 | regulation of RNA export from nucleus(GO:0046831) |
0.4 | 0.4 | GO:0060897 | neural plate anterior/posterior regionalization(GO:0021999) neural plate regionalization(GO:0060897) |
0.4 | 0.8 | GO:0015809 | arginine transport(GO:0015809) |
0.4 | 0.8 | GO:0098900 | regulation of action potential(GO:0098900) |
0.4 | 1.9 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
0.4 | 2.7 | GO:0051489 | regulation of filopodium assembly(GO:0051489) |
0.4 | 0.8 | GO:0090036 | regulation of protein kinase C signaling(GO:0090036) positive regulation of protein kinase C signaling(GO:0090037) |
0.4 | 0.8 | GO:0032048 | phosphatidylglycerol biosynthetic process(GO:0006655) cardiolipin metabolic process(GO:0032048) cardiolipin biosynthetic process(GO:0032049) phosphatidylglycerol metabolic process(GO:0046471) |
0.4 | 0.4 | GO:0090047 | obsolete positive regulation of transcription regulator activity(GO:0090047) |
0.4 | 0.8 | GO:0021542 | dentate gyrus development(GO:0021542) |
0.4 | 1.2 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
0.4 | 1.1 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
0.4 | 1.5 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
0.4 | 0.4 | GO:0042733 | embryonic digit morphogenesis(GO:0042733) |
0.4 | 0.8 | GO:0006929 | substrate-dependent cell migration(GO:0006929) |
0.4 | 0.8 | GO:0070977 | organ maturation(GO:0048799) bone maturation(GO:0070977) |
0.4 | 2.6 | GO:0071295 | cellular response to vitamin(GO:0071295) |
0.4 | 0.4 | GO:0048318 | axial mesoderm development(GO:0048318) |
0.4 | 0.8 | GO:0032691 | negative regulation of interleukin-1 beta production(GO:0032691) |
0.4 | 3.0 | GO:0042474 | middle ear morphogenesis(GO:0042474) |
0.4 | 1.1 | GO:0000089 | mitotic metaphase(GO:0000089) |
0.4 | 1.5 | GO:0010830 | regulation of myotube differentiation(GO:0010830) |
0.4 | 1.9 | GO:0031062 | positive regulation of histone methylation(GO:0031062) |
0.4 | 1.1 | GO:0045747 | positive regulation of Notch signaling pathway(GO:0045747) |
0.4 | 1.1 | GO:0071816 | protein insertion into ER membrane(GO:0045048) tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
0.4 | 1.8 | GO:0060767 | epithelial cell proliferation involved in prostate gland development(GO:0060767) |
0.4 | 1.8 | GO:0043508 | negative regulation of JUN kinase activity(GO:0043508) |
0.4 | 1.1 | GO:0036037 | CD8-positive, alpha-beta T cell activation(GO:0036037) CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
0.4 | 0.4 | GO:0051974 | negative regulation of telomerase activity(GO:0051974) |
0.4 | 0.4 | GO:0060596 | mammary placode formation(GO:0060596) |
0.4 | 1.1 | GO:0002323 | natural killer cell activation involved in immune response(GO:0002323) natural killer cell degranulation(GO:0043320) |
0.4 | 0.7 | GO:0050765 | negative regulation of phagocytosis(GO:0050765) |
0.4 | 1.1 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
0.4 | 0.4 | GO:0060575 | intestinal epithelial cell differentiation(GO:0060575) |
0.4 | 1.1 | GO:0031536 | positive regulation of exit from mitosis(GO:0031536) |
0.4 | 0.4 | GO:0002726 | positive regulation of T cell cytokine production(GO:0002726) |
0.4 | 0.7 | GO:0050703 | interleukin-1 alpha secretion(GO:0050703) |
0.4 | 1.1 | GO:0035455 | response to interferon-alpha(GO:0035455) |
0.4 | 1.1 | GO:0006167 | AMP biosynthetic process(GO:0006167) |
0.4 | 1.1 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
0.4 | 1.1 | GO:0051497 | negative regulation of stress fiber assembly(GO:0051497) |
0.4 | 0.4 | GO:0022417 | protein maturation by protein folding(GO:0022417) |
0.4 | 1.1 | GO:0006565 | L-serine catabolic process(GO:0006565) |
0.4 | 0.7 | GO:0051541 | elastin metabolic process(GO:0051541) |
0.4 | 1.4 | GO:0042635 | positive regulation of hair cycle(GO:0042635) positive regulation of hair follicle development(GO:0051798) |
0.3 | 0.7 | GO:0045112 | integrin biosynthetic process(GO:0045112) |
0.3 | 0.7 | GO:0051302 | regulation of cell division(GO:0051302) |
0.3 | 1.0 | GO:0050685 | positive regulation of mRNA 3'-end processing(GO:0031442) positive regulation of mRNA processing(GO:0050685) positive regulation of mRNA metabolic process(GO:1903313) |
0.3 | 1.7 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
0.3 | 0.7 | GO:0060054 | positive regulation of epithelial cell proliferation involved in wound healing(GO:0060054) |
0.3 | 2.4 | GO:0009404 | toxin metabolic process(GO:0009404) |
0.3 | 1.7 | GO:0006002 | fructose 6-phosphate metabolic process(GO:0006002) |
0.3 | 1.0 | GO:0046548 | retinal rod cell development(GO:0046548) |
0.3 | 0.3 | GO:0003057 | regulation of the force of heart contraction by chemical signal(GO:0003057) |
0.3 | 1.7 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.3 | 0.3 | GO:0048485 | sympathetic nervous system development(GO:0048485) |
0.3 | 1.7 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
0.3 | 1.0 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.3 | 2.7 | GO:1903078 | positive regulation of establishment of protein localization to plasma membrane(GO:0090004) positive regulation of protein localization to plasma membrane(GO:1903078) positive regulation of protein localization to cell periphery(GO:1904377) |
0.3 | 1.0 | GO:0001821 | histamine secretion(GO:0001821) |
0.3 | 1.7 | GO:0033261 | obsolete regulation of S phase(GO:0033261) |
0.3 | 1.0 | GO:0006007 | glucose catabolic process(GO:0006007) |
0.3 | 0.3 | GO:0090400 | stress-induced premature senescence(GO:0090400) |
0.3 | 0.7 | GO:0051346 | negative regulation of hydrolase activity(GO:0051346) |
0.3 | 0.7 | GO:0015732 | prostaglandin transport(GO:0015732) |
0.3 | 1.3 | GO:0006172 | ADP biosynthetic process(GO:0006172) purine nucleoside diphosphate biosynthetic process(GO:0009136) purine ribonucleoside diphosphate biosynthetic process(GO:0009180) ribonucleoside diphosphate biosynthetic process(GO:0009188) |
0.3 | 3.6 | GO:0071559 | response to transforming growth factor beta(GO:0071559) cellular response to transforming growth factor beta stimulus(GO:0071560) |
0.3 | 2.0 | GO:0033233 | regulation of protein sumoylation(GO:0033233) |
0.3 | 2.0 | GO:0060314 | regulation of ryanodine-sensitive calcium-release channel activity(GO:0060314) |
0.3 | 1.0 | GO:0032467 | positive regulation of cytokinesis(GO:0032467) |
0.3 | 0.3 | GO:0070932 | histone H3 deacetylation(GO:0070932) histone H4 deacetylation(GO:0070933) |
0.3 | 1.0 | GO:0048003 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) |
0.3 | 1.0 | GO:0051014 | actin filament severing(GO:0051014) |
0.3 | 1.0 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
0.3 | 1.3 | GO:0034204 | lipid translocation(GO:0034204) phospholipid translocation(GO:0045332) |
0.3 | 3.2 | GO:0070875 | positive regulation of glycogen biosynthetic process(GO:0045725) positive regulation of glycogen metabolic process(GO:0070875) |
0.3 | 0.6 | GO:0002407 | dendritic cell chemotaxis(GO:0002407) dendritic cell migration(GO:0036336) |
0.3 | 1.6 | GO:0030174 | regulation of DNA-dependent DNA replication initiation(GO:0030174) |
0.3 | 0.3 | GO:0043379 | T-helper cell lineage commitment(GO:0002295) CD4-positive, alpha-beta T cell lineage commitment(GO:0043373) memory T cell differentiation(GO:0043379) regulation of memory T cell differentiation(GO:0043380) positive regulation of memory T cell differentiation(GO:0043382) T-helper 17 type immune response(GO:0072538) T-helper 17 cell differentiation(GO:0072539) T-helper 17 cell lineage commitment(GO:0072540) regulation of T-helper 17 type immune response(GO:2000316) positive regulation of T-helper 17 type immune response(GO:2000318) regulation of T-helper 17 cell differentiation(GO:2000319) positive regulation of T-helper 17 cell differentiation(GO:2000321) regulation of T-helper 17 cell lineage commitment(GO:2000328) positive regulation of T-helper 17 cell lineage commitment(GO:2000330) |
0.3 | 0.9 | GO:0060406 | positive regulation of penile erection(GO:0060406) |
0.3 | 0.9 | GO:0017085 | response to insecticide(GO:0017085) |
0.3 | 1.6 | GO:0019987 | obsolete negative regulation of anti-apoptosis(GO:0019987) |
0.3 | 0.9 | GO:0048714 | positive regulation of oligodendrocyte differentiation(GO:0048714) |
0.3 | 0.6 | GO:0048859 | formation of anatomical boundary(GO:0048859) |
0.3 | 1.2 | GO:0003010 | voluntary skeletal muscle contraction(GO:0003010) twitch skeletal muscle contraction(GO:0014721) |
0.3 | 3.1 | GO:0001958 | endochondral ossification(GO:0001958) replacement ossification(GO:0036075) |
0.3 | 0.6 | GO:0032060 | bleb assembly(GO:0032060) |
0.3 | 0.6 | GO:0042420 | dopamine catabolic process(GO:0042420) |
0.3 | 2.2 | GO:0000076 | DNA replication checkpoint(GO:0000076) |
0.3 | 0.6 | GO:0042118 | endothelial cell activation(GO:0042118) |
0.3 | 0.3 | GO:2001235 | positive regulation of mitochondrion organization(GO:0010822) positive regulation of release of cytochrome c from mitochondria(GO:0090200) positive regulation of apoptotic signaling pathway(GO:2001235) |
0.3 | 0.3 | GO:0034447 | very-low-density lipoprotein particle clearance(GO:0034447) |
0.3 | 0.9 | GO:0017121 | phospholipid scrambling(GO:0017121) |
0.3 | 2.1 | GO:0007096 | regulation of exit from mitosis(GO:0007096) |
0.3 | 0.9 | GO:0090281 | negative regulation of calcium ion import(GO:0090281) |
0.3 | 0.6 | GO:0030854 | positive regulation of granulocyte differentiation(GO:0030854) |
0.3 | 1.2 | GO:0031620 | regulation of fever generation(GO:0031620) positive regulation of fever generation(GO:0031622) |
0.3 | 0.3 | GO:0051608 | histamine transport(GO:0051608) |
0.3 | 1.5 | GO:0045071 | negative regulation of viral genome replication(GO:0045071) |
0.3 | 0.6 | GO:0042492 | gamma-delta T cell differentiation(GO:0042492) regulation of gamma-delta T cell differentiation(GO:0045586) positive regulation of gamma-delta T cell differentiation(GO:0045588) |
0.3 | 1.2 | GO:0001542 | ovulation from ovarian follicle(GO:0001542) |
0.3 | 1.2 | GO:0060287 | epithelial cilium movement(GO:0003351) epithelial cilium movement involved in determination of left/right asymmetry(GO:0060287) |
0.3 | 0.9 | GO:0008215 | spermine metabolic process(GO:0008215) |
0.3 | 1.5 | GO:0071378 | growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
0.3 | 2.1 | GO:0002281 | macrophage activation involved in immune response(GO:0002281) |
0.3 | 0.3 | GO:0048521 | negative regulation of circadian sleep/wake cycle, sleep(GO:0042321) negative regulation of circadian rhythm(GO:0042754) negative regulation of behavior(GO:0048521) |
0.3 | 0.9 | GO:0030241 | skeletal muscle myosin thick filament assembly(GO:0030241) myosin filament assembly(GO:0031034) striated muscle myosin thick filament assembly(GO:0071688) |
0.3 | 0.6 | GO:0070572 | positive regulation of axon regeneration(GO:0048680) positive regulation of neuron projection regeneration(GO:0070572) |
0.3 | 0.3 | GO:0006549 | isoleucine metabolic process(GO:0006549) |
0.3 | 0.6 | GO:0003321 | positive regulation of blood pressure by epinephrine-norepinephrine(GO:0003321) |
0.3 | 1.2 | GO:0060017 | parathyroid gland development(GO:0060017) |
0.3 | 2.6 | GO:0019369 | arachidonic acid metabolic process(GO:0019369) |
0.3 | 1.2 | GO:2000171 | negative regulation of dendrite development(GO:2000171) |
0.3 | 0.3 | GO:0071277 | cellular response to calcium ion(GO:0071277) |
0.3 | 2.0 | GO:0051882 | mitochondrial depolarization(GO:0051882) |
0.3 | 0.9 | GO:0071501 | response to sterol depletion(GO:0006991) SREBP signaling pathway(GO:0032933) cellular response to sterol depletion(GO:0071501) |
0.3 | 2.0 | GO:0006469 | negative regulation of protein kinase activity(GO:0006469) |
0.3 | 0.9 | GO:0043922 | negative regulation by host of viral transcription(GO:0043922) |
0.3 | 1.1 | GO:0007567 | parturition(GO:0007567) |
0.3 | 1.7 | GO:0010288 | response to lead ion(GO:0010288) |
0.3 | 0.6 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
0.3 | 0.8 | GO:0033522 | histone H2A ubiquitination(GO:0033522) |
0.3 | 0.6 | GO:0045945 | positive regulation of transcription from RNA polymerase III promoter(GO:0045945) |
0.3 | 0.3 | GO:0070391 | response to lipoteichoic acid(GO:0070391) cellular response to lipoteichoic acid(GO:0071223) |
0.3 | 0.8 | GO:2000178 | negative regulation of neuroblast proliferation(GO:0007406) negative regulation of neural precursor cell proliferation(GO:2000178) negative regulation of stem cell proliferation(GO:2000647) |
0.3 | 0.8 | GO:0007638 | mechanosensory behavior(GO:0007638) |
0.3 | 6.8 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.3 | 0.3 | GO:0046349 | amino sugar biosynthetic process(GO:0046349) |
0.3 | 0.5 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
0.3 | 1.4 | GO:0048013 | ephrin receptor signaling pathway(GO:0048013) |
0.3 | 1.1 | GO:0010107 | potassium ion import(GO:0010107) |
0.3 | 0.3 | GO:0002286 | T cell activation involved in immune response(GO:0002286) |
0.3 | 0.8 | GO:0018119 | protein nitrosylation(GO:0017014) peptidyl-cysteine S-nitrosylation(GO:0018119) |
0.3 | 0.3 | GO:0050665 | hydrogen peroxide biosynthetic process(GO:0050665) |
0.3 | 1.4 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.3 | 0.8 | GO:0007340 | acrosome reaction(GO:0007340) |
0.3 | 1.4 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
0.3 | 0.8 | GO:0051451 | myoblast migration(GO:0051451) |
0.3 | 1.3 | GO:0014912 | negative regulation of smooth muscle cell migration(GO:0014912) |
0.3 | 0.5 | GO:2000008 | regulation of protein localization to cell surface(GO:2000008) |
0.3 | 0.3 | GO:0019336 | phenol-containing compound catabolic process(GO:0019336) catechol-containing compound catabolic process(GO:0019614) catecholamine catabolic process(GO:0042424) |
0.3 | 1.3 | GO:0071459 | protein localization to chromosome, centromeric region(GO:0071459) |
0.3 | 1.3 | GO:0090090 | negative regulation of canonical Wnt signaling pathway(GO:0090090) |
0.3 | 0.5 | GO:0046022 | regulation of transcription from RNA polymerase II promoter, mitotic(GO:0046021) positive regulation of transcription from RNA polymerase II promoter during mitosis(GO:0046022) |
0.3 | 0.3 | GO:0006356 | regulation of transcription from RNA polymerase I promoter(GO:0006356) |
0.3 | 1.6 | GO:0035121 | obsolete tail morphogenesis(GO:0035121) |
0.3 | 0.5 | GO:0010891 | negative regulation of sequestering of triglyceride(GO:0010891) |
0.3 | 0.5 | GO:0006562 | proline catabolic process(GO:0006562) |
0.3 | 1.8 | GO:0045577 | regulation of B cell differentiation(GO:0045577) |
0.3 | 0.8 | GO:0044240 | multicellular organism lipid catabolic process(GO:0044240) |
0.3 | 0.8 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
0.3 | 0.5 | GO:0014041 | regulation of neuron maturation(GO:0014041) regulation of cell maturation(GO:1903429) |
0.3 | 0.3 | GO:0007617 | mating behavior(GO:0007617) reproductive behavior(GO:0019098) multi-organism reproductive behavior(GO:0044705) |
0.3 | 0.3 | GO:0032570 | response to progesterone(GO:0032570) |
0.3 | 1.5 | GO:0009103 | lipopolysaccharide biosynthetic process(GO:0009103) |
0.3 | 0.5 | GO:0048147 | negative regulation of fibroblast proliferation(GO:0048147) |
0.3 | 0.3 | GO:0050850 | positive regulation of calcium-mediated signaling(GO:0050850) |
0.3 | 0.5 | GO:0070265 | necrotic cell death(GO:0070265) |
0.3 | 0.3 | GO:0001865 | NK T cell differentiation(GO:0001865) tolerance induction to self antigen(GO:0002513) regulation of NK T cell differentiation(GO:0051136) positive regulation of NK T cell differentiation(GO:0051138) |
0.3 | 0.8 | GO:0046033 | AMP metabolic process(GO:0046033) |
0.3 | 0.8 | GO:0006434 | seryl-tRNA aminoacylation(GO:0006434) |
0.3 | 1.8 | GO:0009214 | cyclic nucleotide catabolic process(GO:0009214) |
0.2 | 0.5 | GO:0034201 | response to oleic acid(GO:0034201) |
0.2 | 0.7 | GO:0045007 | depurination(GO:0045007) |
0.2 | 0.5 | GO:0032222 | regulation of synaptic transmission, cholinergic(GO:0032222) |
0.2 | 0.5 | GO:0010989 | negative regulation of low-density lipoprotein particle clearance(GO:0010989) |
0.2 | 0.5 | GO:0019348 | polyprenol metabolic process(GO:0016093) dolichol metabolic process(GO:0019348) |
0.2 | 4.5 | GO:0030032 | lamellipodium assembly(GO:0030032) |
0.2 | 0.7 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.2 | 0.7 | GO:2000846 | corticosteroid hormone secretion(GO:0035930) regulation of steroid hormone secretion(GO:2000831) regulation of corticosteroid hormone secretion(GO:2000846) |
0.2 | 1.0 | GO:0045668 | negative regulation of osteoblast differentiation(GO:0045668) |
0.2 | 0.7 | GO:0022614 | membrane to membrane docking(GO:0022614) |
0.2 | 0.5 | GO:0010755 | regulation of plasminogen activation(GO:0010755) |
0.2 | 0.7 | GO:0098656 | anion transmembrane transport(GO:0098656) |
0.2 | 0.7 | GO:0042149 | cellular response to glucose starvation(GO:0042149) |
0.2 | 0.7 | GO:0001757 | somite specification(GO:0001757) |
0.2 | 0.5 | GO:0070365 | hepatocyte differentiation(GO:0070365) |
0.2 | 0.7 | GO:0045943 | positive regulation of transcription from RNA polymerase I promoter(GO:0045943) |
0.2 | 0.5 | GO:0032922 | circadian regulation of gene expression(GO:0032922) |
0.2 | 1.0 | GO:0070120 | ciliary neurotrophic factor-mediated signaling pathway(GO:0070120) |
0.2 | 0.2 | GO:0002679 | respiratory burst involved in defense response(GO:0002679) |
0.2 | 0.5 | GO:0001878 | response to yeast(GO:0001878) |
0.2 | 0.2 | GO:0097709 | connective tissue replacement involved in inflammatory response wound healing(GO:0002248) connective tissue replacement(GO:0097709) |
0.2 | 1.9 | GO:0046329 | negative regulation of JNK cascade(GO:0046329) |
0.2 | 0.2 | GO:0014742 | positive regulation of cardiac muscle hypertrophy(GO:0010613) positive regulation of muscle hypertrophy(GO:0014742) |
0.2 | 0.5 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
0.2 | 0.7 | GO:0032661 | interleukin-18 production(GO:0032621) regulation of interleukin-18 production(GO:0032661) |
0.2 | 1.2 | GO:0060706 | cell differentiation involved in embryonic placenta development(GO:0060706) |
0.2 | 0.7 | GO:0072526 | pyridine-containing compound catabolic process(GO:0072526) |
0.2 | 0.2 | GO:0048634 | regulation of striated muscle tissue development(GO:0016202) regulation of muscle organ development(GO:0048634) regulation of muscle tissue development(GO:1901861) |
0.2 | 0.5 | GO:0008054 | negative regulation of cyclin-dependent protein serine/threonine kinase by cyclin degradation(GO:0008054) |
0.2 | 2.1 | GO:1901678 | iron coordination entity transport(GO:1901678) |
0.2 | 0.7 | GO:0006188 | IMP biosynthetic process(GO:0006188) IMP metabolic process(GO:0046040) |
0.2 | 0.7 | GO:0015864 | pyrimidine nucleoside transport(GO:0015864) |
0.2 | 0.7 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.2 | 0.9 | GO:0031529 | ruffle organization(GO:0031529) |
0.2 | 0.5 | GO:0032355 | response to estradiol(GO:0032355) |
0.2 | 0.9 | GO:0006910 | phagocytosis, recognition(GO:0006910) |
0.2 | 0.5 | GO:0007405 | neuroblast proliferation(GO:0007405) |
0.2 | 0.2 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.2 | 0.7 | GO:0098870 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
0.2 | 1.9 | GO:0001893 | maternal placenta development(GO:0001893) |
0.2 | 1.2 | GO:0006107 | oxaloacetate metabolic process(GO:0006107) |
0.2 | 1.9 | GO:0045749 | obsolete negative regulation of S phase of mitotic cell cycle(GO:0045749) |
0.2 | 0.9 | GO:0006930 | substrate-dependent cell migration, cell extension(GO:0006930) |
0.2 | 0.2 | GO:0014002 | astrocyte development(GO:0014002) |
0.2 | 0.2 | GO:0007416 | synapse assembly(GO:0007416) |
0.2 | 0.9 | GO:1901503 | ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) ether biosynthetic process(GO:1901503) |
0.2 | 0.7 | GO:0071392 | cellular response to estradiol stimulus(GO:0071392) |
0.2 | 0.5 | GO:0060412 | ventricular septum morphogenesis(GO:0060412) |
0.2 | 0.9 | GO:0030643 | cellular phosphate ion homeostasis(GO:0030643) cellular divalent inorganic anion homeostasis(GO:0072501) cellular trivalent inorganic anion homeostasis(GO:0072502) |
0.2 | 0.7 | GO:0030223 | neutrophil differentiation(GO:0030223) |
0.2 | 1.1 | GO:0045911 | positive regulation of isotype switching(GO:0045830) positive regulation of DNA recombination(GO:0045911) |
0.2 | 0.9 | GO:0060561 | apoptotic process involved in morphogenesis(GO:0060561) |
0.2 | 0.7 | GO:0002098 | tRNA wobble base modification(GO:0002097) tRNA wobble uridine modification(GO:0002098) tRNA thio-modification(GO:0034227) |
0.2 | 0.5 | GO:0033240 | positive regulation of cellular amine metabolic process(GO:0033240) |
0.2 | 0.5 | GO:0048266 | behavioral response to pain(GO:0048266) |
0.2 | 0.5 | GO:0043268 | positive regulation of potassium ion transport(GO:0043268) |
0.2 | 0.7 | GO:0045599 | negative regulation of fat cell differentiation(GO:0045599) |
0.2 | 1.4 | GO:0031000 | response to caffeine(GO:0031000) |
0.2 | 1.3 | GO:0007379 | segment specification(GO:0007379) |
0.2 | 0.2 | GO:0001840 | neural plate morphogenesis(GO:0001839) neural plate development(GO:0001840) |
0.2 | 0.9 | GO:0051503 | adenine nucleotide transport(GO:0051503) |
0.2 | 0.9 | GO:0050829 | defense response to Gram-negative bacterium(GO:0050829) |
0.2 | 0.7 | GO:0032288 | myelin assembly(GO:0032288) |
0.2 | 0.2 | GO:0042508 | tyrosine phosphorylation of Stat1 protein(GO:0042508) |
0.2 | 2.9 | GO:0006541 | glutamine metabolic process(GO:0006541) |
0.2 | 0.7 | GO:0060236 | regulation of mitotic spindle organization(GO:0060236) |
0.2 | 0.9 | GO:0048548 | regulation of pinocytosis(GO:0048548) |
0.2 | 0.2 | GO:0045990 | carbon catabolite regulation of transcription(GO:0045990) regulation of transcription by glucose(GO:0046015) |
0.2 | 1.3 | GO:0051189 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
0.2 | 0.9 | GO:0051329 | mitotic interphase(GO:0051329) |
0.2 | 2.9 | GO:0045646 | regulation of erythrocyte differentiation(GO:0045646) |
0.2 | 0.4 | GO:0071502 | cellular response to temperature stimulus(GO:0071502) |
0.2 | 0.7 | GO:0035108 | appendage morphogenesis(GO:0035107) limb morphogenesis(GO:0035108) |
0.2 | 0.2 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
0.2 | 0.7 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
0.2 | 0.2 | GO:0044766 | multi-organism transport(GO:0044766) transport of virus(GO:0046794) intracellular transport of virus(GO:0075733) multi-organism localization(GO:1902579) multi-organism intracellular transport(GO:1902583) |
0.2 | 0.9 | GO:0006654 | phosphatidic acid biosynthetic process(GO:0006654) |
0.2 | 0.2 | GO:0021591 | ventricular system development(GO:0021591) |
0.2 | 1.5 | GO:1903428 | positive regulation of nitric oxide biosynthetic process(GO:0045429) positive regulation of reactive oxygen species biosynthetic process(GO:1903428) positive regulation of nitric oxide metabolic process(GO:1904407) |
0.2 | 0.4 | GO:0070669 | response to interleukin-2(GO:0070669) |
0.2 | 3.2 | GO:0042994 | cytoplasmic sequestering of transcription factor(GO:0042994) |
0.2 | 1.5 | GO:0007007 | inner mitochondrial membrane organization(GO:0007007) |
0.2 | 0.6 | GO:0007413 | axonal fasciculation(GO:0007413) |
0.2 | 0.2 | GO:0002244 | hematopoietic progenitor cell differentiation(GO:0002244) |
0.2 | 1.1 | GO:0008347 | glial cell migration(GO:0008347) |
0.2 | 1.1 | GO:0016233 | telomere capping(GO:0016233) |
0.2 | 0.9 | GO:0000052 | citrulline metabolic process(GO:0000052) |
0.2 | 1.7 | GO:0071108 | protein K48-linked deubiquitination(GO:0071108) |
0.2 | 1.5 | GO:0032042 | mitochondrial DNA metabolic process(GO:0032042) |
0.2 | 1.1 | GO:0008340 | determination of adult lifespan(GO:0008340) |
0.2 | 0.6 | GO:0045070 | positive regulation of viral genome replication(GO:0045070) |
0.2 | 0.8 | GO:0002862 | negative regulation of inflammatory response to antigenic stimulus(GO:0002862) |
0.2 | 1.7 | GO:0006491 | N-glycan processing(GO:0006491) |
0.2 | 0.6 | GO:0051294 | establishment of mitotic spindle orientation(GO:0000132) establishment of spindle orientation(GO:0051294) |
0.2 | 2.5 | GO:0006385 | transcription elongation from RNA polymerase III promoter(GO:0006385) termination of RNA polymerase III transcription(GO:0006386) |
0.2 | 0.6 | GO:0010507 | negative regulation of autophagy(GO:0010507) |
0.2 | 0.8 | GO:0019255 | glucose 1-phosphate metabolic process(GO:0019255) |
0.2 | 1.7 | GO:0034311 | diol metabolic process(GO:0034311) |
0.2 | 1.2 | GO:0010812 | negative regulation of cell-substrate adhesion(GO:0010812) |
0.2 | 1.9 | GO:0051568 | histone H3-K4 methylation(GO:0051568) |
0.2 | 1.0 | GO:0051016 | barbed-end actin filament capping(GO:0051016) |
0.2 | 0.8 | GO:0051290 | protein heterotetramerization(GO:0051290) |
0.2 | 1.0 | GO:0044728 | DNA alkylation(GO:0006305) DNA methylation(GO:0006306) DNA methylation or demethylation(GO:0044728) |
0.2 | 1.2 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.2 | 0.4 | GO:0032914 | positive regulation of transforming growth factor beta1 production(GO:0032914) |
0.2 | 0.2 | GO:0019530 | taurine metabolic process(GO:0019530) |
0.2 | 0.8 | GO:0006498 | N-terminal protein lipidation(GO:0006498) |
0.2 | 0.2 | GO:0072074 | kidney mesenchyme development(GO:0072074) metanephric mesenchyme development(GO:0072075) |
0.2 | 0.6 | GO:0006998 | nuclear envelope organization(GO:0006998) |
0.2 | 0.4 | GO:0032509 | endosome transport via multivesicular body sorting pathway(GO:0032509) |
0.2 | 0.4 | GO:0044803 | multi-organism membrane organization(GO:0044803) |
0.2 | 0.4 | GO:0006678 | glucosylceramide metabolic process(GO:0006678) |
0.2 | 0.4 | GO:0006855 | drug transmembrane transport(GO:0006855) |
0.2 | 0.2 | GO:0042036 | negative regulation of cytokine biosynthetic process(GO:0042036) |
0.2 | 0.4 | GO:0048864 | stem cell development(GO:0048864) |
0.2 | 0.2 | GO:0001556 | oocyte maturation(GO:0001556) |
0.2 | 0.6 | GO:0035269 | protein mannosylation(GO:0035268) protein O-linked mannosylation(GO:0035269) mannosylation(GO:0097502) |
0.2 | 0.2 | GO:0003032 | detection of oxygen(GO:0003032) |
0.2 | 0.6 | GO:0046668 | regulation of retinal cell programmed cell death(GO:0046668) |
0.2 | 0.2 | GO:0034314 | Arp2/3 complex-mediated actin nucleation(GO:0034314) |
0.2 | 0.4 | GO:0050667 | homocysteine metabolic process(GO:0050667) |
0.2 | 0.6 | GO:0007090 | obsolete regulation of S phase of mitotic cell cycle(GO:0007090) |
0.2 | 1.4 | GO:0009435 | NAD biosynthetic process(GO:0009435) |
0.2 | 0.2 | GO:0034446 | substrate adhesion-dependent cell spreading(GO:0034446) |
0.2 | 0.2 | GO:0032898 | neurotrophin production(GO:0032898) |
0.2 | 0.4 | GO:0006591 | ornithine metabolic process(GO:0006591) |
0.2 | 4.7 | GO:0003333 | amino acid transmembrane transport(GO:0003333) |
0.2 | 1.4 | GO:0045737 | positive regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045737) positive regulation of cyclin-dependent protein kinase activity(GO:1904031) |
0.2 | 1.2 | GO:0071157 | negative regulation of cell cycle arrest(GO:0071157) |
0.2 | 0.6 | GO:0036473 | intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0008631) cell death in response to oxidative stress(GO:0036473) |
0.2 | 0.8 | GO:0055003 | cardiac myofibril assembly(GO:0055003) |
0.2 | 1.4 | GO:0006983 | ER overload response(GO:0006983) |
0.2 | 0.4 | GO:0042640 | anagen(GO:0042640) |
0.2 | 0.8 | GO:0008218 | bioluminescence(GO:0008218) |
0.2 | 0.4 | GO:0033147 | negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
0.2 | 1.0 | GO:0033137 | negative regulation of peptidyl-serine phosphorylation(GO:0033137) |
0.2 | 0.2 | GO:0010842 | retina layer formation(GO:0010842) |
0.2 | 2.5 | GO:0015701 | bicarbonate transport(GO:0015701) |
0.2 | 0.4 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
0.2 | 1.2 | GO:0046839 | phospholipid dephosphorylation(GO:0046839) |
0.2 | 0.6 | GO:0071428 | rRNA-containing ribonucleoprotein complex export from nucleus(GO:0071428) |
0.2 | 0.8 | GO:0048240 | sperm capacitation(GO:0048240) |
0.2 | 0.4 | GO:0046174 | polyol catabolic process(GO:0046174) |
0.2 | 1.7 | GO:0051322 | anaphase(GO:0051322) |
0.2 | 1.0 | GO:0000183 | chromatin silencing at rDNA(GO:0000183) |
0.2 | 1.0 | GO:0030730 | positive regulation of sequestering of triglyceride(GO:0010890) sequestering of triglyceride(GO:0030730) |
0.2 | 1.0 | GO:0009109 | coenzyme catabolic process(GO:0009109) |
0.2 | 0.4 | GO:0021831 | embryonic olfactory bulb interneuron precursor migration(GO:0021831) |
0.2 | 1.0 | GO:0008608 | attachment of spindle microtubules to kinetochore(GO:0008608) |
0.2 | 0.2 | GO:0030812 | negative regulation of nucleotide catabolic process(GO:0030812) |
0.2 | 2.9 | GO:0019915 | lipid storage(GO:0019915) |
0.2 | 2.1 | GO:0010039 | response to iron ion(GO:0010039) |
0.2 | 7.8 | GO:0006446 | regulation of translational initiation(GO:0006446) |
0.2 | 0.2 | GO:0051709 | regulation of killing of cells of other organism(GO:0051709) positive regulation of killing of cells of other organism(GO:0051712) |
0.2 | 1.3 | GO:0070189 | kynurenine metabolic process(GO:0070189) |
0.2 | 0.4 | GO:0051881 | regulation of mitochondrial membrane potential(GO:0051881) |
0.2 | 0.6 | GO:0030091 | protein repair(GO:0030091) |
0.2 | 0.7 | GO:0046426 | negative regulation of JAK-STAT cascade(GO:0046426) negative regulation of STAT cascade(GO:1904893) |
0.2 | 0.4 | GO:0006734 | NADH metabolic process(GO:0006734) |
0.2 | 0.7 | GO:0051703 | social behavior(GO:0035176) intraspecies interaction between organisms(GO:0051703) |
0.2 | 2.6 | GO:0006027 | glycosaminoglycan catabolic process(GO:0006027) |
0.2 | 0.4 | GO:0002544 | chronic inflammatory response(GO:0002544) |
0.2 | 1.3 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
0.2 | 2.6 | GO:0030101 | natural killer cell activation(GO:0030101) |
0.2 | 0.4 | GO:0018410 | C-terminal protein amino acid modification(GO:0018410) |
0.2 | 0.4 | GO:0006661 | phosphatidylinositol biosynthetic process(GO:0006661) |
0.2 | 2.0 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.2 | 0.4 | GO:0006927 | obsolete transformed cell apoptotic process(GO:0006927) |
0.2 | 0.5 | GO:2000114 | regulation of establishment of cell polarity(GO:2000114) |
0.2 | 1.3 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
0.2 | 0.5 | GO:0033280 | response to vitamin D(GO:0033280) |
0.2 | 0.9 | GO:0031668 | cellular response to extracellular stimulus(GO:0031668) |
0.2 | 0.4 | GO:0007616 | long-term memory(GO:0007616) |
0.2 | 1.6 | GO:0016558 | protein import into peroxisome matrix(GO:0016558) |
0.2 | 0.2 | GO:0001881 | receptor recycling(GO:0001881) |
0.2 | 0.9 | GO:0060219 | camera-type eye photoreceptor cell differentiation(GO:0060219) |
0.2 | 0.5 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.2 | 0.9 | GO:0060135 | maternal process involved in female pregnancy(GO:0060135) |
0.2 | 0.2 | GO:0043388 | positive regulation of DNA binding(GO:0043388) |
0.2 | 0.4 | GO:0071800 | podosome assembly(GO:0071800) |
0.2 | 1.8 | GO:0031648 | protein destabilization(GO:0031648) |
0.2 | 0.5 | GO:0031958 | corticosteroid receptor signaling pathway(GO:0031958) |
0.2 | 0.5 | GO:0060438 | trachea development(GO:0060438) |
0.2 | 0.5 | GO:0051532 | NFAT protein import into nucleus(GO:0051531) regulation of NFAT protein import into nucleus(GO:0051532) |
0.2 | 1.4 | GO:0019317 | fucose catabolic process(GO:0019317) L-fucose metabolic process(GO:0042354) L-fucose catabolic process(GO:0042355) |
0.2 | 0.2 | GO:0000002 | mitochondrial genome maintenance(GO:0000002) |
0.2 | 0.4 | GO:0045909 | positive regulation of vasodilation(GO:0045909) |
0.2 | 0.3 | GO:0006089 | lactate metabolic process(GO:0006089) |
0.2 | 0.3 | GO:0051155 | positive regulation of striated muscle cell differentiation(GO:0051155) |
0.2 | 0.7 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
0.2 | 0.3 | GO:0048808 | male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
0.2 | 0.3 | GO:0009648 | photoperiodism(GO:0009648) |
0.2 | 1.0 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
0.2 | 0.5 | GO:0006691 | leukotriene metabolic process(GO:0006691) |
0.2 | 1.2 | GO:0006553 | lysine metabolic process(GO:0006553) lysine catabolic process(GO:0006554) |
0.2 | 0.2 | GO:0060088 | auditory receptor cell morphogenesis(GO:0002093) auditory receptor cell stereocilium organization(GO:0060088) |
0.2 | 0.3 | GO:0000212 | meiotic spindle organization(GO:0000212) |
0.2 | 1.0 | GO:0006577 | amino-acid betaine metabolic process(GO:0006577) carnitine metabolic process(GO:0009437) |
0.2 | 0.7 | GO:0007224 | smoothened signaling pathway(GO:0007224) |
0.2 | 0.3 | GO:0090278 | negative regulation of peptide hormone secretion(GO:0090278) |
0.2 | 0.2 | GO:0031268 | pseudopodium organization(GO:0031268) |
0.2 | 0.3 | GO:0051877 | pigment granule aggregation in cell center(GO:0051877) |
0.2 | 0.2 | GO:0051597 | response to methylmercury(GO:0051597) |
0.2 | 0.2 | GO:0031652 | regulation of heat generation(GO:0031650) positive regulation of heat generation(GO:0031652) |
0.2 | 0.5 | GO:0021548 | pons development(GO:0021548) |
0.2 | 0.5 | GO:0033688 | regulation of osteoblast proliferation(GO:0033688) |
0.2 | 0.3 | GO:0048537 | mucosal-associated lymphoid tissue development(GO:0048537) |
0.2 | 1.0 | GO:0030163 | protein catabolic process(GO:0030163) |
0.2 | 0.3 | GO:0071436 | sodium ion export(GO:0071436) |
0.2 | 0.5 | GO:0060292 | long term synaptic depression(GO:0060292) |
0.2 | 0.5 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
0.2 | 1.2 | GO:0001843 | neural tube closure(GO:0001843) tube closure(GO:0060606) |
0.2 | 0.7 | GO:0035025 | positive regulation of Rho protein signal transduction(GO:0035025) |
0.2 | 0.7 | GO:0000394 | RNA splicing, via endonucleolytic cleavage and ligation(GO:0000394) tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
0.2 | 0.3 | GO:1901984 | negative regulation of histone acetylation(GO:0035067) negative regulation of protein acetylation(GO:1901984) negative regulation of peptidyl-lysine acetylation(GO:2000757) |
0.2 | 0.7 | GO:0042104 | positive regulation of activated T cell proliferation(GO:0042104) |
0.2 | 0.2 | GO:0034629 | cellular protein complex localization(GO:0034629) |
0.2 | 2.3 | GO:0007215 | glutamate receptor signaling pathway(GO:0007215) |
0.2 | 3.9 | GO:1902099 | regulation of mitotic metaphase/anaphase transition(GO:0030071) regulation of metaphase/anaphase transition of cell cycle(GO:1902099) |
0.2 | 0.3 | GO:0032025 | response to cobalt ion(GO:0032025) |
0.2 | 0.5 | GO:0002430 | complement receptor mediated signaling pathway(GO:0002430) |
0.2 | 0.6 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
0.2 | 0.6 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.2 | 0.6 | GO:0034453 | microtubule anchoring(GO:0034453) |
0.2 | 0.8 | GO:0060004 | reflex(GO:0060004) |
0.2 | 1.0 | GO:0045351 | type I interferon biosynthetic process(GO:0045351) |
0.2 | 0.5 | GO:0048539 | bone marrow development(GO:0048539) |
0.2 | 2.1 | GO:0019433 | triglyceride catabolic process(GO:0019433) |
0.2 | 0.5 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
0.2 | 3.7 | GO:0006308 | DNA catabolic process(GO:0006308) |
0.2 | 1.9 | GO:0051220 | cytoplasmic sequestering of protein(GO:0051220) |
0.2 | 1.3 | GO:0008655 | pyrimidine-containing compound salvage(GO:0008655) pyrimidine nucleoside salvage(GO:0043097) |
0.2 | 0.3 | GO:0045839 | negative regulation of mitotic nuclear division(GO:0045839) negative regulation of nuclear division(GO:0051784) |
0.2 | 0.6 | GO:0018126 | protein hydroxylation(GO:0018126) |
0.2 | 1.0 | GO:0018065 | protein-cofactor linkage(GO:0018065) |
0.2 | 0.2 | GO:0002673 | regulation of acute inflammatory response(GO:0002673) |
0.2 | 0.3 | GO:0050847 | progesterone receptor signaling pathway(GO:0050847) |
0.2 | 0.5 | GO:0032495 | response to muramyl dipeptide(GO:0032495) |
0.2 | 0.5 | GO:0032506 | cytokinetic process(GO:0032506) |
0.2 | 0.8 | GO:0032368 | regulation of lipid transport(GO:0032368) |
0.2 | 1.3 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.2 | 11.6 | GO:0043123 | positive regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043123) |
0.2 | 0.8 | GO:0009649 | entrainment of circadian clock(GO:0009649) |
0.2 | 0.6 | GO:0016246 | RNA interference(GO:0016246) |
0.2 | 0.6 | GO:0072079 | nephron tubule formation(GO:0072079) |
0.2 | 0.8 | GO:0045059 | positive thymic T cell selection(GO:0045059) |
0.2 | 0.5 | GO:0030309 | poly-N-acetyllactosamine metabolic process(GO:0030309) |
0.2 | 0.5 | GO:0061037 | negative regulation of chondrocyte differentiation(GO:0032331) negative regulation of cartilage development(GO:0061037) |
0.2 | 1.6 | GO:0032008 | positive regulation of TOR signaling(GO:0032008) |
0.2 | 0.6 | GO:0042178 | xenobiotic catabolic process(GO:0042178) |
0.2 | 8.9 | GO:0006754 | ATP biosynthetic process(GO:0006754) |
0.2 | 0.5 | GO:0006513 | protein monoubiquitination(GO:0006513) |
0.2 | 2.8 | GO:0043488 | regulation of mRNA stability(GO:0043488) |
0.2 | 0.3 | GO:0045885 | obsolete positive regulation of survival gene product expression(GO:0045885) |
0.2 | 0.2 | GO:0033080 | immature T cell proliferation in thymus(GO:0033080) regulation of immature T cell proliferation in thymus(GO:0033084) |
0.2 | 0.2 | GO:0034145 | positive regulation of toll-like receptor 4 signaling pathway(GO:0034145) |
0.2 | 0.2 | GO:0051348 | negative regulation of transferase activity(GO:0051348) |
0.2 | 0.5 | GO:0000216 | obsolete M/G1 transition of mitotic cell cycle(GO:0000216) |
0.2 | 1.2 | GO:0007398 | ectoderm development(GO:0007398) |
0.2 | 0.5 | GO:0001991 | regulation of systemic arterial blood pressure by circulatory renin-angiotensin(GO:0001991) |
0.2 | 0.9 | GO:0000085 | mitotic G2 phase(GO:0000085) G2 phase(GO:0051319) |
0.2 | 0.3 | GO:0042268 | regulation of cytolysis(GO:0042268) |
0.2 | 0.6 | GO:0050872 | white fat cell differentiation(GO:0050872) |
0.2 | 0.3 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.2 | 2.8 | GO:0007032 | endosome organization(GO:0007032) |
0.2 | 0.5 | GO:0007199 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger(GO:0007199) |
0.2 | 0.2 | GO:0010766 | negative regulation of sodium ion transport(GO:0010766) |
0.2 | 1.2 | GO:1901072 | amino sugar catabolic process(GO:0046348) glucosamine-containing compound catabolic process(GO:1901072) |
0.2 | 2.3 | GO:0042744 | hydrogen peroxide catabolic process(GO:0042744) |
0.2 | 0.9 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
0.2 | 2.7 | GO:0045103 | intermediate filament-based process(GO:0045103) |
0.2 | 0.3 | GO:0045060 | negative thymic T cell selection(GO:0045060) |
0.2 | 0.5 | GO:0060009 | Sertoli cell development(GO:0060009) |
0.2 | 0.2 | GO:0003310 | pancreatic A cell differentiation(GO:0003310) |
0.2 | 0.6 | GO:0040020 | regulation of meiotic nuclear division(GO:0040020) regulation of meiotic cell cycle(GO:0051445) |
0.1 | 0.3 | GO:0031334 | positive regulation of protein complex assembly(GO:0031334) |
0.1 | 0.9 | GO:0030262 | apoptotic nuclear changes(GO:0030262) |
0.1 | 0.1 | GO:0014037 | Schwann cell differentiation(GO:0014037) |
0.1 | 0.3 | GO:0051547 | regulation of keratinocyte migration(GO:0051547) positive regulation of keratinocyte migration(GO:0051549) |
0.1 | 0.6 | GO:0017183 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
0.1 | 1.0 | GO:0007566 | embryo implantation(GO:0007566) |
0.1 | 0.3 | GO:0021563 | glossopharyngeal nerve development(GO:0021563) glossopharyngeal nerve morphogenesis(GO:0021615) |
0.1 | 0.4 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
0.1 | 0.7 | GO:0016601 | Rac protein signal transduction(GO:0016601) |
0.1 | 1.0 | GO:0032456 | endocytic recycling(GO:0032456) |
0.1 | 2.2 | GO:0019400 | glycerol metabolic process(GO:0006071) alditol metabolic process(GO:0019400) |
0.1 | 1.0 | GO:0034643 | establishment of mitochondrion localization, microtubule-mediated(GO:0034643) mitochondrion transport along microtubule(GO:0047497) |
0.1 | 0.1 | GO:0050919 | negative chemotaxis(GO:0050919) |
0.1 | 0.3 | GO:0032228 | regulation of synaptic transmission, GABAergic(GO:0032228) |
0.1 | 0.3 | GO:0051984 | positive regulation of mitotic metaphase/anaphase transition(GO:0045842) positive regulation of chromosome segregation(GO:0051984) positive regulation of mitotic sister chromatid separation(GO:1901970) positive regulation of metaphase/anaphase transition of cell cycle(GO:1902101) |
0.1 | 1.2 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.1 | 1.3 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
0.1 | 0.7 | GO:0006265 | DNA topological change(GO:0006265) |
0.1 | 0.7 | GO:0015858 | nucleoside transport(GO:0015858) |
0.1 | 0.3 | GO:0009226 | nucleotide-sugar biosynthetic process(GO:0009226) |
0.1 | 0.3 | GO:0033145 | positive regulation of intracellular steroid hormone receptor signaling pathway(GO:0033145) |
0.1 | 1.0 | GO:0001704 | formation of primary germ layer(GO:0001704) |
0.1 | 1.2 | GO:0006278 | RNA-dependent DNA biosynthetic process(GO:0006278) |
0.1 | 6.4 | GO:0002756 | MyD88-independent toll-like receptor signaling pathway(GO:0002756) |
0.1 | 0.4 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.1 | 0.6 | GO:0002329 | immature B cell differentiation(GO:0002327) pre-B cell differentiation(GO:0002329) |
0.1 | 1.3 | GO:0043647 | inositol phosphate metabolic process(GO:0043647) |
0.1 | 0.4 | GO:0007207 | phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
0.1 | 0.6 | GO:0061088 | regulation of sequestering of zinc ion(GO:0061088) |
0.1 | 0.6 | GO:0043550 | regulation of lipid kinase activity(GO:0043550) |
0.1 | 1.3 | GO:0007520 | myoblast fusion(GO:0007520) |
0.1 | 0.4 | GO:0001945 | lymph vessel development(GO:0001945) |
0.1 | 0.3 | GO:0051299 | centrosome separation(GO:0051299) |
0.1 | 0.6 | GO:0070542 | response to fatty acid(GO:0070542) |
0.1 | 0.3 | GO:1903846 | positive regulation of transforming growth factor beta receptor signaling pathway(GO:0030511) positive regulation of cellular response to transforming growth factor beta stimulus(GO:1903846) |
0.1 | 0.9 | GO:0042471 | ear morphogenesis(GO:0042471) |
0.1 | 2.3 | GO:0001522 | pseudouridine synthesis(GO:0001522) |
0.1 | 0.3 | GO:0010833 | telomere maintenance via telomere lengthening(GO:0010833) |
0.1 | 0.6 | GO:0001990 | regulation of systemic arterial blood pressure by hormone(GO:0001990) |
0.1 | 0.4 | GO:0043096 | adenine salvage(GO:0006168) purine nucleobase salvage(GO:0043096) adenine metabolic process(GO:0046083) adenine biosynthetic process(GO:0046084) |
0.1 | 0.4 | GO:0033273 | response to vitamin(GO:0033273) |
0.1 | 0.7 | GO:0048625 | myoblast fate commitment(GO:0048625) |
0.1 | 1.8 | GO:0000380 | alternative mRNA splicing, via spliceosome(GO:0000380) |
0.1 | 0.1 | GO:0090085 | regulation of protein deubiquitination(GO:0090085) |
0.1 | 0.4 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
0.1 | 0.3 | GO:0000966 | RNA 5'-end processing(GO:0000966) |
0.1 | 1.1 | GO:0016575 | histone deacetylation(GO:0016575) |
0.1 | 0.3 | GO:0016139 | glycoside metabolic process(GO:0016137) glycoside catabolic process(GO:0016139) |
0.1 | 0.1 | GO:0001678 | cellular glucose homeostasis(GO:0001678) |
0.1 | 1.1 | GO:0006750 | glutathione biosynthetic process(GO:0006750) |
0.1 | 0.1 | GO:0071462 | cellular response to water stimulus(GO:0071462) |
0.1 | 0.3 | GO:0090399 | replicative senescence(GO:0090399) |
0.1 | 1.1 | GO:0034605 | cellular response to heat(GO:0034605) |
0.1 | 0.3 | GO:0045416 | positive regulation of interleukin-8 biosynthetic process(GO:0045416) |
0.1 | 0.4 | GO:0014812 | muscle cell migration(GO:0014812) |
0.1 | 0.8 | GO:0043954 | cellular component maintenance(GO:0043954) |
0.1 | 0.8 | GO:0060765 | regulation of androgen receptor signaling pathway(GO:0060765) |
0.1 | 1.1 | GO:0007212 | dopamine receptor signaling pathway(GO:0007212) |
0.1 | 0.1 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
0.1 | 0.9 | GO:0046039 | GTP metabolic process(GO:0046039) |
0.1 | 0.3 | GO:0032367 | intracellular sterol transport(GO:0032366) intracellular cholesterol transport(GO:0032367) |
0.1 | 1.1 | GO:0007020 | microtubule nucleation(GO:0007020) |
0.1 | 0.4 | GO:0046835 | carbohydrate phosphorylation(GO:0046835) |
0.1 | 0.1 | GO:0045989 | positive regulation of striated muscle contraction(GO:0045989) |
0.1 | 0.1 | GO:0001841 | neural tube formation(GO:0001841) |
0.1 | 0.3 | GO:0032494 | response to peptidoglycan(GO:0032494) |
0.1 | 0.1 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
0.1 | 1.6 | GO:0006518 | peptide metabolic process(GO:0006518) |
0.1 | 0.3 | GO:0060179 | male mating behavior(GO:0060179) |
0.1 | 0.1 | GO:0043029 | T cell homeostasis(GO:0043029) |
0.1 | 0.4 | GO:0048009 | insulin-like growth factor receptor signaling pathway(GO:0048009) |
0.1 | 0.7 | GO:0051918 | negative regulation of fibrinolysis(GO:0051918) |
0.1 | 0.3 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
0.1 | 5.1 | GO:0051084 | 'de novo' posttranslational protein folding(GO:0051084) |
0.1 | 0.3 | GO:0006984 | ER-nucleus signaling pathway(GO:0006984) |
0.1 | 1.9 | GO:0051789 | obsolete response to protein(GO:0051789) |
0.1 | 1.6 | GO:0016180 | snRNA processing(GO:0016180) |
0.1 | 0.5 | GO:0010826 | negative regulation of centrosome duplication(GO:0010826) negative regulation of centrosome cycle(GO:0046606) |
0.1 | 0.4 | GO:0035590 | purinergic nucleotide receptor signaling pathway(GO:0035590) |
0.1 | 0.5 | GO:0030878 | thyroid gland development(GO:0030878) |
0.1 | 1.4 | GO:0010565 | regulation of cellular ketone metabolic process(GO:0010565) |
0.1 | 1.8 | GO:0007612 | learning(GO:0007612) |
0.1 | 0.8 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
0.1 | 0.1 | GO:0010829 | negative regulation of glucose transport(GO:0010829) |
0.1 | 2.7 | GO:0006370 | 7-methylguanosine mRNA capping(GO:0006370) |
0.1 | 0.5 | GO:0045006 | DNA deamination(GO:0045006) |
0.1 | 1.3 | GO:0050680 | negative regulation of epithelial cell proliferation(GO:0050680) |
0.1 | 1.7 | GO:0006400 | tRNA modification(GO:0006400) |
0.1 | 1.7 | GO:0051324 | prophase(GO:0051324) |
0.1 | 0.8 | GO:0051785 | positive regulation of nuclear division(GO:0051785) |
0.1 | 0.6 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.1 | 0.3 | GO:0060603 | mammary gland duct morphogenesis(GO:0060603) |
0.1 | 0.9 | GO:0015780 | nucleotide-sugar transport(GO:0015780) |
0.1 | 0.4 | GO:0032309 | icosanoid secretion(GO:0032309) |
0.1 | 0.3 | GO:0010216 | maintenance of DNA methylation(GO:0010216) |
0.1 | 0.5 | GO:0071445 | obsolete cellular response to protein stimulus(GO:0071445) |
0.1 | 0.2 | GO:0030157 | pancreatic juice secretion(GO:0030157) |
0.1 | 2.2 | GO:0007041 | lysosomal transport(GO:0007041) |
0.1 | 0.4 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
0.1 | 0.2 | GO:0072112 | renal filtration cell differentiation(GO:0061318) glomerular epithelium development(GO:0072010) glomerular visceral epithelial cell differentiation(GO:0072112) glomerular epithelial cell differentiation(GO:0072311) |
0.1 | 0.1 | GO:0031440 | regulation of mRNA 3'-end processing(GO:0031440) |
0.1 | 0.4 | GO:0033133 | regulation of glucokinase activity(GO:0033131) positive regulation of glucokinase activity(GO:0033133) regulation of hexokinase activity(GO:1903299) positive regulation of hexokinase activity(GO:1903301) |
0.1 | 0.4 | GO:0009301 | snRNA transcription(GO:0009301) |
0.1 | 2.1 | GO:0045727 | positive regulation of translation(GO:0045727) |
0.1 | 2.3 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.1 | 0.5 | GO:0016098 | monoterpenoid metabolic process(GO:0016098) |
0.1 | 0.2 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
0.1 | 1.1 | GO:0048873 | homeostasis of number of cells within a tissue(GO:0048873) |
0.1 | 0.4 | GO:0033119 | negative regulation of RNA splicing(GO:0033119) |
0.1 | 0.4 | GO:0006477 | protein sulfation(GO:0006477) |
0.1 | 1.7 | GO:0010977 | negative regulation of neuron projection development(GO:0010977) |
0.1 | 0.2 | GO:0014046 | dopamine secretion(GO:0014046) regulation of dopamine secretion(GO:0014059) |
0.1 | 0.4 | GO:0048505 | regulation of development, heterochronic(GO:0040034) regulation of timing of cell differentiation(GO:0048505) |
0.1 | 0.5 | GO:0008366 | ensheathment of neurons(GO:0007272) axon ensheathment(GO:0008366) |
0.1 | 0.2 | GO:0015959 | diadenosine polyphosphate metabolic process(GO:0015959) |
0.1 | 0.1 | GO:0006689 | ganglioside catabolic process(GO:0006689) |
0.1 | 0.5 | GO:0000266 | mitochondrial fission(GO:0000266) |
0.1 | 0.2 | GO:0060665 | regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling(GO:0060665) |
0.1 | 0.6 | GO:0014068 | positive regulation of phosphatidylinositol 3-kinase signaling(GO:0014068) |
0.1 | 1.7 | GO:0009954 | proximal/distal pattern formation(GO:0009954) |
0.1 | 0.6 | GO:0050805 | negative regulation of synaptic transmission(GO:0050805) |
0.1 | 0.1 | GO:0002381 | immunoglobulin production involved in immunoglobulin mediated immune response(GO:0002381) |
0.1 | 0.2 | GO:0043254 | regulation of protein complex assembly(GO:0043254) |
0.1 | 0.5 | GO:0031641 | regulation of myelination(GO:0031641) |
0.1 | 0.5 | GO:0060041 | retina development in camera-type eye(GO:0060041) |
0.1 | 0.5 | GO:0016050 | vesicle organization(GO:0016050) |
0.1 | 0.2 | GO:0006573 | valine metabolic process(GO:0006573) |
0.1 | 0.7 | GO:0006743 | ubiquinone metabolic process(GO:0006743) ubiquinone biosynthetic process(GO:0006744) |
0.1 | 0.4 | GO:0048169 | regulation of long-term neuronal synaptic plasticity(GO:0048169) |
0.1 | 0.5 | GO:0031053 | primary miRNA processing(GO:0031053) |
0.1 | 0.2 | GO:0031670 | cellular response to nutrient(GO:0031670) |
0.1 | 1.1 | GO:0030833 | regulation of actin filament polymerization(GO:0030833) |
0.1 | 0.4 | GO:0045824 | negative regulation of innate immune response(GO:0045824) |
0.1 | 0.6 | GO:0032006 | regulation of TOR signaling(GO:0032006) |
0.1 | 0.4 | GO:0046173 | polyol biosynthetic process(GO:0046173) |
0.1 | 2.7 | GO:0006506 | GPI anchor biosynthetic process(GO:0006506) |
0.1 | 1.2 | GO:0019682 | pentose-phosphate shunt(GO:0006098) glyceraldehyde-3-phosphate metabolic process(GO:0019682) |
0.1 | 0.1 | GO:0002328 | pro-B cell differentiation(GO:0002328) |
0.1 | 1.3 | GO:0018208 | peptidyl-proline modification(GO:0018208) |
0.1 | 4.6 | GO:0002576 | platelet degranulation(GO:0002576) |
0.1 | 0.5 | GO:0045768 | obsolete positive regulation of anti-apoptosis(GO:0045768) |
0.1 | 0.1 | GO:0040016 | embryonic cleavage(GO:0040016) |
0.1 | 0.1 | GO:0097384 | cellular lipid biosynthetic process(GO:0097384) |
0.1 | 0.5 | GO:0001836 | release of cytochrome c from mitochondria(GO:0001836) |
0.1 | 0.1 | GO:0031639 | plasminogen activation(GO:0031639) |
0.1 | 3.6 | GO:0030308 | negative regulation of cell growth(GO:0030308) |
0.1 | 0.9 | GO:0042572 | retinol metabolic process(GO:0042572) |
0.1 | 0.3 | GO:0045722 | positive regulation of gluconeogenesis(GO:0045722) |
0.1 | 0.2 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
0.1 | 2.6 | GO:0006636 | unsaturated fatty acid biosynthetic process(GO:0006636) |
0.1 | 1.1 | GO:0018214 | peptidyl-glutamic acid carboxylation(GO:0017187) protein carboxylation(GO:0018214) |
0.1 | 0.2 | GO:0090083 | regulation of inclusion body assembly(GO:0090083) |
0.1 | 0.1 | GO:0006490 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) oligosaccharide-lipid intermediate biosynthetic process(GO:0006490) |
0.1 | 0.3 | GO:0016559 | peroxisome fission(GO:0016559) |
0.1 | 0.3 | GO:1903321 | negative regulation of protein modification by small protein conjugation or removal(GO:1903321) |
0.1 | 0.4 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
0.1 | 0.3 | GO:0010447 | response to acidic pH(GO:0010447) |
0.1 | 0.3 | GO:0060174 | limb bud formation(GO:0060174) |
0.1 | 0.1 | GO:0046685 | response to arsenic-containing substance(GO:0046685) |
0.1 | 0.1 | GO:0015851 | nucleobase transport(GO:0015851) |
0.1 | 0.6 | GO:0048520 | positive regulation of behavior(GO:0048520) |
0.1 | 0.1 | GO:0042448 | progesterone metabolic process(GO:0042448) |
0.1 | 1.4 | GO:0006706 | steroid catabolic process(GO:0006706) |
0.1 | 0.3 | GO:0006368 | transcription elongation from RNA polymerase II promoter(GO:0006368) |
0.1 | 0.8 | GO:0051865 | protein autoubiquitination(GO:0051865) |
0.1 | 0.1 | GO:0010765 | positive regulation of sodium ion transport(GO:0010765) |
0.1 | 0.4 | GO:0070193 | synaptonemal complex organization(GO:0070193) |
0.1 | 0.3 | GO:0006552 | leucine catabolic process(GO:0006552) |
0.1 | 0.3 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.1 | 0.8 | GO:0050772 | positive regulation of axonogenesis(GO:0050772) |
0.1 | 3.0 | GO:0015718 | monocarboxylic acid transport(GO:0015718) |
0.1 | 0.4 | GO:0045736 | negative regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045736) negative regulation of cyclin-dependent protein kinase activity(GO:1904030) |
0.1 | 1.5 | GO:0006084 | acetyl-CoA metabolic process(GO:0006084) |
0.1 | 0.2 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
0.1 | 0.4 | GO:0034394 | protein localization to cell surface(GO:0034394) |
0.1 | 0.5 | GO:0001649 | osteoblast differentiation(GO:0001649) |
0.1 | 0.4 | GO:1904590 | negative regulation of protein import into nucleus(GO:0042308) negative regulation of nucleocytoplasmic transport(GO:0046823) negative regulation of protein localization to nucleus(GO:1900181) negative regulation of protein import(GO:1904590) |
0.1 | 0.2 | GO:0014896 | muscle hypertrophy(GO:0014896) |
0.1 | 0.1 | GO:0043518 | negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) negative regulation of signal transduction by p53 class mediator(GO:1901797) |
0.1 | 0.5 | GO:0045471 | response to ethanol(GO:0045471) |
0.1 | 0.1 | GO:0060206 | estrous cycle phase(GO:0060206) |
0.1 | 0.1 | GO:0072148 | epithelial cell fate commitment(GO:0072148) |
0.1 | 0.2 | GO:0015670 | carbon dioxide transport(GO:0015670) |
0.1 | 0.3 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.1 | 0.5 | GO:0006857 | oligopeptide transport(GO:0006857) |
0.1 | 0.4 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
0.1 | 0.5 | GO:0006895 | Golgi to endosome transport(GO:0006895) Golgi to vacuole transport(GO:0006896) |
0.1 | 0.3 | GO:0000491 | small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
0.1 | 0.2 | GO:0060192 | negative regulation of lipase activity(GO:0060192) |
0.1 | 0.2 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
0.1 | 0.3 | GO:0007341 | penetration of zona pellucida(GO:0007341) |
0.1 | 0.1 | GO:0043586 | tongue development(GO:0043586) |
0.1 | 0.6 | GO:0032526 | response to retinoic acid(GO:0032526) |
0.1 | 2.4 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
0.1 | 0.4 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
0.1 | 0.8 | GO:0045851 | pH reduction(GO:0045851) |
0.1 | 0.1 | GO:0031580 | membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) membrane raft localization(GO:0051665) |
0.1 | 0.1 | GO:0051654 | establishment of mitochondrion localization(GO:0051654) |
0.1 | 0.1 | GO:0032075 | positive regulation of nuclease activity(GO:0032075) |
0.1 | 0.2 | GO:0051325 | interphase(GO:0051325) |
0.1 | 0.2 | GO:0030859 | polarized epithelial cell differentiation(GO:0030859) |
0.1 | 1.3 | GO:0006298 | mismatch repair(GO:0006298) |
0.1 | 1.1 | GO:1901071 | glucosamine-containing compound metabolic process(GO:1901071) |
0.1 | 0.6 | GO:0045670 | regulation of osteoclast differentiation(GO:0045670) |
0.1 | 0.4 | GO:0003214 | cardiac left ventricle morphogenesis(GO:0003214) |
0.1 | 0.7 | GO:0007249 | I-kappaB kinase/NF-kappaB signaling(GO:0007249) |
0.1 | 1.7 | GO:0006699 | bile acid biosynthetic process(GO:0006699) |
0.1 | 0.7 | GO:0070076 | histone lysine demethylation(GO:0070076) |
0.1 | 0.8 | GO:0006103 | 2-oxoglutarate metabolic process(GO:0006103) |
0.1 | 0.4 | GO:0016199 | axon midline choice point recognition(GO:0016199) |
0.1 | 0.6 | GO:0018200 | peptidyl-glutamic acid modification(GO:0018200) |
0.1 | 0.3 | GO:0051156 | glucose 6-phosphate metabolic process(GO:0051156) |
0.1 | 2.5 | GO:0042147 | retrograde transport, endosome to Golgi(GO:0042147) |
0.1 | 0.2 | GO:0042417 | dopamine metabolic process(GO:0042417) |
0.1 | 0.3 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
0.1 | 0.2 | GO:0031112 | positive regulation of microtubule polymerization or depolymerization(GO:0031112) |
0.1 | 1.0 | GO:0031572 | G2 DNA damage checkpoint(GO:0031572) |
0.1 | 1.5 | GO:0006144 | purine nucleobase metabolic process(GO:0006144) |
0.1 | 0.1 | GO:0030516 | regulation of axon extension(GO:0030516) |
0.1 | 0.2 | GO:0006537 | glutamate biosynthetic process(GO:0006537) |
0.1 | 0.4 | GO:0040037 | negative regulation of fibroblast growth factor receptor signaling pathway(GO:0040037) |
0.1 | 0.5 | GO:0060761 | negative regulation of response to cytokine stimulus(GO:0060761) |
0.1 | 1.2 | GO:0008344 | adult locomotory behavior(GO:0008344) |
0.1 | 6.8 | GO:0006487 | protein N-linked glycosylation(GO:0006487) |
0.1 | 0.1 | GO:0033687 | osteoblast proliferation(GO:0033687) |
0.1 | 0.4 | GO:0071158 | positive regulation of cell cycle arrest(GO:0071158) |
0.1 | 0.1 | GO:0085029 | extracellular matrix assembly(GO:0085029) |
0.1 | 6.1 | GO:0006402 | mRNA catabolic process(GO:0006402) |
0.1 | 1.4 | GO:0046854 | phosphatidylinositol phosphorylation(GO:0046854) |
0.1 | 0.1 | GO:0050710 | negative regulation of cytokine secretion(GO:0050710) |
0.1 | 3.7 | GO:0043401 | steroid hormone mediated signaling pathway(GO:0043401) |
0.1 | 0.5 | GO:0018106 | peptidyl-histidine phosphorylation(GO:0018106) peptidyl-histidine modification(GO:0018202) |
0.1 | 0.4 | GO:0050912 | detection of chemical stimulus involved in sensory perception of taste(GO:0050912) |
0.1 | 3.6 | GO:0031295 | lymphocyte costimulation(GO:0031294) T cell costimulation(GO:0031295) |
0.1 | 0.4 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.1 | 0.5 | GO:0045116 | protein neddylation(GO:0045116) |
0.1 | 1.2 | GO:0051225 | spindle assembly(GO:0051225) |
0.1 | 0.1 | GO:0010745 | negative regulation of macrophage derived foam cell differentiation(GO:0010745) |
0.1 | 1.7 | GO:0006413 | translational initiation(GO:0006413) |
0.1 | 0.2 | GO:0001302 | replicative cell aging(GO:0001302) |
0.1 | 1.7 | GO:0000723 | telomere maintenance(GO:0000723) |
0.1 | 0.4 | GO:0046579 | positive regulation of Ras protein signal transduction(GO:0046579) |
0.1 | 1.3 | GO:0006909 | phagocytosis(GO:0006909) |
0.1 | 1.4 | GO:1903902 | positive regulation of viral process(GO:0048524) positive regulation of viral life cycle(GO:1903902) |
0.1 | 0.1 | GO:0001306 | age-dependent response to oxidative stress(GO:0001306) age-dependent general metabolic decline(GO:0007571) |
0.1 | 0.7 | GO:1903322 | positive regulation of protein modification by small protein conjugation or removal(GO:1903322) |
0.1 | 2.3 | GO:0044344 | cellular response to fibroblast growth factor stimulus(GO:0044344) response to fibroblast growth factor(GO:0071774) |
0.1 | 0.6 | GO:0072384 | organelle transport along microtubule(GO:0072384) |
0.1 | 0.4 | GO:0006378 | mRNA polyadenylation(GO:0006378) |
0.1 | 1.9 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
0.1 | 0.2 | GO:0045844 | positive regulation of striated muscle tissue development(GO:0045844) positive regulation of muscle organ development(GO:0048636) positive regulation of muscle tissue development(GO:1901863) |
0.1 | 1.4 | GO:0006006 | glucose metabolic process(GO:0006006) |
0.1 | 0.1 | GO:0051775 | response to redox state(GO:0051775) |
0.1 | 0.2 | GO:0072599 | protein targeting to ER(GO:0045047) establishment of protein localization to endoplasmic reticulum(GO:0072599) |
0.1 | 0.3 | GO:0055092 | cholesterol homeostasis(GO:0042632) sterol homeostasis(GO:0055092) |
0.1 | 0.4 | GO:0016973 | poly(A)+ mRNA export from nucleus(GO:0016973) |
0.1 | 1.6 | GO:0006270 | DNA replication initiation(GO:0006270) |
0.1 | 0.1 | GO:0021631 | optic nerve morphogenesis(GO:0021631) |
0.1 | 0.7 | GO:0044349 | nucleotide-excision repair, DNA damage removal(GO:0000718) DNA excision(GO:0044349) |
0.1 | 0.6 | GO:0000187 | activation of MAPK activity(GO:0000187) |
0.1 | 0.3 | GO:0034620 | endoplasmic reticulum unfolded protein response(GO:0030968) cellular response to unfolded protein(GO:0034620) |
0.1 | 1.4 | GO:0030837 | negative regulation of actin filament polymerization(GO:0030837) |
0.1 | 0.5 | GO:0001676 | long-chain fatty acid metabolic process(GO:0001676) |
0.1 | 0.3 | GO:0006448 | regulation of translational elongation(GO:0006448) |
0.1 | 0.2 | GO:0019852 | L-ascorbic acid metabolic process(GO:0019852) |
0.1 | 0.7 | GO:1901264 | carbohydrate derivative transport(GO:1901264) |
0.1 | 0.4 | GO:0001967 | suckling behavior(GO:0001967) |
0.1 | 1.3 | GO:0000245 | spliceosomal complex assembly(GO:0000245) |
0.1 | 0.6 | GO:0015939 | pantothenate metabolic process(GO:0015939) |
0.1 | 0.6 | GO:0043124 | negative regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043124) |
0.1 | 0.7 | GO:0007492 | endoderm development(GO:0007492) |
0.1 | 0.1 | GO:0043653 | mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
0.1 | 0.3 | GO:0042158 | lipoprotein biosynthetic process(GO:0042158) |
0.1 | 0.6 | GO:0046784 | viral mRNA export from host cell nucleus(GO:0046784) |
0.1 | 0.6 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
0.1 | 0.1 | GO:0072698 | protein localization to cytoskeleton(GO:0044380) protein localization to microtubule cytoskeleton(GO:0072698) |
0.1 | 0.1 | GO:0042362 | fat-soluble vitamin biosynthetic process(GO:0042362) |
0.1 | 0.3 | GO:0050957 | equilibrioception(GO:0050957) |
0.1 | 0.3 | GO:0046328 | regulation of JNK cascade(GO:0046328) |
0.1 | 3.3 | GO:0006914 | autophagy(GO:0006914) |
0.1 | 0.4 | GO:0051602 | response to electrical stimulus(GO:0051602) |
0.1 | 1.4 | GO:0040008 | regulation of growth(GO:0040008) |
0.1 | 1.6 | GO:0006612 | protein targeting to membrane(GO:0006612) |
0.1 | 0.3 | GO:0018107 | peptidyl-threonine phosphorylation(GO:0018107) |
0.1 | 0.3 | GO:0034067 | protein localization to Golgi apparatus(GO:0034067) |
0.1 | 0.1 | GO:0046952 | cellular ketone body metabolic process(GO:0046950) ketone body catabolic process(GO:0046952) |
0.1 | 0.3 | GO:0006911 | phagocytosis, engulfment(GO:0006911) membrane invagination(GO:0010324) |
0.1 | 1.9 | GO:0007623 | circadian rhythm(GO:0007623) |
0.1 | 0.8 | GO:0006379 | mRNA cleavage(GO:0006379) |
0.1 | 0.8 | GO:0009311 | oligosaccharide metabolic process(GO:0009311) |
0.1 | 0.3 | GO:0000050 | urea cycle(GO:0000050) |
0.1 | 0.4 | GO:0032528 | microvillus assembly(GO:0030033) microvillus organization(GO:0032528) |
0.1 | 0.1 | GO:0042311 | vasodilation(GO:0042311) |
0.1 | 0.2 | GO:0035058 | nonmotile primary cilium assembly(GO:0035058) |
0.1 | 0.8 | GO:0006405 | RNA export from nucleus(GO:0006405) |
0.1 | 7.4 | GO:0022900 | electron transport chain(GO:0022900) |
0.1 | 1.0 | GO:0005980 | glycogen catabolic process(GO:0005980) |
0.1 | 0.3 | GO:0042423 | catechol-containing compound biosynthetic process(GO:0009713) catecholamine biosynthetic process(GO:0042423) |
0.1 | 0.1 | GO:0050709 | negative regulation of protein secretion(GO:0050709) |
0.1 | 0.8 | GO:0042255 | ribosome assembly(GO:0042255) |
0.1 | 1.0 | GO:0043484 | regulation of RNA splicing(GO:0043484) |
0.1 | 0.1 | GO:0034650 | aldosterone metabolic process(GO:0032341) aldosterone biosynthetic process(GO:0032342) cortisol metabolic process(GO:0034650) cortisol biosynthetic process(GO:0034651) |
0.1 | 2.3 | GO:0009062 | fatty acid catabolic process(GO:0009062) |
0.1 | 0.2 | GO:0021895 | cerebral cortex neuron differentiation(GO:0021895) |
0.1 | 0.3 | GO:0032924 | activin receptor signaling pathway(GO:0032924) |
0.1 | 0.2 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.1 | 0.1 | GO:0031929 | TOR signaling(GO:0031929) |
0.1 | 1.4 | GO:0036503 | ER-associated ubiquitin-dependent protein catabolic process(GO:0030433) ERAD pathway(GO:0036503) |
0.1 | 0.2 | GO:0007143 | female meiotic division(GO:0007143) |
0.1 | 0.4 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
0.1 | 0.2 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
0.1 | 0.1 | GO:0021915 | neural tube development(GO:0021915) |
0.1 | 0.2 | GO:0030641 | regulation of cellular pH(GO:0030641) |
0.1 | 0.1 | GO:0009251 | glucan catabolic process(GO:0009251) cellular polysaccharide catabolic process(GO:0044247) |
0.1 | 3.2 | GO:0006968 | cellular defense response(GO:0006968) |
0.1 | 0.1 | GO:0021675 | nerve development(GO:0021675) |
0.1 | 0.1 | GO:0071285 | cellular response to lithium ion(GO:0071285) |
0.1 | 0.1 | GO:0072177 | nephric duct development(GO:0072176) mesonephric duct development(GO:0072177) |
0.1 | 0.3 | GO:0048496 | maintenance of organ identity(GO:0048496) |
0.1 | 0.4 | GO:0006073 | cellular glucan metabolic process(GO:0006073) glucan metabolic process(GO:0044042) |
0.1 | 0.2 | GO:0051382 | kinetochore assembly(GO:0051382) |
0.1 | 0.2 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
0.1 | 0.2 | GO:0007220 | Notch receptor processing(GO:0007220) |
0.1 | 0.5 | GO:0045214 | sarcomere organization(GO:0045214) |
0.1 | 0.2 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
0.1 | 0.1 | GO:0032695 | negative regulation of interleukin-12 production(GO:0032695) |
0.1 | 0.3 | GO:0008630 | intrinsic apoptotic signaling pathway in response to DNA damage(GO:0008630) |
0.1 | 0.4 | GO:0000012 | single strand break repair(GO:0000012) |
0.1 | 0.1 | GO:0006303 | double-strand break repair via nonhomologous end joining(GO:0006303) |
0.1 | 0.1 | GO:0006883 | cellular sodium ion homeostasis(GO:0006883) |
0.1 | 1.5 | GO:0018149 | peptide cross-linking(GO:0018149) |
0.1 | 1.1 | GO:0016574 | histone ubiquitination(GO:0016574) |
0.1 | 0.1 | GO:0033238 | regulation of cellular amine metabolic process(GO:0033238) |
0.1 | 0.3 | GO:0000460 | maturation of 5.8S rRNA(GO:0000460) |
0.1 | 0.2 | GO:0031282 | regulation of guanylate cyclase activity(GO:0031282) |
0.1 | 0.5 | GO:0061008 | hepaticobiliary system development(GO:0061008) |
0.1 | 0.2 | GO:0032543 | mitochondrial translation(GO:0032543) |
0.1 | 0.3 | GO:0071806 | intracellular protein transmembrane import(GO:0044743) intracellular protein transmembrane transport(GO:0065002) protein transmembrane transport(GO:0071806) |
0.1 | 0.3 | GO:0019233 | sensory perception of pain(GO:0019233) |
0.1 | 0.4 | GO:0022616 | DNA strand elongation(GO:0022616) |
0.1 | 0.3 | GO:0014047 | glutamate secretion(GO:0014047) |
0.1 | 0.3 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
0.1 | 0.1 | GO:0008628 | hormone-mediated apoptotic signaling pathway(GO:0008628) |
0.1 | 0.2 | GO:0035024 | negative regulation of Rho protein signal transduction(GO:0035024) |
0.1 | 0.6 | GO:0046320 | regulation of fatty acid oxidation(GO:0046320) |
0.1 | 0.1 | GO:0060638 | mesenchymal-epithelial cell signaling(GO:0060638) |
0.1 | 0.1 | GO:0006702 | androgen biosynthetic process(GO:0006702) |
0.1 | 0.6 | GO:0051899 | membrane depolarization(GO:0051899) |
0.1 | 0.1 | GO:0048070 | regulation of developmental pigmentation(GO:0048070) |
0.1 | 0.5 | GO:0042274 | ribosomal small subunit biogenesis(GO:0042274) |
0.1 | 0.3 | GO:0008584 | male gonad development(GO:0008584) development of primary male sexual characteristics(GO:0046546) |
0.1 | 0.9 | GO:0070588 | calcium ion transmembrane transport(GO:0070588) |
0.1 | 0.1 | GO:0032963 | collagen metabolic process(GO:0032963) |
0.1 | 8.0 | GO:0043087 | regulation of GTPase activity(GO:0043087) |
0.1 | 0.1 | GO:0090662 | energy coupled proton transmembrane transport, against electrochemical gradient(GO:0015988) ATP hydrolysis coupled proton transport(GO:0015991) ATP hydrolysis coupled transmembrane transport(GO:0090662) |
0.1 | 0.2 | GO:0071569 | protein ufmylation(GO:0071569) |
0.1 | 0.2 | GO:0033327 | Leydig cell differentiation(GO:0033327) |
0.1 | 6.5 | GO:0006184 | obsolete GTP catabolic process(GO:0006184) |
0.1 | 0.3 | GO:0080111 | DNA demethylation(GO:0080111) |
0.1 | 0.1 | GO:0061041 | regulation of wound healing(GO:0061041) |
0.1 | 5.1 | GO:0000398 | RNA splicing, via transesterification reactions with bulged adenosine as nucleophile(GO:0000377) mRNA splicing, via spliceosome(GO:0000398) |
0.1 | 0.4 | GO:0030901 | midbrain development(GO:0030901) |
0.1 | 0.3 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.1 | 0.1 | GO:0018343 | protein farnesylation(GO:0018343) |
0.1 | 2.3 | GO:0019882 | antigen processing and presentation(GO:0019882) |
0.1 | 0.1 | GO:0071624 | positive regulation of granulocyte chemotaxis(GO:0071624) |
0.1 | 0.2 | GO:0000060 | protein import into nucleus, translocation(GO:0000060) |
0.1 | 0.6 | GO:0046068 | cGMP metabolic process(GO:0046068) |
0.1 | 0.2 | GO:0051187 | cofactor catabolic process(GO:0051187) |
0.1 | 0.1 | GO:0006266 | DNA ligation(GO:0006266) |
0.1 | 0.2 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) protein O-linked glycosylation via threonine(GO:0018243) |
0.1 | 2.4 | GO:0006338 | chromatin remodeling(GO:0006338) |
0.1 | 0.4 | GO:0048771 | tissue remodeling(GO:0048771) |
0.1 | 0.6 | GO:0031032 | actomyosin structure organization(GO:0031032) |
0.1 | 0.1 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
0.1 | 0.1 | GO:0034219 | carbohydrate transmembrane transport(GO:0034219) |
0.1 | 0.1 | GO:0009200 | deoxyribonucleoside triphosphate metabolic process(GO:0009200) |
0.1 | 3.5 | GO:0006631 | fatty acid metabolic process(GO:0006631) |
0.1 | 0.9 | GO:0032874 | positive regulation of stress-activated MAPK cascade(GO:0032874) |
0.1 | 0.1 | GO:0045916 | negative regulation of complement activation(GO:0045916) negative regulation of protein activation cascade(GO:2000258) |
0.1 | 0.1 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
0.1 | 0.6 | GO:0007200 | phospholipase C-activating G-protein coupled receptor signaling pathway(GO:0007200) |
0.1 | 0.2 | GO:0035092 | sperm chromatin condensation(GO:0035092) |
0.1 | 0.3 | GO:0031532 | actin cytoskeleton reorganization(GO:0031532) |
0.1 | 0.5 | GO:0016925 | protein sumoylation(GO:0016925) |
0.1 | 0.5 | GO:0006363 | termination of RNA polymerase I transcription(GO:0006363) |
0.1 | 4.9 | GO:0016042 | lipid catabolic process(GO:0016042) |
0.1 | 0.2 | GO:0090303 | positive regulation of wound healing(GO:0090303) |
0.1 | 0.3 | GO:2000142 | regulation of transcription initiation from RNA polymerase II promoter(GO:0060260) regulation of DNA-templated transcription, initiation(GO:2000142) |
0.1 | 0.2 | GO:0070272 | proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
0.1 | 0.1 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.1 | 0.1 | GO:0006772 | thiamine metabolic process(GO:0006772) |
0.1 | 0.4 | GO:0015074 | DNA integration(GO:0015074) |
0.1 | 0.1 | GO:0050955 | thermoception(GO:0050955) |
0.1 | 0.1 | GO:0032119 | sequestering of zinc ion(GO:0032119) |
0.1 | 0.1 | GO:0008653 | lipopolysaccharide metabolic process(GO:0008653) |
0.1 | 0.1 | GO:0032105 | negative regulation of response to extracellular stimulus(GO:0032105) negative regulation of response to nutrient levels(GO:0032108) |
0.1 | 0.1 | GO:0001702 | gastrulation with mouth forming second(GO:0001702) |
0.1 | 0.3 | GO:0048247 | lymphocyte chemotaxis(GO:0048247) lymphocyte migration(GO:0072676) |
0.1 | 0.4 | GO:0019079 | viral genome replication(GO:0019079) |
0.1 | 0.2 | GO:0032729 | positive regulation of interferon-gamma production(GO:0032729) |
0.1 | 0.6 | GO:0071577 | zinc II ion transmembrane transport(GO:0071577) |
0.1 | 0.3 | GO:1903051 | negative regulation of proteolysis involved in cellular protein catabolic process(GO:1903051) negative regulation of cellular protein catabolic process(GO:1903363) |
0.1 | 0.1 | GO:0045176 | apical protein localization(GO:0045176) |
0.1 | 0.1 | GO:0061081 | positive regulation of myeloid leukocyte cytokine production involved in immune response(GO:0061081) |
0.1 | 0.5 | GO:0007140 | male meiosis(GO:0007140) |
0.1 | 0.2 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
0.1 | 1.2 | GO:0010212 | response to ionizing radiation(GO:0010212) |
0.1 | 0.1 | GO:0050860 | negative regulation of antigen receptor-mediated signaling pathway(GO:0050858) negative regulation of T cell receptor signaling pathway(GO:0050860) |
0.1 | 0.1 | GO:0034086 | maintenance of sister chromatid cohesion(GO:0034086) maintenance of mitotic sister chromatid cohesion(GO:0034088) |
0.1 | 0.1 | GO:0090277 | positive regulation of peptide hormone secretion(GO:0090277) |
0.1 | 0.1 | GO:0090504 | wound healing, spreading of epidermal cells(GO:0035313) wound healing, spreading of cells(GO:0044319) epiboly(GO:0090504) epiboly involved in wound healing(GO:0090505) |
0.1 | 3.1 | GO:0000084 | mitotic S phase(GO:0000084) |
0.1 | 0.3 | GO:0006108 | malate metabolic process(GO:0006108) |
0.1 | 0.2 | GO:0007506 | gonadal mesoderm development(GO:0007506) |
0.1 | 0.4 | GO:0019933 | cAMP-mediated signaling(GO:0019933) |
0.1 | 0.3 | GO:1903320 | regulation of protein modification by small protein conjugation or removal(GO:1903320) |
0.1 | 1.6 | GO:0010952 | positive regulation of peptidase activity(GO:0010952) |
0.1 | 0.2 | GO:0050830 | defense response to Gram-positive bacterium(GO:0050830) |
0.1 | 0.4 | GO:0048017 | phosphatidylinositol-mediated signaling(GO:0048015) inositol lipid-mediated signaling(GO:0048017) |
0.1 | 0.3 | GO:0009812 | flavonoid metabolic process(GO:0009812) |
0.1 | 0.1 | GO:0042273 | ribosomal large subunit biogenesis(GO:0042273) |
0.1 | 1.4 | GO:0006367 | transcription initiation from RNA polymerase II promoter(GO:0006367) |
0.1 | 2.7 | GO:0000236 | mitotic prometaphase(GO:0000236) |
0.1 | 0.1 | GO:0009048 | dosage compensation by inactivation of X chromosome(GO:0009048) |
0.1 | 0.1 | GO:0003279 | cardiac septum development(GO:0003279) |
0.1 | 0.4 | GO:0042542 | response to hydrogen peroxide(GO:0042542) |
0.1 | 4.6 | GO:0006333 | chromatin assembly or disassembly(GO:0006333) |
0.1 | 0.1 | GO:0006354 | DNA-templated transcription, elongation(GO:0006354) |
0.1 | 0.1 | GO:2000054 | negative regulation of Wnt signaling pathway involved in dorsal/ventral axis specification(GO:2000054) |
0.1 | 0.1 | GO:0006216 | cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
0.1 | 1.1 | GO:0006839 | mitochondrial transport(GO:0006839) |
0.1 | 0.3 | GO:0006069 | ethanol metabolic process(GO:0006067) ethanol oxidation(GO:0006069) |
0.1 | 0.3 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
0.1 | 0.3 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.1 | 0.1 | GO:0048645 | organ formation(GO:0048645) |
0.1 | 0.1 | GO:0040009 | regulation of growth rate(GO:0040009) |
0.1 | 5.0 | GO:0016311 | dephosphorylation(GO:0016311) |
0.1 | 0.7 | GO:0006778 | porphyrin-containing compound metabolic process(GO:0006778) |
0.1 | 0.1 | GO:0008634 | obsolete negative regulation of survival gene product expression(GO:0008634) |
0.1 | 6.3 | GO:0006281 | DNA repair(GO:0006281) |
0.1 | 0.1 | GO:0045005 | DNA-dependent DNA replication maintenance of fidelity(GO:0045005) |
0.1 | 0.2 | GO:0016584 | nucleosome positioning(GO:0016584) |
0.1 | 9.5 | GO:0043043 | peptide biosynthetic process(GO:0043043) |
0.1 | 0.3 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
0.1 | 3.9 | GO:0006414 | translational elongation(GO:0006414) |
0.1 | 0.3 | GO:0042462 | eye photoreceptor cell development(GO:0042462) |
0.1 | 0.2 | GO:0051588 | regulation of neurotransmitter transport(GO:0051588) |
0.1 | 3.7 | GO:0008380 | RNA splicing(GO:0008380) |
0.1 | 0.2 | GO:0008045 | motor neuron axon guidance(GO:0008045) |
0.1 | 0.1 | GO:0010669 | epithelial structure maintenance(GO:0010669) maintenance of gastrointestinal epithelium(GO:0030277) |
0.1 | 1.8 | GO:0045454 | cell redox homeostasis(GO:0045454) |
0.1 | 0.1 | GO:0009755 | hormone-mediated signaling pathway(GO:0009755) |
0.1 | 0.4 | GO:0080171 | lysosome organization(GO:0007040) lytic vacuole organization(GO:0080171) |
0.1 | 0.3 | GO:0003009 | skeletal muscle contraction(GO:0003009) |
0.1 | 0.4 | GO:0071356 | cellular response to tumor necrosis factor(GO:0071356) |
0.1 | 0.6 | GO:0032480 | negative regulation of type I interferon production(GO:0032480) |
0.1 | 0.9 | GO:0007189 | adenylate cyclase-activating G-protein coupled receptor signaling pathway(GO:0007189) |
0.1 | 0.8 | GO:0019319 | hexose biosynthetic process(GO:0019319) |
0.1 | 1.0 | GO:1903046 | meiotic cell cycle process(GO:1903046) |
0.1 | 1.9 | GO:0006826 | iron ion transport(GO:0006826) |
0.1 | 0.1 | GO:0039656 | modulation by virus of host gene expression(GO:0039656) |
0.0 | 0.1 | GO:0033008 | regulation of mast cell activation involved in immune response(GO:0033006) positive regulation of mast cell activation involved in immune response(GO:0033008) positive regulation of leukocyte degranulation(GO:0043302) regulation of mast cell degranulation(GO:0043304) positive regulation of mast cell degranulation(GO:0043306) |
0.0 | 0.4 | GO:0051781 | positive regulation of cell division(GO:0051781) |
0.0 | 0.0 | GO:0097028 | myeloid dendritic cell differentiation(GO:0043011) dendritic cell differentiation(GO:0097028) |
0.0 | 0.5 | GO:0002455 | humoral immune response mediated by circulating immunoglobulin(GO:0002455) |
0.0 | 0.4 | GO:0050819 | negative regulation of coagulation(GO:0050819) |
0.0 | 0.1 | GO:0021978 | telencephalon regionalization(GO:0021978) |
0.0 | 0.6 | GO:0007286 | spermatid development(GO:0007286) |
0.0 | 0.1 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) positive regulation of G1/S transition of mitotic cell cycle(GO:1900087) positive regulation of cell cycle G1/S phase transition(GO:1902808) |
0.0 | 0.5 | GO:0017158 | regulation of calcium ion-dependent exocytosis(GO:0017158) regulation of regulated secretory pathway(GO:1903305) |
0.0 | 0.0 | GO:0032508 | DNA duplex unwinding(GO:0032508) |
0.0 | 0.1 | GO:0007029 | endoplasmic reticulum organization(GO:0007029) |
0.0 | 0.2 | GO:0032411 | positive regulation of transporter activity(GO:0032411) |
0.0 | 0.3 | GO:0044070 | regulation of anion transport(GO:0044070) |
0.0 | 0.5 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.0 | 0.1 | GO:0051928 | positive regulation of calcium ion transport(GO:0051928) |
0.0 | 0.0 | GO:0060831 | smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:0060831) |
0.0 | 0.3 | GO:0030301 | cholesterol transport(GO:0030301) |
0.0 | 3.3 | GO:0006457 | protein folding(GO:0006457) |
0.0 | 0.0 | GO:0001976 | neurological system process involved in regulation of systemic arterial blood pressure(GO:0001976) |
0.0 | 0.1 | GO:0006922 | obsolete cleavage of lamin involved in execution phase of apoptosis(GO:0006922) |
0.0 | 0.4 | GO:0042246 | tissue regeneration(GO:0042246) |
0.0 | 0.0 | GO:0009822 | alkaloid catabolic process(GO:0009822) |
0.0 | 0.3 | GO:0031290 | retinal ganglion cell axon guidance(GO:0031290) |
0.0 | 0.1 | GO:0075713 | establishment of viral latency(GO:0019043) establishment of integrated proviral latency(GO:0075713) |
0.0 | 0.0 | GO:0060033 | Mullerian duct regression(GO:0001880) anatomical structure regression(GO:0060033) |
0.0 | 1.5 | GO:0008033 | tRNA processing(GO:0008033) |
0.0 | 0.0 | GO:0006000 | fructose metabolic process(GO:0006000) |
0.0 | 0.1 | GO:0050908 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
0.0 | 0.2 | GO:0046653 | tetrahydrofolate metabolic process(GO:0046653) |
0.0 | 0.1 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
0.0 | 0.3 | GO:0017157 | regulation of exocytosis(GO:0017157) |
0.0 | 0.5 | GO:0071554 | cell wall macromolecule catabolic process(GO:0016998) cell wall macromolecule metabolic process(GO:0044036) cell wall organization or biogenesis(GO:0071554) |
0.0 | 0.1 | GO:0007632 | visual behavior(GO:0007632) |
0.0 | 0.0 | GO:0021569 | rhombomere 3 development(GO:0021569) |
0.0 | 0.0 | GO:0046520 | sphingoid biosynthetic process(GO:0046520) |
0.0 | 0.1 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
0.0 | 0.5 | GO:0006903 | vesicle targeting(GO:0006903) |
0.0 | 3.4 | GO:0044764 | multi-organism cellular process(GO:0044764) |
0.0 | 4.8 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.0 | 2.8 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
0.0 | 0.1 | GO:0033483 | gas homeostasis(GO:0033483) |
0.0 | 0.2 | GO:0033077 | T cell differentiation in thymus(GO:0033077) thymocyte aggregation(GO:0071594) |
0.0 | 0.1 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
0.0 | 19.2 | GO:0006508 | proteolysis(GO:0006508) |
0.0 | 0.2 | GO:0006476 | protein deacetylation(GO:0006476) |
0.0 | 0.2 | GO:0006352 | DNA-templated transcription, initiation(GO:0006352) |
0.0 | 0.2 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
0.0 | 0.2 | GO:0050870 | positive regulation of T cell activation(GO:0050870) positive regulation of leukocyte cell-cell adhesion(GO:1903039) |
0.0 | 0.3 | GO:0032259 | methylation(GO:0032259) |
0.0 | 0.0 | GO:0060836 | lymphatic endothelial cell differentiation(GO:0060836) |
0.0 | 0.0 | GO:0006304 | DNA modification(GO:0006304) |
0.0 | 0.2 | GO:0045762 | positive regulation of adenylate cyclase activity(GO:0045762) |
0.0 | 0.1 | GO:0031069 | hair follicle morphogenesis(GO:0031069) |
0.0 | 1.1 | GO:0007034 | vacuolar transport(GO:0007034) |
0.0 | 0.0 | GO:0070509 | calcium ion import(GO:0070509) |
0.0 | 0.1 | GO:0032606 | type I interferon production(GO:0032606) |
0.0 | 0.2 | GO:0006704 | glucocorticoid biosynthetic process(GO:0006704) |
0.0 | 0.2 | GO:0031047 | gene silencing by RNA(GO:0031047) |
0.0 | 0.3 | GO:0051384 | response to glucocorticoid(GO:0051384) |
0.0 | 0.1 | GO:0019236 | response to pheromone(GO:0019236) |
0.0 | 0.0 | GO:0045630 | positive regulation of type 2 immune response(GO:0002830) positive regulation of T-helper 2 cell differentiation(GO:0045630) |
0.0 | 0.0 | GO:0015810 | C4-dicarboxylate transport(GO:0015740) aspartate transport(GO:0015810) |
0.0 | 0.3 | GO:0015800 | acidic amino acid transport(GO:0015800) |
0.0 | 0.2 | GO:0033108 | mitochondrial respiratory chain complex assembly(GO:0033108) |
0.0 | 0.0 | GO:0031573 | intra-S DNA damage checkpoint(GO:0031573) |
0.0 | 0.5 | GO:0006959 | humoral immune response(GO:0006959) |
0.0 | 1.6 | GO:0070647 | protein modification by small protein conjugation or removal(GO:0070647) |
0.0 | 0.1 | GO:0008614 | pyridoxine metabolic process(GO:0008614) pyridoxine biosynthetic process(GO:0008615) vitamin B6 metabolic process(GO:0042816) vitamin B6 biosynthetic process(GO:0042819) |
0.0 | 0.1 | GO:0050807 | regulation of synapse organization(GO:0050807) |
0.0 | 0.2 | GO:0007270 | neuron-neuron synaptic transmission(GO:0007270) |
0.0 | 0.1 | GO:0098743 | cartilage condensation(GO:0001502) cell aggregation(GO:0098743) |
0.0 | 0.4 | GO:0035966 | response to unfolded protein(GO:0006986) response to topologically incorrect protein(GO:0035966) |
0.0 | 0.1 | GO:0043266 | regulation of potassium ion transport(GO:0043266) |
0.0 | 1.2 | GO:0034470 | ncRNA processing(GO:0034470) |
0.0 | 0.1 | GO:0001508 | action potential(GO:0001508) |
0.0 | 0.7 | GO:0061025 | membrane fusion(GO:0061025) |
0.0 | 0.5 | GO:0044839 | G2/M transition of mitotic cell cycle(GO:0000086) cell cycle G2/M phase transition(GO:0044839) |
0.0 | 0.5 | GO:0006383 | transcription from RNA polymerase III promoter(GO:0006383) |
0.0 | 2.6 | GO:0006325 | chromatin organization(GO:0006325) |
0.0 | 0.8 | GO:0008643 | carbohydrate transport(GO:0008643) |
0.0 | 0.1 | GO:0007080 | mitotic metaphase plate congression(GO:0007080) |
0.0 | 0.4 | GO:0006953 | acute-phase response(GO:0006953) |
0.0 | 0.0 | GO:0016048 | detection of temperature stimulus(GO:0016048) detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
0.0 | 0.0 | GO:0045165 | cell fate commitment(GO:0045165) |
0.0 | 0.1 | GO:0051298 | centrosome duplication(GO:0051298) |
0.0 | 0.1 | GO:0051297 | centrosome organization(GO:0051297) |
0.0 | 0.2 | GO:0007157 | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0007157) |
0.0 | 0.1 | GO:0048515 | spermatid differentiation(GO:0048515) |
0.0 | 0.1 | GO:0006099 | tricarboxylic acid cycle(GO:0006099) |
0.0 | 0.1 | GO:0015695 | organic cation transport(GO:0015695) |
0.0 | 0.1 | GO:0007051 | spindle organization(GO:0007051) |
0.0 | 0.1 | GO:0006879 | cellular iron ion homeostasis(GO:0006879) |
0.0 | 0.0 | GO:0010720 | positive regulation of cell development(GO:0010720) |
0.0 | 0.4 | GO:0016358 | dendrite development(GO:0016358) |
0.0 | 0.2 | GO:0008217 | regulation of blood pressure(GO:0008217) |
0.0 | 0.1 | GO:0048538 | thymus development(GO:0048538) |
0.0 | 0.1 | GO:0009143 | nucleoside triphosphate catabolic process(GO:0009143) |
0.0 | 0.0 | GO:0060972 | left/right pattern formation(GO:0060972) |
0.0 | 0.0 | GO:1902930 | regulation of alcohol biosynthetic process(GO:1902930) |
0.0 | 0.2 | GO:0070206 | protein trimerization(GO:0070206) |
0.0 | 1.5 | GO:0016049 | cell growth(GO:0016049) |
0.0 | 0.2 | GO:0043269 | regulation of ion transport(GO:0043269) |
0.0 | 1.1 | GO:0006396 | RNA processing(GO:0006396) |
0.0 | 0.1 | GO:0072595 | maintenance of protein localization in organelle(GO:0072595) |
0.0 | 0.0 | GO:0043094 | cellular metabolic compound salvage(GO:0043094) |
0.0 | 0.8 | GO:0031424 | keratinization(GO:0031424) |
0.0 | 0.2 | GO:0000279 | M phase(GO:0000279) |
0.0 | 1.7 | GO:0044419 | interspecies interaction between organisms(GO:0044419) |
0.0 | 0.1 | GO:0045616 | regulation of keratinocyte differentiation(GO:0045616) |
0.0 | 1.6 | GO:0048285 | organelle fission(GO:0048285) |
0.0 | 0.0 | GO:0035050 | embryonic heart tube development(GO:0035050) |
0.0 | 0.1 | GO:0046337 | phosphatidylethanolamine biosynthetic process(GO:0006646) phosphatidylethanolamine metabolic process(GO:0046337) |
0.0 | 0.4 | GO:0007338 | single fertilization(GO:0007338) |
0.0 | 0.1 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.0 | 0.7 | GO:0008654 | phospholipid biosynthetic process(GO:0008654) |
0.0 | 0.3 | GO:0006479 | protein methylation(GO:0006479) protein alkylation(GO:0008213) |
0.0 | 0.1 | GO:0034214 | protein hexamerization(GO:0034214) |
0.0 | 0.5 | GO:0048706 | embryonic skeletal system development(GO:0048706) |
0.0 | 0.1 | GO:0007271 | synaptic transmission, cholinergic(GO:0007271) |
0.0 | 0.6 | GO:0007219 | Notch signaling pathway(GO:0007219) |
0.0 | 0.0 | GO:0072523 | purine-containing compound catabolic process(GO:0072523) |
0.0 | 0.2 | GO:0002088 | lens development in camera-type eye(GO:0002088) |
0.0 | 0.2 | GO:0045333 | cellular respiration(GO:0045333) |
0.0 | 0.0 | GO:0051193 | regulation of cofactor metabolic process(GO:0051193) regulation of coenzyme metabolic process(GO:0051196) |
0.0 | 0.1 | GO:0007254 | JNK cascade(GO:0007254) |
0.0 | 0.3 | GO:0007519 | skeletal muscle tissue development(GO:0007519) |
0.0 | 0.3 | GO:0006672 | ceramide metabolic process(GO:0006672) |
0.0 | 0.1 | GO:0035434 | copper ion transmembrane transport(GO:0035434) |
0.0 | 0.1 | GO:0015949 | nucleobase-containing small molecule interconversion(GO:0015949) |
0.0 | 0.0 | GO:1903036 | positive regulation of response to wounding(GO:1903036) |
0.0 | 0.1 | GO:0050910 | detection of mechanical stimulus involved in sensory perception of sound(GO:0050910) |
0.0 | 0.3 | GO:0006493 | protein O-linked glycosylation(GO:0006493) |
0.0 | 0.3 | GO:0007173 | epidermal growth factor receptor signaling pathway(GO:0007173) ERBB signaling pathway(GO:0038127) |
0.0 | 0.1 | GO:0006825 | copper ion transport(GO:0006825) |
0.0 | 0.1 | GO:0006644 | phospholipid metabolic process(GO:0006644) |
0.0 | 0.5 | GO:0006259 | DNA metabolic process(GO:0006259) |
0.0 | 0.1 | GO:0043473 | pigmentation(GO:0043473) |
0.0 | 0.0 | GO:0008214 | protein demethylation(GO:0006482) protein dealkylation(GO:0008214) |
0.0 | 0.0 | GO:0043900 | regulation of multi-organism process(GO:0043900) |
0.0 | 0.3 | GO:0006643 | membrane lipid metabolic process(GO:0006643) |
0.0 | 1.1 | GO:0006814 | sodium ion transport(GO:0006814) |
0.0 | 0.0 | GO:0070989 | oxidative demethylation(GO:0070989) |
0.0 | 0.1 | GO:0043543 | protein acetylation(GO:0006473) protein acylation(GO:0043543) |
0.0 | 0.1 | GO:0050873 | brown fat cell differentiation(GO:0050873) |
0.0 | 0.1 | GO:0051923 | sulfation(GO:0051923) |
0.0 | 13.4 | GO:0032774 | RNA biosynthetic process(GO:0032774) |
0.0 | 0.0 | GO:0007059 | chromosome segregation(GO:0007059) |
0.0 | 0.1 | GO:0034332 | adherens junction organization(GO:0034332) |
0.0 | 0.2 | GO:0046165 | alcohol biosynthetic process(GO:0046165) |
0.0 | 0.0 | GO:0045907 | positive regulation of vasoconstriction(GO:0045907) |
0.0 | 0.1 | GO:0009408 | response to heat(GO:0009408) |
0.0 | 0.1 | GO:0043687 | post-translational protein modification(GO:0043687) |
0.0 | 0.0 | GO:0043406 | positive regulation of MAP kinase activity(GO:0043406) |
0.0 | 0.0 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.0 | 0.0 | GO:0071496 | cellular response to external stimulus(GO:0071496) |
0.0 | 0.0 | GO:0034339 | obsolete regulation of transcription from RNA polymerase II promoter by nuclear hormone receptor(GO:0034339) |
0.0 | 0.0 | GO:0030279 | negative regulation of ossification(GO:0030279) |
0.0 | 0.1 | GO:0051925 | obsolete regulation of calcium ion transport via voltage-gated calcium channel activity(GO:0051925) |
0.0 | 0.0 | GO:0002467 | germinal center formation(GO:0002467) |
0.0 | 0.1 | GO:0042476 | odontogenesis(GO:0042476) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.7 | 2.7 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
0.7 | 2.0 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.6 | 0.6 | GO:0061202 | clathrin-sculpted gamma-aminobutyric acid transport vesicle(GO:0061200) clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane(GO:0061202) |
0.6 | 2.4 | GO:0034992 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.6 | 1.7 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.5 | 1.5 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.5 | 1.5 | GO:0070062 | extracellular exosome(GO:0070062) extracellular vesicle(GO:1903561) |
0.5 | 1.4 | GO:0005594 | collagen type IX trimer(GO:0005594) |
0.5 | 1.4 | GO:0072487 | MSL complex(GO:0072487) |
0.5 | 1.4 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.5 | 0.5 | GO:0070938 | contractile ring(GO:0070938) |
0.4 | 2.1 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.4 | 2.1 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
0.4 | 2.1 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.4 | 1.6 | GO:0032059 | bleb(GO:0032059) |
0.4 | 2.8 | GO:0031095 | platelet dense tubular network membrane(GO:0031095) |
0.4 | 1.6 | GO:0070820 | tertiary granule(GO:0070820) |
0.4 | 3.1 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.4 | 3.1 | GO:0042598 | obsolete vesicular fraction(GO:0042598) |
0.4 | 5.0 | GO:0031528 | microvillus membrane(GO:0031528) |
0.4 | 2.6 | GO:0031143 | pseudopodium(GO:0031143) |
0.4 | 0.4 | GO:0001950 | obsolete plasma membrane enriched fraction(GO:0001950) |
0.4 | 1.1 | GO:0030008 | TRAPP complex(GO:0030008) |
0.4 | 1.1 | GO:0071818 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.4 | 4.1 | GO:0005583 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.4 | 1.5 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.4 | 4.3 | GO:0071565 | nBAF complex(GO:0071565) |
0.4 | 2.8 | GO:0016580 | Sin3 complex(GO:0016580) Sin3-type complex(GO:0070822) |
0.3 | 0.7 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.3 | 1.3 | GO:0043218 | compact myelin(GO:0043218) |
0.3 | 1.0 | GO:0005626 | obsolete insoluble fraction(GO:0005626) |
0.3 | 1.7 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
0.3 | 3.6 | GO:0044291 | intercalated disc(GO:0014704) cell-cell contact zone(GO:0044291) |
0.3 | 1.0 | GO:0031933 | telomeric heterochromatin(GO:0031933) |
0.3 | 0.6 | GO:0042581 | specific granule(GO:0042581) |
0.3 | 1.6 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.3 | 1.2 | GO:0005827 | polar microtubule(GO:0005827) |
0.3 | 0.9 | GO:0033270 | paranode region of axon(GO:0033270) |
0.3 | 0.8 | GO:0005593 | FACIT collagen trimer(GO:0005593) |
0.3 | 2.5 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.3 | 1.9 | GO:0002102 | podosome(GO:0002102) |
0.3 | 1.3 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
0.3 | 2.4 | GO:0090568 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) nuclear transcriptional repressor complex(GO:0090568) |
0.3 | 4.8 | GO:0031519 | PcG protein complex(GO:0031519) |
0.3 | 0.8 | GO:0030895 | apolipoprotein B mRNA editing enzyme complex(GO:0030895) |
0.3 | 0.8 | GO:0030056 | hemidesmosome(GO:0030056) |
0.3 | 0.8 | GO:0032809 | neuronal cell body membrane(GO:0032809) cell body membrane(GO:0044298) |
0.3 | 0.8 | GO:0005639 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) nuclear membrane part(GO:0044453) |
0.3 | 1.3 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.3 | 1.0 | GO:0005667 | transcription factor complex(GO:0005667) |
0.3 | 2.5 | GO:0090533 | cation-transporting ATPase complex(GO:0090533) |
0.2 | 5.2 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.2 | 1.0 | GO:0005915 | zonula adherens(GO:0005915) |
0.2 | 3.7 | GO:0030139 | endocytic vesicle(GO:0030139) |
0.2 | 1.7 | GO:0034451 | centriolar satellite(GO:0034451) |
0.2 | 0.2 | GO:0031094 | platelet dense tubular network(GO:0031094) |
0.2 | 1.0 | GO:0031265 | CD95 death-inducing signaling complex(GO:0031265) |
0.2 | 1.2 | GO:0070775 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.2 | 1.4 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.2 | 3.1 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
0.2 | 0.9 | GO:0042405 | nuclear inclusion body(GO:0042405) |
0.2 | 0.2 | GO:0043083 | synaptic cleft(GO:0043083) |
0.2 | 0.7 | GO:0032444 | activin responsive factor complex(GO:0032444) |
0.2 | 1.8 | GO:0005861 | troponin complex(GO:0005861) |
0.2 | 1.8 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
0.2 | 0.9 | GO:0031988 | membrane-bounded vesicle(GO:0031988) |
0.2 | 0.9 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.2 | 0.7 | GO:0031083 | BLOC complex(GO:0031082) BLOC-1 complex(GO:0031083) |
0.2 | 0.7 | GO:0071986 | Ragulator complex(GO:0071986) |
0.2 | 1.1 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.2 | 1.8 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
0.2 | 0.7 | GO:0032009 | early phagosome(GO:0032009) |
0.2 | 0.9 | GO:0035189 | Rb-E2F complex(GO:0035189) |
0.2 | 1.9 | GO:0042555 | MCM complex(GO:0042555) |
0.2 | 0.8 | GO:0000145 | exocyst(GO:0000145) |
0.2 | 0.8 | GO:0005954 | calcium- and calmodulin-dependent protein kinase complex(GO:0005954) |
0.2 | 0.8 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.2 | 1.0 | GO:0001725 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
0.2 | 2.9 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.2 | 4.3 | GO:0000784 | nuclear chromosome, telomeric region(GO:0000784) |
0.2 | 11.8 | GO:0030496 | midbody(GO:0030496) |
0.2 | 0.2 | GO:0043596 | nuclear replication fork(GO:0043596) |
0.2 | 3.2 | GO:0000299 | obsolete integral to membrane of membrane fraction(GO:0000299) |
0.2 | 0.6 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
0.2 | 3.4 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.2 | 0.6 | GO:0033185 | mannosyltransferase complex(GO:0031501) dolichol-phosphate-mannose synthase complex(GO:0033185) |
0.2 | 1.2 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
0.2 | 1.0 | GO:0032589 | neuron projection membrane(GO:0032589) |
0.2 | 0.4 | GO:0030425 | dendrite(GO:0030425) |
0.2 | 0.2 | GO:0044433 | cytoplasmic vesicle part(GO:0044433) |
0.2 | 4.1 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.2 | 0.4 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.2 | 1.2 | GO:0099738 | cell cortex region(GO:0099738) |
0.2 | 0.4 | GO:0005900 | oncostatin-M receptor complex(GO:0005900) |
0.2 | 0.6 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.2 | 0.4 | GO:0000306 | extrinsic component of vacuolar membrane(GO:0000306) extrinsic component of endosome membrane(GO:0031313) |
0.2 | 1.3 | GO:0034518 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.2 | 0.7 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.2 | 3.7 | GO:0005637 | nuclear inner membrane(GO:0005637) |
0.2 | 3.9 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.2 | 0.6 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.2 | 0.9 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.2 | 1.3 | GO:0008274 | gamma-tubulin large complex(GO:0000931) gamma-tubulin ring complex(GO:0008274) |
0.2 | 0.7 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
0.2 | 0.7 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.2 | 0.2 | GO:0005694 | chromosome(GO:0005694) |
0.2 | 2.3 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.2 | 1.2 | GO:0030118 | clathrin coat(GO:0030118) |
0.2 | 0.2 | GO:0000800 | lateral element(GO:0000800) |
0.2 | 2.6 | GO:0000178 | exosome (RNase complex)(GO:0000178) |
0.2 | 0.5 | GO:0070688 | MLL5-L complex(GO:0070688) |
0.2 | 0.2 | GO:0032432 | actin filament bundle(GO:0032432) |
0.2 | 1.7 | GO:0032154 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
0.2 | 13.7 | GO:0048770 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.2 | 1.5 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.2 | 2.8 | GO:0030530 | obsolete heterogeneous nuclear ribonucleoprotein complex(GO:0030530) |
0.2 | 1.8 | GO:0043204 | perikaryon(GO:0043204) |
0.2 | 0.7 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
0.2 | 1.8 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.2 | 9.5 | GO:0030426 | growth cone(GO:0030426) |
0.2 | 4.1 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
0.2 | 0.5 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.2 | 0.6 | GO:0070552 | BRISC complex(GO:0070552) |
0.2 | 2.7 | GO:0030057 | desmosome(GO:0030057) |
0.2 | 0.2 | GO:0034464 | BBSome(GO:0034464) |
0.2 | 1.1 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.2 | 1.3 | GO:0070652 | HAUS complex(GO:0070652) |
0.2 | 0.5 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
0.2 | 0.3 | GO:0000778 | condensed nuclear chromosome kinetochore(GO:0000778) |
0.2 | 1.1 | GO:1904949 | ATPase dependent transmembrane transport complex(GO:0098533) ATPase complex(GO:1904949) |
0.2 | 2.0 | GO:0005779 | integral component of peroxisomal membrane(GO:0005779) intrinsic component of peroxisomal membrane(GO:0031231) |
0.2 | 0.6 | GO:0032993 | protein-DNA complex(GO:0032993) |
0.2 | 14.3 | GO:0005765 | lysosomal membrane(GO:0005765) lytic vacuole membrane(GO:0098852) |
0.2 | 1.1 | GO:0090576 | RNA polymerase III transcription factor complex(GO:0090576) |
0.2 | 1.1 | GO:0031010 | ISWI-type complex(GO:0031010) |
0.2 | 1.4 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.1 | 0.9 | GO:0032279 | asymmetric synapse(GO:0032279) neuron to neuron synapse(GO:0098984) |
0.1 | 4.6 | GO:0016592 | mediator complex(GO:0016592) |
0.1 | 0.1 | GO:0031252 | cell leading edge(GO:0031252) |
0.1 | 0.1 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
0.1 | 0.6 | GO:0031307 | integral component of mitochondrial outer membrane(GO:0031307) |
0.1 | 5.7 | GO:0000922 | spindle pole(GO:0000922) |
0.1 | 0.4 | GO:0031262 | Ndc80 complex(GO:0031262) |
0.1 | 2.4 | GO:0005762 | organellar large ribosomal subunit(GO:0000315) mitochondrial large ribosomal subunit(GO:0005762) |
0.1 | 2.4 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.1 | 1.3 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.1 | 0.7 | GO:0030897 | HOPS complex(GO:0030897) |
0.1 | 1.0 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
0.1 | 2.6 | GO:0030175 | filopodium(GO:0030175) |
0.1 | 0.4 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.1 | 0.8 | GO:0000242 | pericentriolar material(GO:0000242) |
0.1 | 0.1 | GO:0005927 | muscle tendon junction(GO:0005927) |
0.1 | 0.1 | GO:0030870 | Mre11 complex(GO:0030870) |
0.1 | 0.1 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.1 | 0.7 | GO:0005750 | mitochondrial respiratory chain complex III(GO:0005750) respiratory chain complex III(GO:0045275) |
0.1 | 0.1 | GO:1902555 | endoribonuclease complex(GO:1902555) |
0.1 | 2.9 | GO:0055037 | recycling endosome(GO:0055037) |
0.1 | 1.6 | GO:0032039 | integrator complex(GO:0032039) |
0.1 | 0.7 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.1 | 0.4 | GO:0032591 | dendritic spine membrane(GO:0032591) |
0.1 | 2.5 | GO:0005776 | autophagosome(GO:0005776) |
0.1 | 0.5 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.1 | 2.3 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.1 | 0.5 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
0.1 | 0.3 | GO:0045323 | interleukin-1 receptor complex(GO:0045323) |
0.1 | 0.9 | GO:0001891 | phagocytic cup(GO:0001891) |
0.1 | 5.7 | GO:0031901 | early endosome membrane(GO:0031901) |
0.1 | 1.5 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
0.1 | 1.9 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
0.1 | 2.8 | GO:0031902 | late endosome membrane(GO:0031902) |
0.1 | 0.5 | GO:0017059 | palmitoyltransferase complex(GO:0002178) serine C-palmitoyltransferase complex(GO:0017059) endoplasmic reticulum palmitoyltransferase complex(GO:0031211) |
0.1 | 11.0 | GO:0005741 | mitochondrial outer membrane(GO:0005741) |
0.1 | 1.8 | GO:0030658 | transport vesicle membrane(GO:0030658) |
0.1 | 3.9 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.1 | 0.5 | GO:0000780 | condensed nuclear chromosome, centromeric region(GO:0000780) |
0.1 | 8.3 | GO:0005769 | early endosome(GO:0005769) |
0.1 | 0.1 | GO:0000152 | nuclear ubiquitin ligase complex(GO:0000152) |
0.1 | 0.4 | GO:0001940 | male pronucleus(GO:0001940) |
0.1 | 0.4 | GO:0005719 | nuclear euchromatin(GO:0005719) |
0.1 | 0.6 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
0.1 | 0.7 | GO:0030992 | intraciliary transport particle(GO:0030990) intraciliary transport particle B(GO:0030992) |
0.1 | 2.2 | GO:0001669 | acrosomal vesicle(GO:0001669) |
0.1 | 0.2 | GO:0042382 | paraspeckles(GO:0042382) |
0.1 | 0.2 | GO:0042629 | mast cell granule(GO:0042629) |
0.1 | 2.0 | GO:0005768 | endosome(GO:0005768) |
0.1 | 0.8 | GO:0030681 | nucleolar ribonuclease P complex(GO:0005655) ribonuclease P complex(GO:0030677) multimeric ribonuclease P complex(GO:0030681) |
0.1 | 1.5 | GO:0005811 | lipid particle(GO:0005811) |
0.1 | 1.0 | GO:0030315 | T-tubule(GO:0030315) |
0.1 | 2.5 | GO:0030141 | secretory granule(GO:0030141) |
0.1 | 0.6 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.1 | 0.8 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.1 | 0.6 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
0.1 | 5.6 | GO:0005777 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.1 | 1.4 | GO:0031594 | neuromuscular junction(GO:0031594) |
0.1 | 1.6 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.1 | 2.1 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
0.1 | 0.1 | GO:0005839 | proteasome core complex(GO:0005839) |
0.1 | 1.3 | GO:0030136 | clathrin-coated vesicle(GO:0030136) |
0.1 | 0.1 | GO:0071778 | obsolete WINAC complex(GO:0071778) |
0.1 | 0.5 | GO:0030893 | meiotic cohesin complex(GO:0030893) |
0.1 | 9.0 | GO:0012506 | vesicle membrane(GO:0012506) |
0.1 | 0.6 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.1 | 0.3 | GO:0042587 | glycogen granule(GO:0042587) |
0.1 | 0.2 | GO:0045121 | membrane raft(GO:0045121) membrane microdomain(GO:0098857) |
0.1 | 1.1 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.1 | 0.8 | GO:0032592 | integral component of mitochondrial membrane(GO:0032592) |
0.1 | 0.3 | GO:0000124 | SAGA complex(GO:0000124) |
0.1 | 7.8 | GO:0005774 | vacuolar membrane(GO:0005774) |
0.1 | 0.5 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
0.1 | 0.4 | GO:0036454 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) |
0.1 | 0.3 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.1 | 0.2 | GO:0016600 | flotillin complex(GO:0016600) |
0.1 | 0.3 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.1 | 0.6 | GO:0031234 | extrinsic component of cytoplasmic side of plasma membrane(GO:0031234) |
0.1 | 1.0 | GO:0042588 | zymogen granule(GO:0042588) |
0.1 | 2.2 | GO:0035097 | methyltransferase complex(GO:0034708) histone methyltransferase complex(GO:0035097) |
0.1 | 2.9 | GO:0099501 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
0.1 | 1.7 | GO:0030864 | cortical actin cytoskeleton(GO:0030864) |
0.1 | 0.2 | GO:0002141 | stereocilia coupling link(GO:0002139) stereocilia ankle link(GO:0002141) stereocilia ankle link complex(GO:0002142) |
0.1 | 0.1 | GO:0044215 | host(GO:0018995) host cell part(GO:0033643) host intracellular part(GO:0033646) intracellular region of host(GO:0043656) host cell(GO:0043657) other organism(GO:0044215) other organism cell(GO:0044216) other organism part(GO:0044217) |
0.1 | 0.3 | GO:0042599 | lamellar body(GO:0042599) |
0.1 | 0.1 | GO:0038201 | TORC1 complex(GO:0031931) TOR complex(GO:0038201) |
0.1 | 10.1 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.1 | 1.8 | GO:0031967 | organelle envelope(GO:0031967) |
0.1 | 9.6 | GO:0000785 | chromatin(GO:0000785) |
0.1 | 0.3 | GO:0043209 | myelin sheath(GO:0043209) |
0.1 | 6.3 | GO:0005819 | spindle(GO:0005819) |
0.1 | 0.4 | GO:0016585 | obsolete chromatin remodeling complex(GO:0016585) |
0.1 | 0.4 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
0.1 | 0.2 | GO:0042583 | chromaffin granule(GO:0042583) chromaffin granule membrane(GO:0042584) |
0.1 | 0.1 | GO:0042582 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
0.1 | 2.2 | GO:0005802 | trans-Golgi network(GO:0005802) |
0.1 | 0.4 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
0.1 | 95.6 | GO:0005739 | mitochondrion(GO:0005739) |
0.1 | 5.6 | GO:0019717 | obsolete synaptosome(GO:0019717) |
0.1 | 2.0 | GO:0031526 | brush border membrane(GO:0031526) |
0.1 | 0.6 | GO:0032040 | small-subunit processome(GO:0032040) |
0.1 | 0.4 | GO:0005786 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) signal recognition particle(GO:0048500) |
0.1 | 0.6 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.1 | 0.3 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.1 | 0.6 | GO:0005683 | U7 snRNP(GO:0005683) |
0.1 | 12.2 | GO:0005815 | microtubule organizing center(GO:0005815) |
0.1 | 9.1 | GO:0030424 | axon(GO:0030424) |
0.1 | 1.6 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.1 | 0.8 | GO:0005732 | small nucleolar ribonucleoprotein complex(GO:0005732) |
0.1 | 0.4 | GO:0016234 | inclusion body(GO:0016234) |
0.1 | 2.7 | GO:0016605 | PML body(GO:0016605) |
0.1 | 0.6 | GO:0000346 | transcription export complex(GO:0000346) |
0.1 | 4.1 | GO:0044432 | endoplasmic reticulum part(GO:0044432) |
0.1 | 3.5 | GO:0030176 | integral component of endoplasmic reticulum membrane(GO:0030176) |
0.1 | 2.5 | GO:0031674 | I band(GO:0031674) |
0.1 | 0.2 | GO:0071256 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
0.1 | 5.1 | GO:0005681 | spliceosomal complex(GO:0005681) |
0.1 | 0.8 | GO:0000781 | chromosome, telomeric region(GO:0000781) |
0.1 | 0.6 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
0.1 | 0.3 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.1 | 1.4 | GO:0019861 | obsolete flagellum(GO:0019861) |
0.1 | 0.3 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
0.1 | 0.3 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.1 | 7.3 | GO:0016607 | nuclear speck(GO:0016607) |
0.1 | 0.9 | GO:0005929 | cilium(GO:0005929) |
0.1 | 51.0 | GO:0005730 | nucleolus(GO:0005730) |
0.1 | 2.1 | GO:0031091 | platelet alpha granule(GO:0031091) |
0.1 | 0.1 | GO:0030117 | membrane coat(GO:0030117) coated membrane(GO:0048475) |
0.1 | 3.0 | GO:0016363 | nuclear matrix(GO:0016363) |
0.1 | 28.3 | GO:0031090 | organelle membrane(GO:0031090) |
0.1 | 0.2 | GO:0070531 | BRCA1-A complex(GO:0070531) |
0.1 | 0.5 | GO:0005664 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.1 | 0.2 | GO:0033018 | sarcoplasmic reticulum lumen(GO:0033018) |
0.1 | 3.8 | GO:0005643 | nuclear pore(GO:0005643) |
0.1 | 0.4 | GO:0016272 | prefoldin complex(GO:0016272) |
0.1 | 44.2 | GO:0005794 | Golgi apparatus(GO:0005794) |
0.1 | 4.3 | GO:0031965 | nuclear membrane(GO:0031965) |
0.1 | 26.2 | GO:0005654 | nucleoplasm(GO:0005654) |
0.1 | 4.7 | GO:0000775 | chromosome, centromeric region(GO:0000775) |
0.1 | 3.2 | GO:0043296 | apical junction complex(GO:0043296) |
0.1 | 186.5 | GO:0005634 | nucleus(GO:0005634) |
0.1 | 0.3 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.1 | 0.2 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
0.1 | 0.1 | GO:0030904 | retromer complex(GO:0030904) |
0.1 | 0.1 | GO:0031932 | TORC2 complex(GO:0031932) |
0.1 | 0.4 | GO:0005844 | polysome(GO:0005844) |
0.1 | 0.2 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
0.1 | 2.6 | GO:0098794 | postsynapse(GO:0098794) |
0.1 | 1.0 | GO:0001533 | cornified envelope(GO:0001533) |
0.1 | 0.3 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.1 | 0.4 | GO:0005587 | collagen type IV trimer(GO:0005587) |
0.1 | 4.0 | GO:0005840 | ribosome(GO:0005840) |
0.1 | 0.1 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.1 | 4.8 | GO:0045095 | keratin filament(GO:0045095) |
0.1 | 0.2 | GO:0048179 | activin receptor complex(GO:0048179) |
0.1 | 0.6 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.1 | 1.6 | GO:0000151 | ubiquitin ligase complex(GO:0000151) |
0.1 | 7.8 | GO:0005625 | obsolete soluble fraction(GO:0005625) |
0.1 | 0.3 | GO:0044309 | neuron spine(GO:0044309) |
0.1 | 0.4 | GO:0005614 | interstitial matrix(GO:0005614) |
0.1 | 0.5 | GO:0072372 | primary cilium(GO:0072372) |
0.0 | 0.8 | GO:0005792 | obsolete microsome(GO:0005792) |
0.0 | 3.9 | GO:0005783 | endoplasmic reticulum(GO:0005783) |
0.0 | 0.1 | GO:0070022 | transforming growth factor beta receptor homodimeric complex(GO:0070022) |
0.0 | 2.8 | GO:0005764 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
0.0 | 3.4 | GO:0005882 | intermediate filament(GO:0005882) |
0.0 | 0.1 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
0.0 | 0.6 | GO:0019898 | extrinsic component of membrane(GO:0019898) |
0.0 | 0.0 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.0 | 0.1 | GO:0016469 | proton-transporting two-sector ATPase complex(GO:0016469) |
0.0 | 0.5 | GO:0016010 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
0.0 | 3.2 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.0 | 0.3 | GO:0045177 | apical part of cell(GO:0045177) |
0.0 | 3.1 | GO:0016324 | apical plasma membrane(GO:0016324) |
0.0 | 4.6 | GO:0005886 | plasma membrane(GO:0005886) |
0.0 | 0.0 | GO:0005771 | multivesicular body(GO:0005771) |
0.0 | 0.2 | GO:0001527 | microfibril(GO:0001527) |
0.0 | 21.9 | GO:0005829 | cytosol(GO:0005829) |
0.0 | 44.6 | GO:0044424 | intracellular part(GO:0044424) |
0.0 | 0.1 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
0.0 | 4.2 | GO:0005624 | obsolete membrane fraction(GO:0005624) |
0.0 | 0.1 | GO:0005902 | microvillus(GO:0005902) |
0.0 | 77.7 | GO:0016021 | integral component of membrane(GO:0016021) |
0.0 | 5.9 | GO:0005622 | intracellular(GO:0005622) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.3 | 3.8 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
0.8 | 2.4 | GO:0016842 | amidine-lyase activity(GO:0016842) |
0.8 | 2.3 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) |
0.8 | 0.8 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
0.8 | 3.0 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.7 | 3.0 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.7 | 2.9 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
0.7 | 2.1 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.7 | 2.1 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.7 | 2.0 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
0.7 | 4.0 | GO:0016165 | linoleate 13S-lipoxygenase activity(GO:0016165) |
0.7 | 3.3 | GO:0016717 | oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water(GO:0016717) |
0.6 | 3.8 | GO:0016290 | palmitoyl-CoA hydrolase activity(GO:0016290) |
0.6 | 2.5 | GO:0031014 | troponin T binding(GO:0031014) |
0.6 | 0.6 | GO:0045159 | myosin II binding(GO:0045159) |
0.6 | 1.8 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
0.6 | 3.6 | GO:0051400 | BH domain binding(GO:0051400) |
0.6 | 6.2 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.6 | 2.2 | GO:0055103 | ligase regulator activity(GO:0055103) ubiquitin-protein transferase regulator activity(GO:0055106) |
0.6 | 1.7 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.6 | 1.7 | GO:0050698 | proteoglycan sulfotransferase activity(GO:0050698) |
0.5 | 3.2 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.5 | 1.6 | GO:0050693 | LBD domain binding(GO:0050693) |
0.5 | 2.1 | GO:0004645 | phosphorylase activity(GO:0004645) |
0.5 | 1.6 | GO:0070735 | protein-glycine ligase activity(GO:0070735) |
0.5 | 4.7 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.5 | 5.7 | GO:0043548 | phosphatidylinositol 3-kinase binding(GO:0043548) |
0.5 | 1.5 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
0.5 | 1.5 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
0.5 | 2.6 | GO:0015355 | secondary active monocarboxylate transmembrane transporter activity(GO:0015355) |
0.5 | 1.5 | GO:0030881 | beta-2-microglobulin binding(GO:0030881) |
0.5 | 1.0 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.5 | 3.6 | GO:0017166 | vinculin binding(GO:0017166) |
0.5 | 1.5 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.5 | 2.0 | GO:0030911 | TPR domain binding(GO:0030911) |
0.5 | 1.0 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
0.5 | 2.0 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
0.5 | 1.5 | GO:0015137 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
0.5 | 3.4 | GO:0008469 | histone-arginine N-methyltransferase activity(GO:0008469) |
0.5 | 1.4 | GO:0004466 | long-chain-acyl-CoA dehydrogenase activity(GO:0004466) |
0.5 | 1.4 | GO:0071208 | histone pre-mRNA DCP binding(GO:0071208) |
0.4 | 2.7 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.4 | 1.8 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
0.4 | 1.3 | GO:0015254 | glycerol channel activity(GO:0015254) |
0.4 | 1.8 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
0.4 | 0.9 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.4 | 1.7 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.4 | 2.6 | GO:0005521 | lamin binding(GO:0005521) |
0.4 | 0.4 | GO:0005017 | platelet-derived growth factor-activated receptor activity(GO:0005017) |
0.4 | 0.4 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.4 | 0.4 | GO:0016453 | C-acetyltransferase activity(GO:0016453) |
0.4 | 3.3 | GO:0030371 | translation repressor activity(GO:0030371) |
0.4 | 1.6 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.4 | 4.1 | GO:0030276 | clathrin binding(GO:0030276) |
0.4 | 1.6 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
0.4 | 1.2 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.4 | 0.8 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.4 | 3.2 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.4 | 2.0 | GO:0004904 | interferon receptor activity(GO:0004904) |
0.4 | 0.4 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) ubiquitin-like protein conjugating enzyme binding(GO:0044390) |
0.4 | 1.2 | GO:0046848 | hydroxyapatite binding(GO:0046848) |
0.4 | 1.2 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
0.4 | 1.9 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
0.4 | 3.1 | GO:0003785 | actin monomer binding(GO:0003785) |
0.4 | 2.3 | GO:0030020 | extracellular matrix structural constituent conferring tensile strength(GO:0030020) |
0.4 | 1.9 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
0.4 | 1.5 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.4 | 0.4 | GO:0019211 | phosphatase activator activity(GO:0019211) |
0.4 | 1.1 | GO:0030151 | molybdenum ion binding(GO:0030151) |
0.4 | 2.3 | GO:0019789 | SUMO transferase activity(GO:0019789) |
0.4 | 1.9 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.4 | 1.5 | GO:0005148 | prolactin receptor binding(GO:0005148) |
0.4 | 1.1 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.4 | 1.1 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
0.4 | 1.1 | GO:0035184 | histone threonine kinase activity(GO:0035184) |
0.4 | 1.1 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
0.4 | 5.1 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.4 | 1.1 | GO:0001159 | RNA polymerase II core promoter proximal region sequence-specific DNA binding(GO:0000978) core promoter proximal region sequence-specific DNA binding(GO:0000987) core promoter proximal region DNA binding(GO:0001159) |
0.4 | 1.1 | GO:0034187 | obsolete apolipoprotein E binding(GO:0034187) |
0.4 | 1.4 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) |
0.4 | 2.1 | GO:0004415 | hyalurononglucosaminidase activity(GO:0004415) |
0.4 | 1.1 | GO:0070215 | obsolete MDM2 binding(GO:0070215) |
0.4 | 1.1 | GO:0004516 | nicotinate phosphoribosyltransferase activity(GO:0004516) |
0.3 | 1.0 | GO:0070052 | collagen V binding(GO:0070052) |
0.3 | 0.3 | GO:0051880 | G-quadruplex DNA binding(GO:0051880) |
0.3 | 1.4 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
0.3 | 1.4 | GO:0043139 | 5'-3' DNA helicase activity(GO:0043139) |
0.3 | 1.0 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.3 | 1.0 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
0.3 | 1.3 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) |
0.3 | 2.0 | GO:0070402 | NADPH binding(GO:0070402) |
0.3 | 2.3 | GO:1900750 | glutathione binding(GO:0043295) oligopeptide binding(GO:1900750) |
0.3 | 1.3 | GO:0004157 | dihydropyrimidinase activity(GO:0004157) |
0.3 | 2.3 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.3 | 1.0 | GO:0050682 | AF-2 domain binding(GO:0050682) |
0.3 | 1.7 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.3 | 2.0 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
0.3 | 1.0 | GO:0005534 | galactose binding(GO:0005534) |
0.3 | 1.6 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.3 | 1.3 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.3 | 0.6 | GO:0031434 | mitogen-activated protein kinase kinase binding(GO:0031434) |
0.3 | 1.0 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.3 | 1.6 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.3 | 0.3 | GO:0032813 | tumor necrosis factor receptor superfamily binding(GO:0032813) |
0.3 | 1.3 | GO:0003997 | acyl-CoA oxidase activity(GO:0003997) |
0.3 | 1.3 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
0.3 | 1.0 | GO:0003701 | obsolete RNA polymerase I transcription factor activity(GO:0003701) |
0.3 | 1.0 | GO:0043184 | vascular endothelial growth factor receptor 2 binding(GO:0043184) |
0.3 | 5.1 | GO:0003730 | mRNA 3'-UTR binding(GO:0003730) |
0.3 | 2.5 | GO:0005112 | Notch binding(GO:0005112) |
0.3 | 1.9 | GO:0070888 | E-box binding(GO:0070888) |
0.3 | 0.9 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.3 | 0.6 | GO:0004331 | fructose-2,6-bisphosphate 2-phosphatase activity(GO:0004331) |
0.3 | 1.6 | GO:0004972 | NMDA glutamate receptor activity(GO:0004972) |
0.3 | 0.6 | GO:0002054 | nucleobase binding(GO:0002054) purine nucleobase binding(GO:0002060) |
0.3 | 1.2 | GO:0052743 | inositol tetrakisphosphate phosphatase activity(GO:0052743) |
0.3 | 1.8 | GO:0000014 | single-stranded DNA endodeoxyribonuclease activity(GO:0000014) |
0.3 | 0.9 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.3 | 0.3 | GO:0035014 | phosphatidylinositol 3-kinase regulator activity(GO:0035014) |
0.3 | 0.9 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.3 | 0.9 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
0.3 | 1.5 | GO:0001595 | angiotensin receptor activity(GO:0001595) angiotensin type II receptor activity(GO:0004945) |
0.3 | 0.9 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
0.3 | 1.2 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
0.3 | 0.9 | GO:0046965 | retinoid X receptor binding(GO:0046965) |
0.3 | 0.6 | GO:0070643 | vitamin D3 25-hydroxylase activity(GO:0030343) vitamin D 25-hydroxylase activity(GO:0070643) |
0.3 | 1.2 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.3 | 0.6 | GO:0043125 | ErbB-3 class receptor binding(GO:0043125) |
0.3 | 1.2 | GO:0015185 | gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
0.3 | 1.2 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
0.3 | 0.9 | GO:0030375 | thyroid hormone receptor coactivator activity(GO:0030375) |
0.3 | 0.9 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.3 | 1.2 | GO:0022897 | peptide:proton symporter activity(GO:0015333) proton-dependent peptide secondary active transmembrane transporter activity(GO:0022897) |
0.3 | 5.5 | GO:0050699 | WW domain binding(GO:0050699) |
0.3 | 2.6 | GO:0008106 | alcohol dehydrogenase (NADP+) activity(GO:0008106) |
0.3 | 1.2 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.3 | 0.9 | GO:0048039 | ubiquinone binding(GO:0048039) |
0.3 | 0.9 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
0.3 | 0.6 | GO:0042153 | obsolete RPTP-like protein binding(GO:0042153) |
0.3 | 1.7 | GO:0019206 | nucleoside kinase activity(GO:0019206) |
0.3 | 5.3 | GO:0005548 | phospholipid transporter activity(GO:0005548) |
0.3 | 1.1 | GO:0045569 | TRAIL binding(GO:0045569) |
0.3 | 0.8 | GO:0003941 | L-serine ammonia-lyase activity(GO:0003941) |
0.3 | 1.1 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
0.3 | 1.9 | GO:0000339 | RNA cap binding(GO:0000339) |
0.3 | 0.8 | GO:0031127 | galactoside 2-alpha-L-fucosyltransferase activity(GO:0008107) alpha-(1,2)-fucosyltransferase activity(GO:0031127) |
0.3 | 0.8 | GO:0051393 | alpha-actinin binding(GO:0051393) |
0.3 | 1.7 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.3 | 0.8 | GO:0000247 | C-8 sterol isomerase activity(GO:0000247) |
0.3 | 1.4 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.3 | 1.4 | GO:0003706 | obsolete ligand-regulated transcription factor activity(GO:0003706) |
0.3 | 1.1 | GO:0015925 | galactosidase activity(GO:0015925) |
0.3 | 3.8 | GO:0033549 | MAP kinase phosphatase activity(GO:0033549) |
0.3 | 0.8 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
0.3 | 1.6 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
0.3 | 1.1 | GO:0070492 | oligosaccharide binding(GO:0070492) |
0.3 | 0.8 | GO:0016212 | kynurenine-oxoglutarate transaminase activity(GO:0016212) kynurenine aminotransferase activity(GO:0036137) |
0.3 | 0.8 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.3 | 0.8 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.3 | 1.6 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.3 | 2.7 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
0.3 | 0.5 | GO:0042978 | ornithine decarboxylase activator activity(GO:0042978) |
0.3 | 1.1 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.3 | 0.3 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.3 | 1.1 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.3 | 0.8 | GO:0031705 | bombesin receptor binding(GO:0031705) endothelin B receptor binding(GO:0031708) |
0.3 | 2.4 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.3 | 0.3 | GO:0044212 | regulatory region DNA binding(GO:0000975) regulatory region nucleic acid binding(GO:0001067) transcription regulatory region DNA binding(GO:0044212) |
0.3 | 1.3 | GO:0015520 | tetracycline:proton antiporter activity(GO:0015520) |
0.3 | 1.6 | GO:0050700 | CARD domain binding(GO:0050700) |
0.3 | 0.3 | GO:0048156 | tau protein binding(GO:0048156) |
0.3 | 0.8 | GO:0004879 | RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding(GO:0004879) transcription factor activity, direct ligand regulated sequence-specific DNA binding(GO:0098531) |
0.3 | 3.1 | GO:0001619 | obsolete lysosphingolipid and lysophosphatidic acid receptor activity(GO:0001619) |
0.3 | 3.3 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.3 | 3.1 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.3 | 1.3 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.3 | 0.8 | GO:0004828 | serine-tRNA ligase activity(GO:0004828) |
0.2 | 0.5 | GO:0032451 | demethylase activity(GO:0032451) |
0.2 | 2.5 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
0.2 | 2.5 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.2 | 2.5 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.2 | 1.0 | GO:0004340 | glucokinase activity(GO:0004340) |
0.2 | 1.2 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
0.2 | 0.5 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
0.2 | 3.2 | GO:0032393 | MHC class I receptor activity(GO:0032393) |
0.2 | 0.2 | GO:0030332 | cyclin binding(GO:0030332) |
0.2 | 0.7 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
0.2 | 0.7 | GO:0070996 | type 1 melanocortin receptor binding(GO:0070996) |
0.2 | 3.3 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.2 | 0.7 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
0.2 | 1.4 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
0.2 | 1.2 | GO:0017081 | chloride channel regulator activity(GO:0017081) |
0.2 | 4.5 | GO:0051117 | ATPase binding(GO:0051117) |
0.2 | 0.9 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.2 | 2.3 | GO:0008199 | ferric iron binding(GO:0008199) |
0.2 | 2.6 | GO:0030553 | cGMP binding(GO:0030553) |
0.2 | 0.7 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.2 | 0.9 | GO:0071553 | uridine nucleotide receptor activity(GO:0015065) G-protein coupled pyrimidinergic nucleotide receptor activity(GO:0071553) |
0.2 | 0.7 | GO:0070576 | vitamin D 24-hydroxylase activity(GO:0070576) |
0.2 | 0.7 | GO:0008061 | chitin binding(GO:0008061) |
0.2 | 0.5 | GO:0004075 | biotin carboxylase activity(GO:0004075) |
0.2 | 0.5 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.2 | 1.1 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.2 | 0.7 | GO:0008900 | hydrogen:potassium-exchanging ATPase activity(GO:0008900) |
0.2 | 0.2 | GO:0031491 | nucleosome binding(GO:0031491) |
0.2 | 0.7 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.2 | 3.3 | GO:0008656 | cysteine-type endopeptidase activator activity involved in apoptotic process(GO:0008656) |
0.2 | 2.2 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.2 | 4.7 | GO:0017046 | peptide hormone binding(GO:0017046) |
0.2 | 2.7 | GO:0016504 | peptidase activator activity(GO:0016504) |
0.2 | 1.5 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.2 | 0.9 | GO:0044548 | S100 protein binding(GO:0044548) |
0.2 | 1.5 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
0.2 | 2.2 | GO:0015924 | mannosyl-oligosaccharide mannosidase activity(GO:0015924) |
0.2 | 0.7 | GO:0050815 | phosphoserine binding(GO:0050815) |
0.2 | 0.4 | GO:0042806 | fucose binding(GO:0042806) |
0.2 | 1.1 | GO:0005338 | nucleotide-sugar transmembrane transporter activity(GO:0005338) |
0.2 | 1.1 | GO:0019238 | cyclohydrolase activity(GO:0019238) |
0.2 | 1.3 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.2 | 1.1 | GO:0016019 | peptidoglycan receptor activity(GO:0016019) |
0.2 | 2.8 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.2 | 0.6 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.2 | 1.7 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.2 | 0.2 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
0.2 | 0.6 | GO:0019237 | centromeric DNA binding(GO:0019237) |
0.2 | 0.4 | GO:0003680 | AT DNA binding(GO:0003680) |
0.2 | 0.4 | GO:0050664 | superoxide-generating NADPH oxidase activity(GO:0016175) oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor(GO:0050664) |
0.2 | 2.3 | GO:0035064 | methylated histone binding(GO:0035064) |
0.2 | 2.1 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.2 | 1.3 | GO:0070008 | serine-type exopeptidase activity(GO:0070008) |
0.2 | 2.5 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.2 | 6.6 | GO:0004860 | protein kinase inhibitor activity(GO:0004860) |
0.2 | 0.6 | GO:0000977 | RNA polymerase II regulatory region sequence-specific DNA binding(GO:0000977) RNA polymerase II regulatory region DNA binding(GO:0001012) |
0.2 | 1.0 | GO:0008028 | monocarboxylic acid transmembrane transporter activity(GO:0008028) |
0.2 | 0.6 | GO:0019863 | IgE binding(GO:0019863) |
0.2 | 1.4 | GO:0050786 | RAGE receptor binding(GO:0050786) |
0.2 | 0.6 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.2 | 1.0 | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) |
0.2 | 0.6 | GO:0034711 | inhibin binding(GO:0034711) |
0.2 | 1.0 | GO:0034452 | dynactin binding(GO:0034452) |
0.2 | 0.8 | GO:0051731 | polynucleotide 5'-hydroxyl-kinase activity(GO:0051731) |
0.2 | 0.6 | GO:0098847 | single-stranded telomeric DNA binding(GO:0043047) sequence-specific single stranded DNA binding(GO:0098847) |
0.2 | 0.6 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.2 | 1.2 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
0.2 | 5.5 | GO:0097472 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) cyclin-dependent protein kinase activity(GO:0097472) |
0.2 | 0.8 | GO:0015421 | oligopeptide-transporting ATPase activity(GO:0015421) |
0.2 | 1.0 | GO:0004568 | chitinase activity(GO:0004568) |
0.2 | 0.8 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.2 | 0.4 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
0.2 | 1.4 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
0.2 | 0.4 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.2 | 0.6 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.2 | 2.6 | GO:0005035 | death receptor activity(GO:0005035) |
0.2 | 3.2 | GO:0015464 | acetylcholine receptor activity(GO:0015464) |
0.2 | 0.6 | GO:0005152 | interleukin-1 receptor antagonist activity(GO:0005152) |
0.2 | 0.4 | GO:0019210 | kinase inhibitor activity(GO:0019210) |
0.2 | 0.6 | GO:0008934 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate phosphatase activity(GO:0052834) |
0.2 | 1.2 | GO:0009922 | fatty acid elongase activity(GO:0009922) |
0.2 | 1.0 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
0.2 | 12.5 | GO:0008017 | microtubule binding(GO:0008017) |
0.2 | 0.2 | GO:0051192 | ACP phosphopantetheine attachment site binding involved in fatty acid biosynthetic process(GO:0000036) ACP phosphopantetheine attachment site binding(GO:0044620) prosthetic group binding(GO:0051192) |
0.2 | 1.0 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
0.2 | 0.4 | GO:0005113 | patched binding(GO:0005113) |
0.2 | 0.8 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
0.2 | 0.8 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.2 | 0.8 | GO:0008486 | diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) |
0.2 | 1.7 | GO:0008556 | sodium:potassium-exchanging ATPase activity(GO:0005391) potassium-transporting ATPase activity(GO:0008556) |
0.2 | 0.2 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
0.2 | 1.5 | GO:0005402 | sugar:proton symporter activity(GO:0005351) cation:sugar symporter activity(GO:0005402) |
0.2 | 0.6 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.2 | 0.9 | GO:0016417 | S-acyltransferase activity(GO:0016417) |
0.2 | 1.1 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.2 | 0.6 | GO:0004607 | phosphatidylcholine-sterol O-acyltransferase activity(GO:0004607) |
0.2 | 0.4 | GO:0031013 | troponin I binding(GO:0031013) |
0.2 | 1.7 | GO:0005003 | ephrin receptor activity(GO:0005003) |
0.2 | 0.4 | GO:0004977 | melanocortin receptor activity(GO:0004977) |
0.2 | 0.7 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
0.2 | 0.7 | GO:0051427 | hormone receptor binding(GO:0051427) |
0.2 | 0.5 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.2 | 0.9 | GO:0009374 | biotin binding(GO:0009374) |
0.2 | 0.5 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.2 | 0.4 | GO:0042808 | obsolete neuronal Cdc2-like kinase binding(GO:0042808) |
0.2 | 0.4 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.2 | 6.9 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
0.2 | 2.0 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
0.2 | 1.1 | GO:0005123 | death receptor binding(GO:0005123) |
0.2 | 1.4 | GO:0008242 | omega peptidase activity(GO:0008242) |
0.2 | 3.2 | GO:0043028 | cysteine-type endopeptidase regulator activity involved in apoptotic process(GO:0043028) |
0.2 | 0.9 | GO:0031490 | chromatin DNA binding(GO:0031490) |
0.2 | 0.5 | GO:0050544 | arachidonic acid binding(GO:0050544) |
0.2 | 0.5 | GO:0051861 | glycolipid binding(GO:0051861) |
0.2 | 1.2 | GO:0016565 | obsolete general transcriptional repressor activity(GO:0016565) |
0.2 | 1.7 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
0.2 | 0.7 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
0.2 | 0.3 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
0.2 | 4.3 | GO:0004623 | phospholipase A2 activity(GO:0004623) |
0.2 | 4.5 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
0.2 | 0.7 | GO:0004931 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.2 | 1.9 | GO:0004835 | tubulin-tyrosine ligase activity(GO:0004835) |
0.2 | 1.0 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
0.2 | 0.7 | GO:0004301 | epoxide hydrolase activity(GO:0004301) ether hydrolase activity(GO:0016803) |
0.2 | 1.0 | GO:0031432 | titin binding(GO:0031432) |
0.2 | 0.5 | GO:0055077 | gap junction hemi-channel activity(GO:0055077) |
0.2 | 1.5 | GO:0048487 | beta-tubulin binding(GO:0048487) |
0.2 | 1.7 | GO:0008200 | ion channel inhibitor activity(GO:0008200) channel inhibitor activity(GO:0016248) |
0.2 | 0.5 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.2 | 0.5 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.2 | 0.5 | GO:0005294 | neutral L-amino acid secondary active transmembrane transporter activity(GO:0005294) |
0.2 | 1.6 | GO:0042301 | phosphate ion binding(GO:0042301) |
0.2 | 3.3 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.2 | 0.3 | GO:0043398 | HLH domain binding(GO:0043398) |
0.2 | 0.7 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.2 | 1.1 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
0.2 | 0.3 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
0.2 | 0.5 | GO:0004875 | complement receptor activity(GO:0004875) |
0.2 | 0.8 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.2 | 0.2 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.2 | 1.0 | GO:1901505 | carbohydrate derivative transporter activity(GO:1901505) |
0.2 | 0.2 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
0.2 | 0.5 | GO:0016728 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
0.2 | 0.6 | GO:0070513 | death domain binding(GO:0070513) |
0.2 | 1.0 | GO:0008159 | obsolete positive transcription elongation factor activity(GO:0008159) |
0.2 | 4.1 | GO:0008378 | galactosyltransferase activity(GO:0008378) |
0.2 | 0.2 | GO:0035591 | signaling adaptor activity(GO:0035591) |
0.2 | 3.6 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.2 | 0.9 | GO:0005522 | profilin binding(GO:0005522) |
0.2 | 7.4 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.2 | 0.6 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.2 | 2.7 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
0.2 | 0.5 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.2 | 0.8 | GO:0001517 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) |
0.2 | 0.5 | GO:0008241 | peptidyl-dipeptidase activity(GO:0008241) |
0.2 | 1.4 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
0.2 | 0.5 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.2 | 0.8 | GO:0051635 | obsolete bacterial cell surface binding(GO:0051635) |
0.2 | 0.5 | GO:0019959 | C-X-C chemokine binding(GO:0019958) interleukin-8 binding(GO:0019959) |
0.2 | 0.8 | GO:0045309 | protein phosphorylated amino acid binding(GO:0045309) |
0.2 | 0.6 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
0.2 | 0.8 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
0.2 | 0.6 | GO:0003691 | double-stranded telomeric DNA binding(GO:0003691) |
0.2 | 0.9 | GO:0015271 | outward rectifier potassium channel activity(GO:0015271) |
0.2 | 1.4 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.2 | 0.5 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.2 | 3.2 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.2 | 0.9 | GO:0003993 | acid phosphatase activity(GO:0003993) |
0.2 | 3.6 | GO:0010843 | obsolete promoter binding(GO:0010843) |
0.2 | 0.6 | GO:0016004 | phospholipase activator activity(GO:0016004) |
0.2 | 1.7 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.1 | 1.2 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.1 | 0.9 | GO:0032452 | histone demethylase activity(GO:0032452) |
0.1 | 1.0 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.1 | 0.3 | GO:0019956 | chemokine binding(GO:0019956) |
0.1 | 0.6 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.1 | 1.9 | GO:0043621 | protein self-association(GO:0043621) |
0.1 | 0.9 | GO:0030515 | snoRNA binding(GO:0030515) |
0.1 | 0.3 | GO:0042054 | histone methyltransferase activity(GO:0042054) |
0.1 | 0.4 | GO:0004117 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) |
0.1 | 0.4 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.1 | 0.4 | GO:0001671 | ATPase activator activity(GO:0001671) |
0.1 | 6.3 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.1 | 0.6 | GO:0034190 | apolipoprotein receptor binding(GO:0034190) |
0.1 | 0.4 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.1 | 1.3 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.1 | 1.6 | GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) |
0.1 | 0.4 | GO:0000309 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
0.1 | 10.6 | GO:0003704 | obsolete specific RNA polymerase II transcription factor activity(GO:0003704) |
0.1 | 1.7 | GO:0016888 | endodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016888) |
0.1 | 3.4 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.1 | 0.6 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.1 | 1.5 | GO:0000062 | fatty-acyl-CoA binding(GO:0000062) |
0.1 | 1.2 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.1 | 0.8 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
0.1 | 0.3 | GO:0015929 | hexosaminidase activity(GO:0015929) |
0.1 | 0.3 | GO:0000099 | sulfur amino acid transmembrane transporter activity(GO:0000099) L-cystine transmembrane transporter activity(GO:0015184) |
0.1 | 0.8 | GO:0046625 | sphingolipid binding(GO:0046625) |
0.1 | 0.5 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
0.1 | 4.5 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.1 | 0.5 | GO:0004559 | alpha-mannosidase activity(GO:0004559) |
0.1 | 0.7 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.1 | 0.8 | GO:0042393 | histone binding(GO:0042393) |
0.1 | 0.9 | GO:0030506 | ankyrin binding(GO:0030506) |
0.1 | 2.5 | GO:0003690 | double-stranded DNA binding(GO:0003690) |
0.1 | 0.5 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
0.1 | 0.9 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.1 | 1.0 | GO:0004550 | nucleoside diphosphate kinase activity(GO:0004550) |
0.1 | 3.0 | GO:0019843 | rRNA binding(GO:0019843) |
0.1 | 0.5 | GO:0004597 | peptide-aspartate beta-dioxygenase activity(GO:0004597) |
0.1 | 0.1 | GO:0043142 | single-stranded DNA-dependent ATPase activity(GO:0043142) |
0.1 | 0.7 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
0.1 | 6.4 | GO:0008094 | DNA-dependent ATPase activity(GO:0008094) |
0.1 | 3.0 | GO:0002020 | protease binding(GO:0002020) |
0.1 | 0.4 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.1 | 1.2 | GO:0008198 | ferrous iron binding(GO:0008198) |
0.1 | 0.4 | GO:0031544 | procollagen-proline 3-dioxygenase activity(GO:0019797) peptidyl-proline 3-dioxygenase activity(GO:0031544) |
0.1 | 0.4 | GO:0017060 | 3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase activity(GO:0017060) |
0.1 | 3.7 | GO:0042826 | histone deacetylase binding(GO:0042826) |
0.1 | 0.8 | GO:0004457 | lactate dehydrogenase activity(GO:0004457) |
0.1 | 0.6 | GO:0070403 | NAD+ binding(GO:0070403) |
0.1 | 0.1 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.1 | 0.8 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.1 | 1.9 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.1 | 0.3 | GO:0015307 | drug:proton antiporter activity(GO:0015307) |
0.1 | 0.5 | GO:0004470 | malic enzyme activity(GO:0004470) |
0.1 | 7.7 | GO:0019838 | growth factor binding(GO:0019838) |
0.1 | 0.9 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.1 | 1.9 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
0.1 | 1.5 | GO:1990782 | receptor tyrosine kinase binding(GO:0030971) protein tyrosine kinase binding(GO:1990782) |
0.1 | 0.6 | GO:0019894 | kinesin binding(GO:0019894) |
0.1 | 1.5 | GO:0000175 | 3'-5'-exoribonuclease activity(GO:0000175) |
0.1 | 0.6 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.1 | 2.2 | GO:0016566 | obsolete specific transcriptional repressor activity(GO:0016566) |
0.1 | 3.4 | GO:0016278 | lysine N-methyltransferase activity(GO:0016278) protein-lysine N-methyltransferase activity(GO:0016279) |
0.1 | 0.5 | GO:0030618 | transforming growth factor beta receptor, pathway-specific cytoplasmic mediator activity(GO:0030618) |
0.1 | 1.9 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.1 | 0.4 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
0.1 | 1.5 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.1 | 2.0 | GO:0030165 | PDZ domain binding(GO:0030165) |
0.1 | 4.0 | GO:0044822 | mRNA binding(GO:0003729) poly(A) RNA binding(GO:0044822) |
0.1 | 2.0 | GO:0015662 | ATPase activity, coupled to transmembrane movement of ions, phosphorylative mechanism(GO:0015662) |
0.1 | 0.6 | GO:0000832 | inositol hexakisphosphate kinase activity(GO:0000828) inositol hexakisphosphate 5-kinase activity(GO:0000832) |
0.1 | 0.7 | GO:0004022 | alcohol dehydrogenase (NAD) activity(GO:0004022) |
0.1 | 0.4 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
0.1 | 0.2 | GO:0070548 | L-glutamine aminotransferase activity(GO:0070548) |
0.1 | 0.4 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
0.1 | 0.1 | GO:0015923 | mannosidase activity(GO:0015923) |
0.1 | 0.2 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
0.1 | 2.7 | GO:0003727 | single-stranded RNA binding(GO:0003727) |
0.1 | 0.6 | GO:0034593 | phosphatidylinositol bisphosphate phosphatase activity(GO:0034593) |
0.1 | 1.2 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.1 | 12.5 | GO:0003714 | transcription corepressor activity(GO:0003714) |
0.1 | 2.2 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.1 | 0.8 | GO:0030544 | Hsp70 protein binding(GO:0030544) |
0.1 | 1.3 | GO:0008276 | protein methyltransferase activity(GO:0008276) |
0.1 | 0.3 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.1 | 0.9 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.1 | 0.2 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
0.1 | 0.9 | GO:0051537 | 2 iron, 2 sulfur cluster binding(GO:0051537) |
0.1 | 0.3 | GO:0048495 | Roundabout binding(GO:0048495) |
0.1 | 0.5 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.1 | 6.7 | GO:0042277 | peptide binding(GO:0042277) |
0.1 | 1.0 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
0.1 | 2.6 | GO:0003684 | damaged DNA binding(GO:0003684) |
0.1 | 3.8 | GO:0047485 | protein N-terminus binding(GO:0047485) |
0.1 | 0.1 | GO:0098518 | polynucleotide phosphatase activity(GO:0098518) |
0.1 | 1.9 | GO:0030145 | manganese ion binding(GO:0030145) |
0.1 | 2.6 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.1 | 2.0 | GO:0051287 | NAD binding(GO:0051287) |
0.1 | 0.8 | GO:0008121 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors(GO:0016679) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
0.1 | 0.1 | GO:0005345 | purine nucleobase transmembrane transporter activity(GO:0005345) |
0.1 | 3.9 | GO:0019783 | ubiquitin-like protein-specific protease activity(GO:0019783) |
0.1 | 0.3 | GO:0047623 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.1 | 2.1 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.1 | 0.4 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.1 | 0.5 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.1 | 0.4 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.1 | 0.4 | GO:0008967 | phosphoglycolate phosphatase activity(GO:0008967) |
0.1 | 0.5 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
0.1 | 0.3 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.1 | 0.4 | GO:0016901 | oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
0.1 | 13.4 | GO:0016564 | obsolete transcription repressor activity(GO:0016564) |
0.1 | 0.5 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
0.1 | 0.1 | GO:0046870 | cadmium ion binding(GO:0046870) |
0.1 | 0.5 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
0.1 | 2.4 | GO:0003707 | steroid hormone receptor activity(GO:0003707) |
0.1 | 0.3 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.1 | 0.5 | GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor(GO:0016634) |
0.1 | 0.5 | GO:0016423 | tRNA (guanine) methyltransferase activity(GO:0016423) |
0.1 | 1.0 | GO:0016251 | obsolete general RNA polymerase II transcription factor activity(GO:0016251) |
0.1 | 0.4 | GO:0016933 | extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
0.1 | 0.3 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
0.1 | 0.1 | GO:0008192 | RNA guanylyltransferase activity(GO:0008192) |
0.1 | 1.3 | GO:0004402 | histone acetyltransferase activity(GO:0004402) |
0.1 | 0.2 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
0.1 | 0.3 | GO:0047894 | flavonol 3-sulfotransferase activity(GO:0047894) |
0.1 | 0.3 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.1 | 0.4 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
0.1 | 2.3 | GO:0016879 | ligase activity, forming carbon-nitrogen bonds(GO:0016879) |
0.1 | 0.6 | GO:0043176 | amine binding(GO:0043176) |
0.1 | 2.7 | GO:0004527 | exonuclease activity(GO:0004527) |
0.1 | 0.3 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
0.1 | 0.2 | GO:0060590 | ATPase regulator activity(GO:0060590) |
0.1 | 0.3 | GO:0016972 | thiol oxidase activity(GO:0016972) |
0.1 | 1.5 | GO:0001076 | transcription factor activity, RNA polymerase II transcription factor binding(GO:0001076) |
0.1 | 0.1 | GO:0008545 | JUN kinase kinase activity(GO:0008545) |
0.1 | 10.9 | GO:0016563 | obsolete transcription activator activity(GO:0016563) |
0.1 | 1.6 | GO:0008066 | glutamate receptor activity(GO:0008066) |
0.1 | 0.5 | GO:0016595 | glutamate binding(GO:0016595) |
0.1 | 1.7 | GO:0016620 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor(GO:0016620) |
0.1 | 12.3 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.1 | 0.2 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
0.1 | 0.1 | GO:0008252 | nucleotidase activity(GO:0008252) |
0.1 | 1.5 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.1 | 0.3 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
0.1 | 0.5 | GO:0046920 | alpha-(1->3)-fucosyltransferase activity(GO:0046920) |
0.1 | 0.4 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.1 | 0.1 | GO:0015038 | glutathione disulfide oxidoreductase activity(GO:0015038) |
0.1 | 0.4 | GO:0004583 | dolichyl-phosphate-glucose-glycolipid alpha-glucosyltransferase activity(GO:0004583) |
0.1 | 0.2 | GO:0042156 | obsolete zinc-mediated transcriptional activator activity(GO:0042156) |
0.1 | 0.5 | GO:0010181 | FMN binding(GO:0010181) |
0.1 | 0.7 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.1 | 0.3 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
0.1 | 7.8 | GO:0003702 | obsolete RNA polymerase II transcription factor activity(GO:0003702) |
0.1 | 0.3 | GO:0048185 | activin binding(GO:0048185) |
0.1 | 0.2 | GO:0030197 | extracellular matrix constituent, lubricant activity(GO:0030197) |
0.1 | 0.2 | GO:0016312 | inositol bisphosphate phosphatase activity(GO:0016312) |
0.1 | 1.2 | GO:0005227 | calcium activated cation channel activity(GO:0005227) |
0.1 | 0.3 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
0.1 | 0.2 | GO:0047617 | acyl-CoA hydrolase activity(GO:0047617) |
0.1 | 0.7 | GO:0000030 | mannosyltransferase activity(GO:0000030) |
0.1 | 0.4 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
0.1 | 0.4 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.1 | 0.3 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
0.1 | 0.5 | GO:0004303 | estradiol 17-beta-dehydrogenase activity(GO:0004303) |
0.1 | 17.6 | GO:0043565 | sequence-specific DNA binding(GO:0043565) |
0.1 | 1.2 | GO:0016780 | phosphotransferase activity, for other substituted phosphate groups(GO:0016780) |
0.1 | 3.1 | GO:0034062 | DNA-directed RNA polymerase activity(GO:0003899) RNA polymerase activity(GO:0034062) |
0.1 | 1.1 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.1 | 0.4 | GO:0051721 | protein phosphatase 2A binding(GO:0051721) |
0.1 | 1.0 | GO:0003756 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.1 | 3.1 | GO:0051015 | actin filament binding(GO:0051015) |
0.1 | 0.2 | GO:0030955 | potassium ion binding(GO:0030955) alkali metal ion binding(GO:0031420) |
0.1 | 1.6 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.1 | 14.8 | GO:0004842 | ubiquitin-protein transferase activity(GO:0004842) |
0.1 | 0.4 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.1 | 0.2 | GO:0042608 | T cell receptor binding(GO:0042608) |
0.1 | 0.2 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.1 | 0.7 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.1 | 1.0 | GO:0032182 | ubiquitin-like protein binding(GO:0032182) |
0.1 | 0.3 | GO:0030492 | hemoglobin binding(GO:0030492) |
0.1 | 0.9 | GO:0019200 | carbohydrate kinase activity(GO:0019200) |
0.1 | 0.8 | GO:0051539 | 4 iron, 4 sulfur cluster binding(GO:0051539) |
0.1 | 0.4 | GO:0019787 | ubiquitin-like protein transferase activity(GO:0019787) |
0.1 | 0.1 | GO:0032139 | dinucleotide insertion or deletion binding(GO:0032139) |
0.1 | 0.3 | GO:0005047 | signal recognition particle binding(GO:0005047) |
0.1 | 0.3 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
0.1 | 0.5 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.1 | 3.4 | GO:0031072 | heat shock protein binding(GO:0031072) |
0.1 | 0.3 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.1 | 0.8 | GO:0004467 | long-chain fatty acid-CoA ligase activity(GO:0004467) |
0.1 | 0.2 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.1 | 0.2 | GO:1990837 | sequence-specific double-stranded DNA binding(GO:1990837) |
0.1 | 4.7 | GO:0035091 | phosphatidylinositol binding(GO:0035091) |
0.1 | 0.3 | GO:0051920 | thioredoxin peroxidase activity(GO:0008379) peroxiredoxin activity(GO:0051920) |
0.1 | 0.4 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
0.1 | 0.5 | GO:0017069 | snRNA binding(GO:0017069) |
0.1 | 2.5 | GO:0003954 | NADH dehydrogenase activity(GO:0003954) NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
0.1 | 0.2 | GO:0015932 | nucleobase-containing compound transmembrane transporter activity(GO:0015932) |
0.1 | 1.2 | GO:0032934 | sterol binding(GO:0032934) |
0.1 | 0.2 | GO:0008898 | S-adenosylmethionine-homocysteine S-methyltransferase activity(GO:0008898) |
0.1 | 0.7 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.1 | 101.2 | GO:0008270 | zinc ion binding(GO:0008270) |
0.1 | 0.1 | GO:0004004 | ATP-dependent RNA helicase activity(GO:0004004) |
0.1 | 0.2 | GO:0030172 | troponin C binding(GO:0030172) |
0.1 | 0.1 | GO:0016151 | nickel cation binding(GO:0016151) |
0.1 | 0.3 | GO:0004180 | carboxypeptidase activity(GO:0004180) |
0.1 | 0.2 | GO:0008109 | N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity(GO:0008109) |
0.1 | 0.2 | GO:0033765 | steroid dehydrogenase activity, acting on the CH-CH group of donors(GO:0033765) |
0.1 | 0.6 | GO:0005372 | water transmembrane transporter activity(GO:0005372) |
0.1 | 0.5 | GO:0008430 | selenium binding(GO:0008430) |
0.1 | 3.0 | GO:0051082 | unfolded protein binding(GO:0051082) |
0.1 | 0.8 | GO:0016763 | transferase activity, transferring pentosyl groups(GO:0016763) |
0.1 | 1.5 | GO:0015002 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors(GO:0016675) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.1 | 1.7 | GO:0008376 | acetylgalactosaminyltransferase activity(GO:0008376) |
0.1 | 0.6 | GO:0015301 | anion:anion antiporter activity(GO:0015301) |
0.1 | 0.1 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
0.1 | 0.1 | GO:0061733 | peptide N-acetyltransferase activity(GO:0034212) peptide-lysine-N-acetyltransferase activity(GO:0061733) |
0.1 | 0.4 | GO:0003678 | DNA helicase activity(GO:0003678) |
0.1 | 0.1 | GO:0016832 | aldehyde-lyase activity(GO:0016832) |
0.1 | 0.2 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
0.1 | 0.5 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
0.1 | 0.1 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.1 | 0.3 | GO:0047429 | nucleoside-triphosphate diphosphatase activity(GO:0047429) |
0.1 | 0.3 | GO:0004339 | glucan 1,4-alpha-glucosidase activity(GO:0004339) |
0.1 | 1.2 | GO:0000049 | tRNA binding(GO:0000049) |
0.1 | 0.1 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.1 | 0.8 | GO:0005328 | neurotransmitter:sodium symporter activity(GO:0005328) |
0.1 | 0.2 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
0.1 | 8.2 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.1 | 0.3 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.1 | 0.3 | GO:0015651 | quaternary ammonium group transmembrane transporter activity(GO:0015651) |
0.1 | 0.7 | GO:0016779 | nucleotidyltransferase activity(GO:0016779) |
0.1 | 0.7 | GO:0043021 | ribonucleoprotein complex binding(GO:0043021) |
0.1 | 0.4 | GO:0050733 | RS domain binding(GO:0050733) |
0.1 | 0.4 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
0.1 | 0.3 | GO:0019104 | DNA N-glycosylase activity(GO:0019104) |
0.1 | 0.3 | GO:0043498 | obsolete cell surface binding(GO:0043498) |
0.1 | 0.3 | GO:0016668 | oxidoreductase activity, acting on a sulfur group of donors, NAD(P) as acceptor(GO:0016668) |
0.1 | 0.6 | GO:0008135 | translation factor activity, RNA binding(GO:0008135) |
0.1 | 0.2 | GO:0004815 | aspartate-tRNA ligase activity(GO:0004815) |
0.1 | 0.5 | GO:0003995 | acyl-CoA dehydrogenase activity(GO:0003995) |
0.1 | 0.1 | GO:0042379 | chemokine receptor binding(GO:0042379) |
0.1 | 0.2 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.1 | 0.2 | GO:0070325 | lipoprotein particle receptor binding(GO:0070325) |
0.1 | 16.2 | GO:0019001 | guanyl nucleotide binding(GO:0019001) guanyl ribonucleotide binding(GO:0032561) |
0.1 | 0.5 | GO:0004697 | protein kinase C activity(GO:0004697) |
0.1 | 0.4 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.1 | 0.1 | GO:0045295 | gamma-catenin binding(GO:0045295) |
0.1 | 0.5 | GO:0045296 | cadherin binding(GO:0045296) |
0.1 | 0.2 | GO:0004308 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) |
0.1 | 0.2 | GO:0015248 | sterol transporter activity(GO:0015248) |
0.1 | 0.5 | GO:0004659 | prenyltransferase activity(GO:0004659) |
0.1 | 0.1 | GO:0004803 | transposase activity(GO:0004803) |
0.1 | 0.3 | GO:0016713 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen(GO:0016713) |
0.1 | 0.1 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.1 | 0.2 | GO:0097493 | extracellular matrix constituent conferring elasticity(GO:0030023) structural molecule activity conferring elasticity(GO:0097493) |
0.1 | 0.2 | GO:0016944 | obsolete RNA polymerase II transcription elongation factor activity(GO:0016944) |
0.1 | 0.3 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.1 | 2.1 | GO:0003682 | chromatin binding(GO:0003682) |
0.1 | 0.1 | GO:0030331 | estrogen receptor binding(GO:0030331) |
0.1 | 0.2 | GO:0016628 | oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor(GO:0016628) |
0.1 | 3.0 | GO:0000287 | magnesium ion binding(GO:0000287) |
0.1 | 0.1 | GO:0016531 | metallochaperone activity(GO:0016530) copper chaperone activity(GO:0016531) |
0.1 | 0.4 | GO:0004526 | ribonuclease P activity(GO:0004526) |
0.1 | 0.2 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.1 | 0.6 | GO:0008483 | transaminase activity(GO:0008483) |
0.1 | 0.2 | GO:0099589 | G-protein coupled serotonin receptor activity(GO:0004993) serotonin receptor activity(GO:0099589) |
0.1 | 0.2 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) C-palmitoyltransferase activity(GO:0016454) |
0.1 | 0.2 | GO:0015232 | heme transporter activity(GO:0015232) |
0.1 | 0.8 | GO:0016410 | N-acyltransferase activity(GO:0016410) |
0.1 | 0.1 | GO:0016885 | CoA carboxylase activity(GO:0016421) ligase activity, forming carbon-carbon bonds(GO:0016885) |
0.1 | 0.6 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
0.1 | 2.6 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.1 | 1.0 | GO:0008375 | acetylglucosaminyltransferase activity(GO:0008375) |
0.1 | 2.9 | GO:0004721 | phosphoprotein phosphatase activity(GO:0004721) |
0.1 | 2.0 | GO:0004518 | nuclease activity(GO:0004518) |
0.1 | 0.1 | GO:0031782 | melanocortin receptor binding(GO:0031779) type 3 melanocortin receptor binding(GO:0031781) type 4 melanocortin receptor binding(GO:0031782) |
0.0 | 0.2 | GO:0004046 | aminoacylase activity(GO:0004046) |
0.0 | 2.5 | GO:0015293 | symporter activity(GO:0015293) |
0.0 | 1.3 | GO:0004812 | aminoacyl-tRNA ligase activity(GO:0004812) ligase activity, forming carbon-oxygen bonds(GO:0016875) ligase activity, forming aminoacyl-tRNA and related compounds(GO:0016876) |
0.0 | 7.9 | GO:0005125 | cytokine activity(GO:0005125) |
0.0 | 0.9 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
0.0 | 0.5 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.0 | 0.1 | GO:0042979 | ornithine decarboxylase regulator activity(GO:0042979) |
0.0 | 0.7 | GO:0008527 | taste receptor activity(GO:0008527) |
0.0 | 4.0 | GO:0008168 | methyltransferase activity(GO:0008168) |
0.0 | 1.7 | GO:0016701 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen(GO:0016701) |
0.0 | 0.7 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
0.0 | 13.6 | GO:0003723 | RNA binding(GO:0003723) |
0.0 | 2.0 | GO:0043492 | ATPase activity, coupled to movement of substances(GO:0043492) |
0.0 | 0.4 | GO:0043499 | obsolete eukaryotic cell surface binding(GO:0043499) |
0.0 | 0.1 | GO:0005326 | neurotransmitter transporter activity(GO:0005326) |
0.0 | 0.3 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.0 | 0.0 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
0.0 | 0.8 | GO:0016709 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen(GO:0016709) |
0.0 | 0.0 | GO:0015205 | nucleobase transmembrane transporter activity(GO:0015205) |
0.0 | 0.1 | GO:0015295 | solute:proton symporter activity(GO:0015295) |
0.0 | 8.0 | GO:0060589 | nucleoside-triphosphatase regulator activity(GO:0060589) |
0.0 | 0.6 | GO:0005506 | iron ion binding(GO:0005506) |
0.0 | 0.2 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
0.0 | 0.0 | GO:0070095 | fructose-6-phosphate binding(GO:0070095) |
0.0 | 0.1 | GO:0019534 | toxin transporter activity(GO:0019534) |
0.0 | 0.3 | GO:0008641 | small protein activating enzyme activity(GO:0008641) |
0.0 | 0.8 | GO:0030170 | pyridoxal phosphate binding(GO:0030170) |
0.0 | 0.1 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.0 | 0.1 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
0.0 | 0.2 | GO:0030249 | cyclase regulator activity(GO:0010851) cyclase activator activity(GO:0010853) guanylate cyclase regulator activity(GO:0030249) guanylate cyclase activator activity(GO:0030250) |
0.0 | 0.2 | GO:0001537 | N-acetylgalactosamine 4-O-sulfotransferase activity(GO:0001537) |
0.0 | 0.1 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.0 | 0.1 | GO:0016776 | phosphotransferase activity, phosphate group as acceptor(GO:0016776) |
0.0 | 0.1 | GO:0016503 | pheromone receptor activity(GO:0016503) |
0.0 | 0.9 | GO:0015297 | antiporter activity(GO:0015297) |
0.0 | 0.2 | GO:0003846 | 2-acylglycerol O-acyltransferase activity(GO:0003846) |
0.0 | 0.8 | GO:0008146 | sulfotransferase activity(GO:0008146) |
0.0 | 0.1 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
0.0 | 0.6 | GO:0003755 | peptidyl-prolyl cis-trans isomerase activity(GO:0003755) |
0.0 | 0.1 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
0.0 | 1.8 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.0 | 0.1 | GO:0008113 | peptide-methionine (S)-S-oxide reductase activity(GO:0008113) |
0.0 | 0.5 | GO:0070001 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
0.0 | 0.1 | GO:0003724 | RNA helicase activity(GO:0003724) |
0.0 | 0.3 | GO:0032395 | MHC class II receptor activity(GO:0032395) |
0.0 | 0.1 | GO:0015101 | organic cation transmembrane transporter activity(GO:0015101) |
0.0 | 0.2 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
0.0 | 0.1 | GO:0004013 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.0 | 0.1 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.0 | 0.2 | GO:0016651 | oxidoreductase activity, acting on NAD(P)H(GO:0016651) |
0.0 | 0.1 | GO:0031701 | angiotensin receptor binding(GO:0031701) |
0.0 | 0.1 | GO:0030247 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
0.0 | 0.1 | GO:0047760 | butyrate-CoA ligase activity(GO:0047760) |
0.0 | 2.2 | GO:0005179 | hormone activity(GO:0005179) |
0.0 | 0.1 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.0 | 0.1 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.0 | 0.3 | GO:0004673 | phosphorelay sensor kinase activity(GO:0000155) protein histidine kinase activity(GO:0004673) |
0.0 | 1.8 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.0 | 0.1 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
0.0 | 0.2 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
0.0 | 0.1 | GO:0008308 | voltage-gated anion channel activity(GO:0008308) |
0.0 | 0.0 | GO:0016814 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines(GO:0016814) |
0.0 | 1.4 | GO:0003777 | microtubule motor activity(GO:0003777) |
0.0 | 0.0 | GO:0004630 | phospholipase D activity(GO:0004630) |
0.0 | 0.9 | GO:0016798 | hydrolase activity, acting on glycosyl bonds(GO:0016798) |
0.0 | 0.1 | GO:0051219 | phosphoprotein binding(GO:0051219) |
0.0 | 0.3 | GO:0004890 | GABA-A receptor activity(GO:0004890) |
0.0 | 0.0 | GO:0032190 | acrosin binding(GO:0032190) |
0.0 | 0.0 | GO:0097642 | calcitonin family receptor activity(GO:0097642) |
0.0 | 0.1 | GO:0016854 | racemase and epimerase activity(GO:0016854) |
0.0 | 0.1 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.0 | 0.2 | GO:0005242 | inward rectifier potassium channel activity(GO:0005242) |
0.0 | 0.4 | GO:0004221 | obsolete ubiquitin thiolesterase activity(GO:0004221) |
0.0 | 0.1 | GO:0003709 | obsolete RNA polymerase III transcription factor activity(GO:0003709) |
0.0 | 0.0 | GO:0005497 | androgen binding(GO:0005497) |
0.0 | 0.2 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.0 | 0.2 | GO:0005543 | phospholipid binding(GO:0005543) |
0.0 | 0.0 | GO:0016725 | oxidoreductase activity, acting on CH or CH2 groups(GO:0016725) |
0.0 | 0.0 | GO:0016229 | steroid dehydrogenase activity(GO:0016229) |
0.0 | 0.0 | GO:0035173 | histone kinase activity(GO:0035173) |
0.0 | 0.1 | GO:0050660 | flavin adenine dinucleotide binding(GO:0050660) |
0.0 | 0.0 | GO:0032404 | mismatch repair complex binding(GO:0032404) |
0.0 | 0.0 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
0.0 | 5.7 | GO:0003676 | nucleic acid binding(GO:0003676) |
0.0 | 0.0 | GO:0004576 | oligosaccharyl transferase activity(GO:0004576) |
0.0 | 0.4 | GO:0008234 | cysteine-type peptidase activity(GO:0008234) |
0.0 | 0.0 | GO:0005549 | odorant binding(GO:0005549) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.4 | 2.9 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.6 | 1.3 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.5 | 5.5 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.4 | 3.1 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.4 | 8.3 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.4 | 2.9 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.3 | 1.6 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.3 | 7.2 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
0.3 | 1.0 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.3 | 9.8 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.3 | 5.9 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.3 | 6.5 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.3 | 0.9 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.3 | 2.2 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.3 | 0.8 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.3 | 10.4 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
0.2 | 5.5 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.2 | 2.5 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.2 | 1.5 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
0.2 | 1.4 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.2 | 0.7 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.2 | 9.3 | PID P73PATHWAY | p73 transcription factor network |
0.2 | 5.6 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.2 | 2.4 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.2 | 8.5 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.2 | 4.8 | ST GAQ PATHWAY | G alpha q Pathway |
0.2 | 2.2 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.2 | 0.9 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.2 | 3.9 | PID IFNG PATHWAY | IFN-gamma pathway |
0.2 | 1.3 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.2 | 2.1 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.2 | 0.8 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.2 | 2.5 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.2 | 0.2 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.2 | 4.8 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.2 | 0.8 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
0.2 | 4.9 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.2 | 3.9 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.2 | 6.9 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.2 | 4.0 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.2 | 5.8 | PID FOXO PATHWAY | FoxO family signaling |
0.2 | 4.1 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.2 | 5.5 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.2 | 6.1 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.2 | 1.0 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.2 | 1.1 | PID CDC42 PATHWAY | CDC42 signaling events |
0.2 | 5.5 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.2 | 3.5 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.2 | 6.9 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.2 | 2.5 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.2 | 6.2 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.2 | 3.2 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.2 | 2.1 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.2 | 1.6 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.2 | 3.3 | PID SHP2 PATHWAY | SHP2 signaling |
0.2 | 2.1 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.2 | 4.3 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.2 | 2.0 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
0.2 | 4.2 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.2 | 0.2 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.2 | 0.8 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.2 | 1.8 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.2 | 1.0 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.2 | 2.0 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.2 | 0.8 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.2 | 4.2 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.2 | 1.4 | ST GA13 PATHWAY | G alpha 13 Pathway |
0.2 | 3.8 | PID P53 REGULATION PATHWAY | p53 pathway |
0.1 | 0.1 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.1 | 1.2 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
0.1 | 0.7 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.1 | 0.3 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.1 | 0.4 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.1 | 0.4 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
0.1 | 2.3 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.1 | 1.6 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.1 | 1.6 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.1 | 0.7 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.1 | 4.3 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
0.1 | 0.6 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.1 | 2.6 | PID FGF PATHWAY | FGF signaling pathway |
0.1 | 2.7 | PID ATM PATHWAY | ATM pathway |
0.1 | 0.8 | PID INSULIN PATHWAY | Insulin Pathway |
0.1 | 0.4 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.1 | 0.2 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.1 | 0.6 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
0.1 | 1.0 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.1 | 0.7 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.1 | 0.7 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.1 | 2.0 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.1 | 0.7 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.1 | 0.3 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.1 | 0.8 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.1 | 0.6 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.1 | 2.4 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
0.1 | 0.6 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.1 | 2.7 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.1 | 1.5 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.1 | 2.6 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.1 | 0.5 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.1 | 0.7 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.1 | 0.4 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.1 | 0.3 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.1 | 0.2 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.1 | 0.6 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.1 | 2.9 | PID PLK1 PATHWAY | PLK1 signaling events |
0.1 | 1.5 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.1 | 1.1 | PID ATR PATHWAY | ATR signaling pathway |
0.1 | 0.9 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.1 | 1.0 | PID BARD1 PATHWAY | BARD1 signaling events |
0.1 | 3.2 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
0.1 | 1.1 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.1 | 4.2 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.1 | 0.5 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.1 | 2.4 | PID E2F PATHWAY | E2F transcription factor network |
0.1 | 0.5 | ST ADRENERGIC | Adrenergic Pathway |
0.1 | 0.7 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.1 | 0.8 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.1 | 0.7 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.1 | 0.1 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
0.1 | 2.2 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.1 | 0.5 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.1 | 1.3 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
0.1 | 0.1 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.1 | 1.0 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.1 | 0.9 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.1 | 0.2 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.0 | 0.5 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.0 | 0.4 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.0 | 1.2 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
0.0 | 0.2 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.0 | 1.0 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.0 | 0.3 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.0 | 0.1 | ST INTEGRIN SIGNALING PATHWAY | Integrin Signaling Pathway |
0.0 | 0.8 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.0 | 0.3 | PID AURORA A PATHWAY | Aurora A signaling |
0.0 | 0.8 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.0 | 0.5 | PID NOTCH PATHWAY | Notch signaling pathway |
0.0 | 0.3 | PID RHOA PATHWAY | RhoA signaling pathway |
0.0 | 0.3 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.0 | 0.8 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.0 | 0.5 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.0 | 0.1 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.0 | 0.0 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.0 | 2.8 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.0 | 0.3 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.0 | 0.2 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.0 | 0.0 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.0 | 0.1 | PID AP1 PATHWAY | AP-1 transcription factor network |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.7 | 0.7 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.6 | 0.6 | REACTOME SCF BETA TRCP MEDIATED DEGRADATION OF EMI1 | Genes involved in SCF-beta-TrCP mediated degradation of Emi1 |
0.5 | 0.5 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
0.5 | 0.5 | REACTOME VIF MEDIATED DEGRADATION OF APOBEC3G | Genes involved in Vif-mediated degradation of APOBEC3G |
0.5 | 0.5 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.5 | 0.5 | REACTOME TGF BETA RECEPTOR SIGNALING ACTIVATES SMADS | Genes involved in TGF-beta receptor signaling activates SMADs |
0.4 | 0.4 | REACTOME PI 3K CASCADE | Genes involved in PI-3K cascade |
0.4 | 5.0 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.4 | 2.5 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.4 | 4.4 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
0.4 | 9.2 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.4 | 0.7 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
0.4 | 2.2 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.4 | 4.3 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.4 | 4.9 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.4 | 5.6 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.4 | 2.1 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
0.3 | 1.7 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
0.3 | 0.7 | REACTOME DESTABILIZATION OF MRNA BY KSRP | Genes involved in Destabilization of mRNA by KSRP |
0.3 | 5.3 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
0.3 | 11.2 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.3 | 2.5 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.3 | 3.3 | REACTOME SIGNALING BY ACTIVATED POINT MUTANTS OF FGFR1 | Genes involved in Signaling by activated point mutants of FGFR1 |
0.3 | 0.9 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.3 | 4.8 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.3 | 2.1 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.3 | 3.3 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.3 | 0.3 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.3 | 5.6 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
0.3 | 8.4 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.3 | 2.9 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.3 | 0.9 | REACTOME REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS | Genes involved in Regulation of mRNA Stability by Proteins that Bind AU-rich Elements |
0.3 | 5.4 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |
0.3 | 0.6 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
0.3 | 2.2 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
0.3 | 5.5 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.3 | 8.9 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.3 | 0.5 | REACTOME GASTRIN CREB SIGNALLING PATHWAY VIA PKC AND MAPK | Genes involved in Gastrin-CREB signalling pathway via PKC and MAPK |
0.3 | 3.7 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
0.3 | 0.8 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.3 | 1.0 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
0.3 | 2.8 | REACTOME SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS | Genes involved in SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs |
0.3 | 5.4 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.3 | 2.8 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.3 | 3.3 | REACTOME ADENYLATE CYCLASE INHIBITORY PATHWAY | Genes involved in Adenylate cyclase inhibitory pathway |
0.3 | 2.8 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.2 | 2.5 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.2 | 3.5 | REACTOME VIRAL MESSENGER RNA SYNTHESIS | Genes involved in Viral Messenger RNA Synthesis |
0.2 | 2.6 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.2 | 2.4 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.2 | 1.9 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.2 | 2.1 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
0.2 | 1.2 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.2 | 2.5 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
0.2 | 1.6 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
0.2 | 0.7 | REACTOME INHIBITION OF THE PROTEOLYTIC ACTIVITY OF APC C REQUIRED FOR THE ONSET OF ANAPHASE BY MITOTIC SPINDLE CHECKPOINT COMPONENTS | Genes involved in Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components |
0.2 | 3.3 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
0.2 | 6.9 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |
0.2 | 4.4 | REACTOME IL 3 5 AND GM CSF SIGNALING | Genes involved in Interleukin-3, 5 and GM-CSF signaling |
0.2 | 0.7 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
0.2 | 3.5 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.2 | 1.5 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.2 | 2.8 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.2 | 3.8 | REACTOME BOTULINUM NEUROTOXICITY | Genes involved in Botulinum neurotoxicity |
0.2 | 4.8 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.2 | 3.3 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
0.2 | 0.8 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.2 | 2.0 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.2 | 1.9 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
0.2 | 1.4 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.2 | 1.2 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.2 | 3.5 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.2 | 5.7 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.2 | 1.5 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.2 | 0.2 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
0.2 | 2.1 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.2 | 3.1 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.2 | 2.7 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
0.2 | 0.4 | REACTOME ORC1 REMOVAL FROM CHROMATIN | Genes involved in Orc1 removal from chromatin |
0.2 | 1.5 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
0.2 | 2.0 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.2 | 2.1 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.2 | 0.9 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
0.2 | 1.6 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.2 | 0.3 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
0.2 | 0.7 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.2 | 2.5 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.2 | 0.8 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.2 | 4.4 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.2 | 1.7 | REACTOME ACTIVATION OF GENES BY ATF4 | Genes involved in Activation of Genes by ATF4 |
0.2 | 4.2 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
0.2 | 1.8 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.2 | 0.8 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.2 | 1.1 | REACTOME ELONGATION ARREST AND RECOVERY | Genes involved in Elongation arrest and recovery |
0.2 | 2.2 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
0.2 | 1.9 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
0.2 | 2.3 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
0.2 | 1.7 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.2 | 0.5 | REACTOME TRANSFERRIN ENDOCYTOSIS AND RECYCLING | Genes involved in Transferrin endocytosis and recycling |
0.2 | 0.2 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
0.1 | 2.1 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
0.1 | 1.9 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.1 | 1.3 | REACTOME TRANSCRIPTIONAL ACTIVITY OF SMAD2 SMAD3 SMAD4 HETEROTRIMER | Genes involved in Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer |
0.1 | 0.1 | REACTOME AUTODEGRADATION OF THE E3 UBIQUITIN LIGASE COP1 | Genes involved in Autodegradation of the E3 ubiquitin ligase COP1 |
0.1 | 0.9 | REACTOME ACYL CHAIN REMODELLING OF PE | Genes involved in Acyl chain remodelling of PE |
0.1 | 2.0 | REACTOME FORMATION OF TRANSCRIPTION COUPLED NER TC NER REPAIR COMPLEX | Genes involved in Formation of transcription-coupled NER (TC-NER) repair complex |
0.1 | 1.6 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.1 | 2.1 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.1 | 0.4 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
0.1 | 0.1 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.1 | 0.3 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.1 | 1.9 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.1 | 3.9 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.1 | 1.4 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
0.1 | 3.6 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.1 | 0.5 | REACTOME POST NMDA RECEPTOR ACTIVATION EVENTS | Genes involved in Post NMDA receptor activation events |
0.1 | 1.2 | REACTOME ACTIVATION OF IRF3 IRF7 MEDIATED BY TBK1 IKK EPSILON | Genes involved in Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon |
0.1 | 0.1 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
0.1 | 1.2 | REACTOME RNA POL I TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase I Transcription Termination |
0.1 | 1.2 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
0.1 | 0.8 | REACTOME SIGNALING BY TGF BETA RECEPTOR COMPLEX | Genes involved in Signaling by TGF-beta Receptor Complex |
0.1 | 3.4 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.1 | 3.4 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.1 | 2.1 | REACTOME CHONDROITIN SULFATE DERMATAN SULFATE METABOLISM | Genes involved in Chondroitin sulfate/dermatan sulfate metabolism |
0.1 | 2.9 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.1 | 7.7 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.1 | 0.6 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
0.1 | 0.1 | REACTOME NUCLEAR EVENTS KINASE AND TRANSCRIPTION FACTOR ACTIVATION | Genes involved in Nuclear Events (kinase and transcription factor activation) |
0.1 | 0.7 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
0.1 | 0.1 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
0.1 | 0.6 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
0.1 | 0.7 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.1 | 1.1 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.1 | 30.4 | REACTOME GENERIC TRANSCRIPTION PATHWAY | Genes involved in Generic Transcription Pathway |
0.1 | 1.1 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.1 | 2.5 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.1 | 1.2 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.1 | 1.5 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.1 | 0.5 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
0.1 | 0.1 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.1 | 0.4 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
0.1 | 1.1 | REACTOME REMOVAL OF THE FLAP INTERMEDIATE FROM THE C STRAND | Genes involved in Removal of the Flap Intermediate from the C-strand |
0.1 | 1.6 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.1 | 3.4 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
0.1 | 0.4 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
0.1 | 1.0 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.1 | 1.2 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.1 | 1.7 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.1 | 3.0 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.1 | 4.9 | REACTOME PACKAGING OF TELOMERE ENDS | Genes involved in Packaging Of Telomere Ends |
0.1 | 1.1 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.1 | 0.1 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
0.1 | 1.7 | REACTOME DOUBLE STRAND BREAK REPAIR | Genes involved in Double-Strand Break Repair |
0.1 | 1.6 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
0.1 | 6.6 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.1 | 1.2 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
0.1 | 1.2 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.1 | 0.9 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.1 | 0.2 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
0.1 | 1.4 | REACTOME PREFOLDIN MEDIATED TRANSFER OF SUBSTRATE TO CCT TRIC | Genes involved in Prefoldin mediated transfer of substrate to CCT/TriC |
0.1 | 0.4 | REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
0.1 | 2.7 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.1 | 1.4 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
0.1 | 0.4 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
0.1 | 7.0 | REACTOME RESPIRATORY ELECTRON TRANSPORT ATP SYNTHESIS BY CHEMIOSMOTIC COUPLING AND HEAT PRODUCTION BY UNCOUPLING PROTEINS | Genes involved in Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins. |
0.1 | 2.8 | REACTOME ACTIVATED TLR4 SIGNALLING | Genes involved in Activated TLR4 signalling |
0.1 | 4.4 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
0.1 | 1.0 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.1 | 0.5 | REACTOME PROLONGED ERK ACTIVATION EVENTS | Genes involved in Prolonged ERK activation events |
0.1 | 1.4 | REACTOME INWARDLY RECTIFYING K CHANNELS | Genes involved in Inwardly rectifying K+ channels |
0.1 | 7.1 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
0.1 | 1.5 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.1 | 2.1 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
0.1 | 0.5 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS | Genes involved in Synthesis of bile acids and bile salts |
0.1 | 3.8 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
0.1 | 0.3 | REACTOME ACTIVATION OF KAINATE RECEPTORS UPON GLUTAMATE BINDING | Genes involved in Activation of Kainate Receptors upon glutamate binding |
0.1 | 1.3 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.1 | 1.7 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.1 | 1.2 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.1 | 5.4 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.1 | 10.9 | REACTOME G ALPHA Q SIGNALLING EVENTS | Genes involved in G alpha (q) signalling events |
0.1 | 3.1 | REACTOME HEPARAN SULFATE HEPARIN HS GAG METABOLISM | Genes involved in Heparan sulfate/heparin (HS-GAG) metabolism |
0.1 | 2.5 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.1 | 1.3 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
0.1 | 0.5 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
0.1 | 0.9 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
0.1 | 12.4 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.1 | 1.5 | REACTOME TOLL RECEPTOR CASCADES | Genes involved in Toll Receptor Cascades |
0.1 | 1.2 | REACTOME REGULATION OF IFNA SIGNALING | Genes involved in Regulation of IFNA signaling |
0.1 | 1.5 | REACTOME TRNA AMINOACYLATION | Genes involved in tRNA Aminoacylation |
0.1 | 2.3 | REACTOME PYRUVATE METABOLISM AND CITRIC ACID TCA CYCLE | Genes involved in Pyruvate metabolism and Citric Acid (TCA) cycle |
0.1 | 0.8 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.1 | 2.5 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
0.1 | 1.8 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
0.1 | 0.2 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
0.1 | 0.3 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.1 | 0.9 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.1 | 3.7 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
0.1 | 0.4 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.1 | 4.7 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.1 | 0.7 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.1 | 0.3 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
0.1 | 0.3 | REACTOME CELL JUNCTION ORGANIZATION | Genes involved in Cell junction organization |
0.1 | 0.9 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.1 | 0.4 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.1 | 0.7 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.1 | 1.1 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.1 | 0.6 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
0.1 | 1.2 | REACTOME MITOTIC M M G1 PHASES | Genes involved in Mitotic M-M/G1 phases |
0.1 | 0.9 | REACTOME SIGNALING BY SCF KIT | Genes involved in Signaling by SCF-KIT |
0.1 | 0.4 | REACTOME METABOLISM OF STEROID HORMONES AND VITAMINS A AND D | Genes involved in Metabolism of steroid hormones and vitamins A and D |
0.1 | 0.4 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.1 | 3.1 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.1 | 0.2 | REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
0.1 | 0.2 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.1 | 1.5 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.1 | 2.5 | REACTOME GLYCEROPHOSPHOLIPID BIOSYNTHESIS | Genes involved in Glycerophospholipid biosynthesis |
0.1 | 0.1 | REACTOME MRNA CAPPING | Genes involved in mRNA Capping |
0.1 | 0.3 | REACTOME G2 M CHECKPOINTS | Genes involved in G2/M Checkpoints |
0.1 | 1.0 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.1 | 0.2 | REACTOME ER PHAGOSOME PATHWAY | Genes involved in ER-Phagosome pathway |
0.1 | 0.3 | REACTOME NGF SIGNALLING VIA TRKA FROM THE PLASMA MEMBRANE | Genes involved in NGF signalling via TRKA from the plasma membrane |
0.1 | 0.7 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.1 | 0.4 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.1 | 1.3 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.0 | 0.6 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
0.0 | 0.8 | REACTOME SIGNALING BY NOTCH1 | Genes involved in Signaling by NOTCH1 |
0.0 | 0.5 | REACTOME METABOLISM OF RNA | Genes involved in Metabolism of RNA |
0.0 | 0.2 | REACTOME TELOMERE MAINTENANCE | Genes involved in Telomere Maintenance |
0.0 | 0.1 | REACTOME TCR SIGNALING | Genes involved in TCR signaling |
0.0 | 0.0 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.0 | 0.3 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.0 | 0.4 | REACTOME FRS2 MEDIATED CASCADE | Genes involved in FRS2-mediated cascade |
0.0 | 2.2 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.0 | 1.3 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.0 | 1.6 | REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
0.0 | 0.0 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.0 | 0.6 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.0 | 0.5 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.0 | 2.5 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.0 | 2.1 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.0 | 0.8 | REACTOME ASPARAGINE N LINKED GLYCOSYLATION | Genes involved in Asparagine N-linked glycosylation |
0.0 | 0.4 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.0 | 0.4 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.0 | 0.5 | REACTOME DNA REPAIR | Genes involved in DNA Repair |
0.0 | 0.6 | REACTOME SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | Genes involved in SRP-dependent cotranslational protein targeting to membrane |
0.0 | 0.4 | REACTOME TRANSLATION | Genes involved in Translation |
0.0 | 0.6 | REACTOME LATE PHASE OF HIV LIFE CYCLE | Genes involved in Late Phase of HIV Life Cycle |
0.0 | 0.1 | REACTOME S PHASE | Genes involved in S Phase |
0.0 | 0.2 | REACTOME MICRORNA MIRNA BIOGENESIS | Genes involved in MicroRNA (miRNA) Biogenesis |
0.0 | 1.2 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.0 | 0.1 | REACTOME PRESYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
0.0 | 0.4 | REACTOME PKB MEDIATED EVENTS | Genes involved in PKB-mediated events |
0.0 | 0.0 | REACTOME TRANSPORT OF MATURE MRNA DERIVED FROM AN INTRONLESS TRANSCRIPT | Genes involved in Transport of Mature mRNA Derived from an Intronless Transcript |
0.0 | 0.2 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.0 | 0.3 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.0 | 0.2 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.0 | 3.0 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
0.0 | 0.2 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.0 | 0.2 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.0 | 0.1 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.0 | 0.4 | REACTOME KERATAN SULFATE BIOSYNTHESIS | Genes involved in Keratan sulfate biosynthesis |
0.0 | 0.0 | REACTOME LIPOPROTEIN METABOLISM | Genes involved in Lipoprotein metabolism |
0.0 | 0.3 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.0 | 0.0 | REACTOME CELL DEATH SIGNALLING VIA NRAGE NRIF AND NADE | Genes involved in Cell death signalling via NRAGE, NRIF and NADE |
0.0 | 0.2 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
0.0 | 0.1 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.0 | 0.0 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
0.0 | 0.3 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.0 | 0.2 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |